This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Need for immunization against other single viral diseases
Z21_NEED_IMMUNI_OTH_SINGLE_VIRAL_DISEA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
732 |
4. Check minimum number of eventsNone |
732 |
5. Include endpointsNone |
732 |
6. Filter based on genotype QC (FinnGen only) |
681 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_W_POTEN_HEALTH_HAZARDS_RELATED_COMMUNICAB_DISEA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z2
Similar endpoints
↥List of similar endpoints to
Need for immunization against other single viral diseases
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to communicable diseases
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 681 | 282 | 399 |
| Unadjusted period prevalence (%) | 0.15 | 0.10 | 0.18 |
| Median age at first event (years) | 56.44 | 57.26 | 55.87 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 732
- Matched controls
- 7320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z25.1
ICD-10 Finland
Need for immunization against influenza
338.9
307.7
637
142
WW200
NOMESCO Finland
Immunization
450.7
307.7
583
63
Z3231
NOMESCO Finland
Registered nurse
14.4
272.7
557
1323
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
36.6
248.2
161
56
Z49.1
ICD-10 Finland
Extracorporeal dialysis
47.6
222.7
133
34
TK800
NOMESCO Finland
Hemodialysis
29.5
219.7
153
65
Z2221
NOMESCO Finland
Medical doctor
10.1
217.5
497
1265
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
326.2
216.8
210
9
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
29.0
212.9
149
64
A11CC03
ATC
alfacalcidol; systemic
27.9
208.4
148
66
Z2446
NOMESCO Finland
Social worker
12.4
197.7
232
264
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
63.2
193.3
108
20
Z49.0
ICD-10 Finland
Preparatory care for dialysis
46.8
181.1
108
27
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
48.0
180.6
107
26
Z3226
NOMESCO Finland
Physiotherapist
7.8
170.4
358
799
N18.0
ICD-10 Finland
End-stage renal disease
46.7
169.5
101
25
Z94.0
ICD-10 Finland
Kidney transplant status
41.3
157.8
97
27
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
9.8
154.7
213
294
127
Kela drug reimbursment
Transplant complication
28.7
153.4
106
43
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.7
145.1
181
219
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
12.0
139.4
156
162
B03XA02
ATC
darbepoetin alfa; parenteral
22.5
138.2
105
54
ZX120
NOMESCO Finland
Intravenous
8.4
135.0
213
342
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
10.5
130.8
162
193
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
27.6
129.2
90
37
R4110
NOMESCO Finland
Physiotherapy
6.0
128.9
425
1379
A12AA04
ATC
calcium carbonate; oral
24.4
128.4
94
44
RD210, ,
NOMESCO Finland
23.6
128.0
95
46
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
49.8
123.2
72
16
L04AA06
ATC
mycophenolic acid; systemic
18.4
121.3
101
63
V03AE01
ATC
polystyrene sulfonate; oral
32.2
118.5
78
27
L04AD02
ATC
tacrolimus; systemic
29.4
116.4
79
30
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
44.7
115.2
69
17
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
266.7
113.2
113
5
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
16.7
113.0
99
68
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
50.9
111.8
65
14
KA1AE
NOMESCO Finland
Kidney ultrasound examination
16.0
109.4
98
70
ZXD10
NOMESCO Finland
Scheduled procedure
5.4
109.3
470
1836
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
32.7
108.6
71
24
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.5
96.5
553
2622
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.1
96.5
103
98
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
9.2
92.5
123
158
Z49.2
ICD-10 Finland
Other dialysis
38.5
91.7
57
16
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.3
90.8
236
599
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
33.1
89.3
58
19
N18.8
ICD-10 Finland
Other chronic renal failure
17.4
87.5
74
47
ZXE10
NOMESCO Finland
More than one and less than three hours
4.4
87.2
423
1729
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
4.7
85.4
273
816
RS221, ,
NOMESCO Finland
17.3
84.9
72
46
ZXE00
NOMESCO Finland
One hour or less
4.3
83.9
442
1902
XF400
NOMESCO Finland
ECG with 12 standard connections
4.9
82.8
236
642
RS220, ,
NOMESCO Finland
22.9
82.2
61
29
137
Kela drug reimbursment
Uraemia requiring dialysis
26.9
79.1
55
22
WX892
NOMESCO Finland
Monitored bed care
6.4
78.1
148
279
WX202
NOMESCO Finland
Supraclavicular plexus blockade
17.2
77.8
66
42
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.6
77.8
254
765
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.5
77.1
178
403
ZXE20
NOMESCO Finland
More than three and less than five hours
4.8
76.0
217
587
3AC01, ,
NOMESCO Finland
31.5
75.9
50
17
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
75.3
71
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
16.5
75.1
65
43
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
14.8
75.1
69
51
ZXA05
NOMESCO Finland
Left side
4.1
72.8
299
1058
TK810
NOMESCO Finland
Hemofiltration
31.3
71.2
47
16
H05BX01
ATC
cinacalcet; oral
32.7
70.6
46
15
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.4
69.8
163
371
B05DA
ATC
Isotonic solutions
27.0
69.2
48
19
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.5
66.4
119
211
XPX08
NOMESCO Finland
Intraoperative flow measurement
22.8
66.2
49
23
Z3229
NOMESCO Finland
Other healthcare associate professional
5.5
66.0
147
320
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
6.2
64.2
122
229
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
6.3
63.5
119
220
B05DB
ATC
Hypertonic solutions
29.6
62.6
42
15
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
341.0
62.4
62
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
92.1
61.1
67
8
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
8.2
60.1
85
116
WX203
NOMESCO Finland
Infraclavicular plexus blockade
10.7
59.5
67
68
WW500
NOMESCO Finland
Blood transfusion
7.7
59.3
89
130
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
58.9
308
1249
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.1
58.2
94
149
C03CA01
ATC
furosemide; systemic
3.5
58.0
298
1193
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
21.2
57.8
44
22
ZXA00
NOMESCO Finland
Right side
3.5
57.6
298
1198
V03AE02
ATC
sevelamer; oral
86.1
57.0
63
8
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.6
56.2
158
415
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
6.8
56.0
94
155
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
14.7
55.8
51
37
WX002
NOMESCO Finland
Sedation and analgesia
3.7
54.8
233
822
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
4.6
54.7
154
404
TKC20
NOMESCO Finland
Catheterisation of bladder
5.8
54.1
109
215
RS222, ,
NOMESCO Finland
17.1
53.4
45
28
GD1LA
NOMESCO Finland
GD
14.5
53.2
49
36
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
5.8
52.6
106
209
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.3
52.6
160
445
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.6
49.9
208
719
JN4BD
NOMESCO Finland
Extensive body CT
4.4
49.9
147
398
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
74.1
48.8
55
8
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
6.0
48.6
93
174
TPH04
NOMESCO Finland
Cathetrisation of vein
3.3
47.6
257
1040
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
7.0
46.9
75
117
ZY010
NOMESCO Finland
Hospital outpatient
5.3
46.3
101
213
R4120
NOMESCO Finland
Occupational therapy
4.9
46.2
113
263
V03AE03
ATC
lanthanum carbonate; oral
63.3
46.0
53
9
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
7.1
45.9
73
113
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
45.8
309
1417
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
167.1
45.4
47
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
45.3
235
925
TPH07
NOMESCO Finland
Cathetrisation of artery
3.9
44.4
154
467
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.1
44.1
101
222
WX730
NOMESCO Finland
Conventional respirator
14.0
43.7
41
31
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.0
43.2
102
230
196
Kela drug reimbursment
Paricalcitol and cinacalcet
59.5
43.0
50
9
J01MA12
ATC
levofloxacin; systemic
3.3
42.9
213
814
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
11.4
42.1
45
42
ZXA10
NOMESCO Finland
Bilateral
3.3
41.9
196
721
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.5
41.8
112
280
XCK10
NOMESCO Finland
Photography of fundus of eye
4.1
41.1
129
363
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
10.6
41.1
46
46
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
5.3
40.6
88
184
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
4.9
40.5
96
217
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.4
39.9
84
171
L04AD01
ATC
ciclosporin; systemic
9.6
39.9
48
53
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
61.2
39.8
46
8
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.1
39.6
90
196
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.2
39.6
88
188
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
39.3
287
1351
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
8.8
38.1
49
59
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
8.8
38.1
49
59
ZXD05
NOMESCO Finland
Urgent procedure
2.8
37.3
293
1426
H02AB04
ATC
methylprednisolone; systemic
3.4
37.1
162
567
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.1
35.4
79
169
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
35.1
185
723
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
34.7
117
345
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
5.5
33.9
69
136
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
341.8
33.2
33
*
WX882
NOMESCO Finland
High dependency care
6.5
33.2
56
92
N19
ICD-10 Finland
Unspecified kidney failure
5.8
33.0
63
117
ZY000
NOMESCO Finland
Hospital inpatient
10.5
32.9
37
37
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
32.6
247
1166
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
32.5
31
*
TQW40
NOMESCO Finland
Remowal of suture of skin
4.1
31.8
96
261
R50.9
ICD-10 Finland
Fever, unspecified
3.0
31.6
172
681
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
73.3
31.1
35
5
B01AB04
ATC
dalteparin; parenteral
5.1
31.0
69
147
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.6
30.8
77
181
R4190
NOMESCO Finland
Nutritional therapy
5.0
30.8
69
148
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.6
30.6
40
49
L28
ICPC
Limited function/disability (L)
2.9
30.6
176
717
C02AC05
ATC
moxonidine; oral
4.8
30.6
73
165
NHQ40
NOMESCO Finland
Amputation of toe
8.7
30.2
39
47
EBA15
NOMESCO Finland
Extraction of multiple teeth
5.2
29.3
63
130
J01MA14
ATC
moxifloxacin; systemic
3.6
29.3
109
342
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
303.5
29.0
29
*
A51.0
ICD-10 Finland
Primary genital syphilis
303.5
29.0
29
*
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
50.8
28.6
34
7
A28
ICPC
Limited function/disability NOS
2.9
28.5
164
666
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.5
28.4
111
359
A41.9
ICD-10 Finland
Sepsis, unspecified
5.8
28.3
54
100
H02AB07
ATC
prednisone; oral
3.1
28.1
134
490
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
5.3
28.0
58
116
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.3
27.5
115
388
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.2
26.7
124
445
ZXD35
NOMESCO Finland
Usual procedure
5.5
26.6
53
102
UJF30
NOMESCO Finland
Ileoscopy through colon
3.3
26.4
115
397
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.8
26.2
62
139
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
25.2
25.9
36
15
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
7.8
25.7
36
48
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.9
25.7
59
129
Z71.8
ICD-10 Finland
Other specified counselling
2.3
25.2
307
1759
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
5.8
25.2
47
85
J01FF01
ATC
clindamycin; systemic
2.4
25.2
250
1313
B03XA01
ATC
erythropoietin; parenteral
22.2
25.0
36
17
J01MA02
ATC
ciprofloxacin; systemic
2.3
24.9
328
1938
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.6
24.9
62
145
321
Kela drug reimbursment
Paricalcitol and cinacalcet
23.7
24.1
34
15
U14
ICPC
Kidney symptom/complaint
8.3
24.0
32
40
205
Kela drug reimbursment
Chronic hypertension
2.4
23.9
213
1063
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.5
23.8
90
284
C08CA01
ATC
amlodipine; oral
2.2
23.7
321
1910
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.5
23.5
89
281
XF404
NOMESCO Finland
Ambulatory ECG
3.3
23.3
95
314
TK820
NOMESCO Finland
Peritoneal dialysis
25.7
23.2
32
13
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
25.7
23.2
32
13
WX110, ,
SPAT
3.7
23.2
77
223
WX872
NOMESCO Finland
Intensive care
4.0
23.1
70
190
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
+∞
23.0
22
*
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
26.9
22.8
31
12
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
237.1
22.7
23
*
ZX114
NOMESCO Finland
Intramuscular
7.5
22.6
33
46
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
9.1
22.5
28
32
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.5
22.4
81
248
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
5.3
22.4
46
91
AA1AD
NOMESCO Finland
CT of head and brain
2.3
22.1
246
1344
A53.9
ICD-10 Finland
Syphilis, unspecified
+∞
22.0
21
*
A54.6
ICD-10 Finland
Gonococcal infection of anus and rectum
+∞
22.0
21
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
7.4
21.8
32
45
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
8.5
21.5
28
34
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
7.5
21.3
31
43
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
3.6
21.2
75
226
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.8
21.2
68
192
N05CD07
ATC
temazepam; oral
3.0
20.8
104
387
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.2
20.8
91
314
N05CF01
ATC
zopiclone; oral
2.2
20.7
263
1507
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.7
20.4
48
107
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.7
20.1
48
108
K02.9
ICD-10 Finland
Dental caries, unspecified
6.2
20.1
35
59
A63.0
ICD-10 Finland
Anogenital (venereal) warts
4.7
19.9
47
105
WX722
NOMESCO Finland
PEEP
3.8
19.9
64
181
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.2
19.8
54
135
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
6.1
19.8
35
60
WNF00
NOMESCO Finland
Infection source and contact determination
29.9
19.8
26
9
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.2
19.7
84
285
A46
ICD-10 Finland
Erysipelas
2.5
19.6
145
658
Z2445
NOMESCO Finland
Psychologist
3.9
19.5
60
164
WX110
NOMESCO Finland
Infiltration anesthesia
2.3
19.5
576
4491
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.9
19.4
44
95
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.1
19.4
55
142
X57
ICD-10 Finland
Unspecified privation
5.6
19.2
37
69
K65.0
ICD-10 Finland
Acute peritonitis
14.7
18.7
31
22
PBU99
NOMESCO Finland
Other repair after previous reconstruction of arteries of upper extremity
194.8
18.6
19
*
WX402
NOMESCO Finland
General anaesthesia
2.2
18.5
201
1075
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.7
18.2
43
96
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.0
18.2
85
304
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
6.9
18.0
28
42
B99
ICD-10 Finland
Other and unspecified infectious diseases
6.2
17.9
31
52
I77.0
ICD-10 Finland
Arteriovenous fistula, acquired
68.4
17.8
20
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
68.4
17.8
20
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.2
17.8
37
74
A51.9
ICD-10 Finland
Early syphilis, unspecified
+∞
17.8
17
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.6
17.8
62
185
ZXD20
NOMESCO Finland
Day surgery
2.6
17.6
117
503
A06AD11
ATC
lactulose; oral
2.6
17.6
117
503
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
97.5
17.6
19
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
17.6
175
901
AB14W, ,
NOMESCO Finland
184.3
17.6
18
*
WX213
NOMESCO Finland
Lower leg blockade
17.5
17.5
27
16
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.6
17.3
33
61
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
17.2
247
1464
B01AB10
ATC
tinzaparin; parenteral
2.6
17.0
105
436
RJ129, ,
NOMESCO Finland
+∞
16.7
16
*
ZX100
NOMESCO Finland
Oral
6.9
16.7
26
39
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
16.6
108
460
A54.5
ICD-10 Finland
Gonococcal pharyngitis
173.8
16.6
17
*
RJ420, ,
NOMESCO Finland
20.6
16.5
24
12
L04AX01
ATC
azathioprine; systemic
3.9
16.4
49
131
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.7
16.2
54
156
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
17.2
16.2
25
15
N03AX16
ATC
[U] pregabalin
2.1
16.1
190
1043
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.4
15.9
121
553
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
17.7
15.7
24
14
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
12.1
15.7
28
24
A51.3
ICD-10 Finland
Secondary syphilis of skin and mucous membranes
87.0
15.6
17
*
C07AB07
ATC
bisoprolol; oral
1.9
15.6
360
2484
E87.5
ICD-10 Finland
Hyperkalaemia
6.4
15.6
26
42
B01AC04
ATC
clopidogrel; oral
2.3
15.6
140
689
A10AC01
ATC
insulin (human); parenteral
2.9
15.5
79
296
KBV00
NOMESCO Finland
Insertion of stent into ureter
15.2
15.4
25
17
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
15.2
15.4
25
17
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.8
15.4
80
303
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.1
15.3
43
110
GD1AD
NOMESCO Finland
Thorax CT examination
3.0
15.3
70
247
A10AB05
ATC
insulin aspart; parenteral
2.7
15.3
85
334
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
20.6
15.2
22
11
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
15.1
168
899
B01AA03
ATC
warfarin; systemic
2.3
15.1
133
648
B18.2
ICD-10 Finland
Chronic viral hepatitis C
5.9
15.0
27
47
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
12.8
15.0
26
21
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
15.5
15.0
24
16
XF600
NOMESCO Finland
Bloodpressure measurement
3.1
14.9
65
223
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.2
14.9
31
62
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.0
14.9
32
66
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
57.9
14.8
17
*
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
18.9
14.8
22
12
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
14.7
175
960
Y25
ICPC
Fear sexually transm disease male
4.4
14.7
37
87
R11
ICD-10 Finland
Nausea and vomiting
2.7
14.7
86
347
XW000
NOMESCO Finland
Bone marrow biopsy
3.8
14.6
45
123
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.1
14.5
40
101
RJ414, ,
NOMESCO Finland
36.8
14.5
18
5
ZX108
NOMESCO Finland
Inhalation
12.9
14.5
25
20
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
5.2
14.4
30
60
H3603, E103,
ICD-10 Finland
11.7
14.4
26
23
M04AA01
ATC
allopurinol; systemic
2.4
14.3
109
498
S97
ICPC
Chronic ulcer skin
2.9
14.3
69
251
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
3.3
14.1
55
176
K05.31
ICD-10 Finland
Periodontitis pronounced
2.4
14.1
106
481
C09AA02
ATC
enalapril; systemic
2.1
14.0
151
797
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
4.5
13.9
34
78
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.0
13.9
30
62
F43.29
ICD-10 Finland
Adaptation disorder UNS
4.6
13.9
33
74
A12AA12
ATC
[U] calcium acetate
54.4
13.9
16
*
A10AE04
ATC
insulin glargine; parenteral
2.5
13.8
98
433
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.4
13.8
99
440
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
13.7
89
377
XF402
NOMESCO Finland
ECG with work load test
2.5
13.7
92
396
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.0
13.6
63
224
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
26.3
13.4
18
7
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.7
13.3
73
284
N02AX02
ATC
tramadol; systemic, rectal
1.8
13.3
335
2338
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.3
13.2
50
157
RJ120, ,
NOMESCO Finland
40.9
13.2
16
*
EB1WA, ,
NOMESCO Finland
12.5
13.2
23
19
RJ411, ,
NOMESCO Finland
15.4
13.2
21
14
C07AG02
ATC
carvedilol; oral
3.1
13.1
57
195
XCH00
NOMESCO Finland
Eye pressure measurement
3.4
13.1
47
143
A07AA09
ATC
vancomycin; oral
9.6
13.1
26
28
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
9.6
13.1
26
28
H43.1
ICD-10 Finland
Vitreous haemorrhage
4.4
13.0
33
78
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.9
13.0
39
105
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
13.0
150
811
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.7
12.8
42
120
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
14.4
12.8
21
15
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
14.4
12.8
21
15
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
14.4
12.8
21
15
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
4.1
12.8
35
88
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.6
12.7
24
44
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
10.3
12.6
24
24
L04AA01
ATC
[U] ciclosporin
10.3
12.6
24
24
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
10.3
12.6
24
24
3025
Kela drug reimbursment
Calcium carbonate
13.5
12.5
21
16
J05AB11
ATC
valaciclovir; oral
2.2
12.5
125
639
WW200, ,
SPAT
0.4
12.4
71
1538
I50.9
ICD-10 Finland
Heart failure, unspecified
2.3
12.3
99
462
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
4.1
12.3
34
86
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.4
12.3
95
436
KH1EE
NOMESCO Finland
Urologic ultrasound examination
38.2
12.2
15
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
12.2
110
539
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
12.1
320
2246
5AB14, ,
NOMESCO Finland
27.2
12.1
16
6
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
21.7
12.0
17
8
K99
ICPC
Cardiovascular disease other
5.0
12.0
26
54
TGC00
NOMESCO Finland
Bronchial lavation
4.0
11.9
34
88
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.3
11.9
31
75
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
11.9
86
383
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
5.5
11.9
23
43
C08DB01
ATC
diltiazem; oral
3.5
11.8
41
122
A41.8
ICD-10 Finland
Other specified sepsis
5.0
11.8
25
51
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.4
11.7
83
366
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
12.8
11.7
20
16
6BA02, ,
NOMESCO Finland
30.6
11.7
15
5
HA1AA
NOMESCO Finland
X-ray mammography
2.8
11.6
62
238
A07AA02
ATC
nystatin; oral
3.1
11.6
49
165
J45.1
ICD-10 Finland
Nonallergic asthma
2.7
11.6
66
262
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
9.5
11.6
23
25
P01AB01
ATC
metronidazole; oral, rectal
1.7
11.5
284
1948
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.7
11.5
66
263
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
4.8
11.5
26
56
AB18W, ,
NOMESCO Finland
+∞
11.5
11
*
H05BX02
ATC
paricalcitol; systemic
+∞
11.5
11
*
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
3.3
11.4
43
135
A10AE05
ATC
insulin detemir; parenteral
2.8
11.4
58
217
A10AB04
ATC
insulin lispro; parenteral
3.4
11.4
41
125
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.3
11.4
29
69
RS230, ,
NOMESCO Finland
15.3
11.3
18
12
J01CF05
ATC
flucloxacillin; systemic
2.5
11.3
73
308
C02CA01
ATC
prazosin; oral
9.1
11.3
23
26
N30.0
ICD-10 Finland
Acute cystitis
2.1
11.3
111
562
TQW99
NOMESCO Finland
Other minor procedure on skin
3.0
11.3
50
173
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
35.6
11.3
14
*
WX212
NOMESCO Finland
Femoral plexus blockade
4.6
11.3
27
61
ZX112
NOMESCO Finland
Subcutaneous
4.4
11.1
28
66
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.9
11.1
175
1048
WYA30, ,
SPAT
10.3
11.1
21
21
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.7
11.0
35
98
J01DB01
ATC
cefalexin; oral
2.0
11.0
614
5278
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.9
10.9
32
85
EB1AA, ,
SPAT
2.6
10.8
63
253
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.0
10.8
49
172
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
5.0
10.8
23
47
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.8
10.8
33
90
Z94.4
ICD-10 Finland
Liver transplant status
18.1
10.8
16
9
N25.0
ICD-10 Finland
Renal osteodystrophy
28.5
10.8
14
5
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
10.7
112
580
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.6
10.7
35
100
K02.2
ICD-10 Finland
Caries of cementum
3.0
10.7
49
173
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.4
10.7
39
120
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
4.0
10.7
30
77
C08CA02
ATC
felodipine; oral
2.5
10.7
70
298
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.4
10.6
73
317
A02BC02
ATC
pantoprazole; systemic
1.7
10.6
496
4013
N05BA01
ATC
diazepam; systemic, rectal
2.1
10.6
105
533
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.5
10.6
69
293
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.8
10.5
32
87
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
111.6
10.4
11
*
N02AA05
ATC
oxycodone; systemic
2.0
10.4
136
763
1AD02, ,
NOMESCO Finland
+∞
10.4
10
*
B23
ICD-10 Finland
Human immunodeficiency virus [HIV] disease resulting in other conditions
+∞
10.4
10
*
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
10.4
10
*
C02EA02, ,
ATC
3.6
10.4
34
97
A12BA01
ATC
potassium chloride; oral
3.6
10.4
34
97
RK320, ,
NOMESCO Finland
12.3
10.4
18
15
QDA10
NOMESCO Finland
Incision of skin of lower limb
12.3
10.4
18
15
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
8.4
10.4
22
27
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
33.0
10.4
13
*
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
4.5
10.3
25
57
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
10.8
10.3
19
18
H3601, E113,
ICD-10 Finland
5.0
10.3
22
45
H02AB09
ATC
hydrocortisone; systemic
4.1
10.3
28
70
Z5132
NOMESCO Finland
Nursing associate professional
9.8
10.3
20
21
N30.9
ICD-10 Finland
Cystitis, unspecified
2.9
10.2
50
183
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.2
10.2
27
66
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.6
10.2
61
248
C08CA13
ATC
lercanidipine; oral
2.0
10.2
115
613
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
5.4
10.2
20
38
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.8
10.1
170
1036
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
11.5
10.1
18
16
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
5.1
10.1
21
42
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
5.1
10.1
21
42
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
5.1
10.1
21
42
NF1AA
NOMESCO Finland
Hip X-ray examination
2.4
10.1
72
319
R4140
NOMESCO Finland
Psychotherapy
14.8
10.0
16
11
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
3.1
10.0
41
136
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
9.9
64
270
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.3
9.8
37
116
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
26.4
9.8
13
5
R03BB04
ATC
tiotropium bromide; inhalant
2.3
9.8
78
362
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.4
9.7
68
298
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
13.6
9.7
16
12
A56.4
ICD-10 Finland
Chlamydial infection of pharynx
55.7
9.7
11
*
T89
ICPC
Diabetes insulin dependent
2.8
9.6
50
189
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
11.6
9.6
17
15
NGQ20
NOMESCO Finland
Amputation of lower leg
10.2
9.6
18
18
J01DA01
ATC
[U] cefalexin
1.6
9.5
435
3451
I50.0
ICD-10 Finland
Congestive heart failure
2.6
9.5
54
214
M10.9
ICD-10 Finland
Gout, unspecified
2.5
9.5
62
263
Z99.2
ICD-10 Finland
Dependence on renal dialysis
30.5
9.4
12
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
30.5
9.4
12
*
Z20.6
ICD-10 Finland
Contact with and exposure to human immunodeficiency virus [HIV]
+∞
9.4
9
*
R2110
NOMESCO Finland
Giving the first information
2.8
9.4
49
186
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.8
9.4
46
169
I95.9
ICD-10 Finland
Hypotension, unspecified
5.0
9.4
20
41
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
4.8
9.3
21
45
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.5
9.3
59
247
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
3.6
9.3
31
90
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.4
9.3
21
29
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.8
9.3
46
170
D64.8
ICD-10 Finland
Other specified anaemias
4.7
9.1
21
46
R5110, ,
SPAT
2.3
9.1
68
307
H3603, E107,
ICD-10 Finland
37.2
9.0
11
*
TK830
NOMESCO Finland
Ultrafiltration
37.2
9.0
11
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.6
9.0
53
214
SPAT1153
SPAT
Removal of sutures
0.5
9.0
81
1504
C01DA14
ATC
isosorbide mononitrate; oral
2.1
9.0
96
501
A10AA02, ,
ATC
3.2
8.9
36
118
KAC00
NOMESCO Finland
Nephrectomy
24.3
8.9
12
5
WX214
NOMESCO Finland
Plexus blockade at the ankle
12.7
8.9
15
12
TNG34
NOMESCO Finland
Major custom moulded orthopaedic cast, knee or lower leg
5.0
8.9
19
39
A02BC01
ATC
omeprazole; systemic
1.7
8.8
186
1206
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
10.9
8.8
16
15
J01MA06
ATC
norfloxacin; oral
2.1
8.8
89
455
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.0
8.8
38
130
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.6
8.7
51
205
S42.2
ICD-10 Finland
Fracture of upper end of humerus
3.1
8.7
37
125
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.6
8.7
29
84
A97
ICPC
No disease
1.8
8.7
154
949
WW400
NOMESCO Finland
Plasmaferesis
50.6
8.7
10
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
8.7
109
602
D07AB08
ATC
desonide; topical
2.1
8.7
88
450
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.8
8.7
26
70
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.5
8.6
56
237
A04
ICPC
Weakness/tiredness general
1.9
8.6
114
641
S91.3
ICD-10 Finland
Open wound of other parts of foot
3.3
8.6
32
100
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
16.5
8.6
13
8
OAB43, ,
SPAT
0.5
8.6
108
1803
5AH02, ,
NOMESCO Finland
27.9
8.5
11
*
U13
ICPC
Bladder symptom/complaint other
3.7
8.5
27
76
A10AB01
ATC
insulin (human); parenteral
3.0
8.4
38
133
NK3AT
NOMESCO Finland
Muscle puncture with ultrasound guidance
91.1
8.4
9
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
91.1
8.4
9
*
Z3232
NOMESCO Finland
Midwife
2.7
8.4
46
179
PD5BD
NOMESCO Finland
Extensive CT of aorta
5.0
8.4
18
37
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.5
8.4
54
228
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
8.3
103
566
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
10.9
8.3
15
14
K08.3
ICD-10 Finland
Retained dental root
2.2
8.3
69
326
TAB00
NOMESCO Finland
Lumbar puncture
2.7
8.3
44
169
JN4AD
NOMESCO Finland
Body CT examination
2.0
8.2
89
466
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.8
8.2
25
68
I15.0
ICD-10 Finland
Renovascular hypertension
14.7
8.2
13
9
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.2
8.2
72
348
N05BA06
ATC
lorazepam; systemic, sublingual
2.6
8.1
47
188
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
33.7
8.1
10
*
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
33.7
8.1
10
*
WX610
NOMESCO Finland
Patient controlled analgesia
9.1
8.1
16
18
RK110, ,
NOMESCO Finland
10.2
8.1
15
15
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
6.4
8.1
20
32
RD112, ,
NOMESCO Finland
22.3
8.0
11
5
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
22.3
8.0
11
5
RK290, ,
NOMESCO Finland
22.3
8.0
11
5
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
3.4
8.0
28
84
J04AB02
ATC
rifampicin; systemic
7.4
8.0
18
25
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.8
8.0
24
65
J05AB01
ATC
aciclovir; systemic
1.7
8.0
151
948
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
4.0
7.9
22
56
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
7.9
7.9
17
22
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
6.2
7.9
20
33
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.3
7.9
29
90
L84
ICD-10 Finland
Corns and callosities
3.1
7.9
33
111
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
8.6
7.8
16
19
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.9
7.7
22
57
4AA12, ,
NOMESCO Finland
15.2
7.7
12
8
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
15.2
7.7
12
8
ZX197, ,
NOMESCO Finland
45.5
7.7
9
*
J01FA06
ATC
roxithromycin; oral
1.6
7.7
269
1970
H3603, E113,
ICD-10 Finland
7.5
7.7
17
23
N06AB04
ATC
citalopram; systemic
1.8
7.7
142
884
N05BA04
ATC
oxazepam; oral
1.7
7.6
184
1231
ZX199
NOMESCO Finland
Other rote
18.6
7.6
11
6
PD4CM
NOMESCO Finland
Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet
25.3
7.6
10
*
WX290, ,
SPAT
2.9
7.6
34
119
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
7.6
186
1251
J12.8
ICD-10 Finland
Other viral pneumonia
10.2
7.6
14
14
UJH02
NOMESCO Finland
Anoscopy
2.8
7.6
37
136
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.6
253
1834
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.9
7.5
35
125
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
7.2
7.5
17
24
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
7.2
7.5
17
24
B07.9
ICD-10 Finland
Verruca simplex
2.8
7.5
36
131
H04AA01
ATC
glucagon; nasal, parenteral
3.6
7.5
24
68
M79.6
ICD-10 Finland
Pain in limb
1.5
7.4
305
2312
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
7.4
60
280
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.1
7.4
31
104
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
80.9
7.4
8
*
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
80.9
7.4
8
*
A52.1
ICD-10 Finland
Symptomatic neurosyphilis
80.9
7.4
8
*
PG5ST
NOMESCO Finland
Endovascular thrombolysis of arterio-venous shunt for dialysis with radiological guidance
80.9
7.4
8
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
7.4
420
3415
XQ800
NOMESCO Finland
Prick test
2.3
7.4
57
261
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.3
7.4
56
255
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
3.0
7.3
31
105
RS224, ,
NOMESCO Finland
9.5
7.3
14
15
R80
ICD-10 Finland
Isolated proteinuria
9.5
7.3
14
15
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.7
7.3
141
888
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.4
7.3
26
79
PBU81
NOMESCO Finland
Thrombectomy in arteriovenous fistula from artery of upper extremity
+∞
7.3
7
*
N0832, E102,
ICD-10 Finland
+∞
7.3
7
*
A55
ICD-10 Finland
Chlamydial lymphogranuloma (venereum)
+∞
7.3
7
*
N0832, E112,
ICD-10 Finland
+∞
7.3
7
*
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.9
7.3
21
55
WX320
NOMESCO Finland
Spinalanesthesy
1.7
7.3
166
1093
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
5.9
7.3
19
33
RJ410, ,
NOMESCO Finland
15.9
7.2
11
7
N05AA02
ATC
levomepromazine; systemic
2.7
7.2
38
145
XQ848
NOMESCO Finland
Dermatological photography
3.1
7.2
29
95
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.7
7.2
22
60
H25.1
ICD-10 Finland
Senile nuclear cataract
1.7
7.2
153
988
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.8
7.2
35
128
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
7.4
7.2
16
22
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
7.2
542
6022
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
3.2
7.2
28
90
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.0
7.2
80
423
M01AH05
ATC
etoricoxib; oral
0.7
7.2
299
3762
M05BA04
ATC
alendronic acid; oral
2.3
7.2
52
232
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.3
7.2
26
80
N05AH02
ATC
clozapine; systemic
3.4
7.2
25
75
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
30.3
7.2
9
*
XX9XW, ,
NOMESCO Finland
8.0
7.1
15
19
OAB42, ,
SPAT
0.3
7.1
22
646
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
6.1
7.1
18
30
TDA90
NOMESCO Finland
Removal wax from ear
6.1
7.1
18
30
Z94.1
ICD-10 Finland
Heart transplant status
12.2
7.1
12
10
NG4AA
NOMESCO Finland
Lower leg X-ray examination
2.9
7.1
33
118
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
8.9
7.1
14
16
K92.1
ICD-10 Finland
Melaena
2.5
7.1
43
177
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
10.2
7.1
13
13
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.3
7.0
26
81
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
7.1
7.0
16
23
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.4
7.0
17
39
H3601, E103,
ICD-10 Finland
6.4
7.0
17
27
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
7.0
73
378
D50.8
ICD-10 Finland
Other iron deficiency anaemias
5.5
7.0
19
35
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
6.9
191
1318
RS121, ,
NOMESCO Finland
7.6
6.9
15
20
Z29.9
ICD-10 Finland
Prophylactic measure, unspecified
13.9
6.9
11
8
RT250, ,
NOMESCO Finland
13.9
6.9
11
8
M01AC06
ATC
meloxicam; systemic, rectal
0.6
6.9
119
1839
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.5
6.9
42
173
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
6.9
129
805
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.8
6.9
34
126
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.9
6.8
20
53
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.1
6.8
28
93
WX720
NOMESCO Finland
Own respiration
0.0
6.8
*
200
5BA08, ,
NOMESCO Finland
11.1
6.8
12
11
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
11.1
6.8
12
11
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.2
6.8
26
83
RJ425, ,
NOMESCO Finland
40.4
6.8
8
*
RJ521, ,
NOMESCO Finland
40.4
6.8
8
*
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
40.4
6.8
8
*
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.7
6.8
123
761
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
3.6
6.8
22
63
RS120, ,
NOMESCO Finland
16.9
6.8
10
6
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
16.9
6.8
10
6
R31
ICD-10 Finland
Unspecified haematuria
2.0
6.7
78
419
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
22.7
6.7
9
*
K65.9
ICD-10 Finland
Peritonitis, unspecified
22.7
6.7
9
*
3A064, ,
NOMESCO Finland
22.7
6.7
9
*
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
22.7
6.7
9
*
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
6.7
199
1398
WX204
NOMESCO Finland
Axillary plexus blockaced
2.7
6.7
34
128
Z50.1
ICD-10 Finland
Other physical therapy
2.5
6.7
42
176
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.1
6.6
66
335
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
5.6
6.6
18
33
N20.9
ICD-10 Finland
Urinary calculus, unspecified
3.2
6.6
25
79
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.5
6.6
22
64
M10.3
ICD-10 Finland
Gout due to impairment of renal function
10.1
6.5
12
12
CD2S4
NOMESCO Finland
Photography of eye
10.1
6.5
12
12
N05AH03
ATC
olanzapine; systemic
2.2
6.5
57
275
J20
ICD-10 Finland
Acute bronchitis
1.9
6.5
80
438
ULA02
NOMESCO Finland
Kolposcopy
2.2
6.5
52
242
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.7
6.5
20
55
OAA67, ,
SPAT
0.4
6.5
43
903
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.7
6.5
33
124
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.9
6.5
30
107
N06AX11
ATC
mirtazapine; oral
1.5
6.5
237
1741
E10
ICD-10 Finland
Type 1 diabetes mellitus
3.5
6.5
22
65
RJ122, ,
NOMESCO Finland
70.4
6.4
7
*
B90
ICPC
HIV-infection/AIDS
70.4
6.4
7
*
I12.9
ICD-10 Finland
Hypertensive renal disease without renal failure
70.4
6.4
7
*
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
70.4
6.4
7
*
A10AA01, ,
ATC
2.9
6.4
29
102
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
14.5
6.4
10
7
1CX08, ,
NOMESCO Finland
14.5
6.4
10
7
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
14.5
6.4
10
7
M10.0
ICD-10 Finland
Idiopathic gout
2.7
6.4
33
125
CKC12
NOMESCO Finland
Photocoagulation of retina
2.5
6.4
39
161
R1250
NOMESCO Finland
Evaluation of functional capability
3.2
6.4
25
81
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
6.4
51
238
PE1AT
NOMESCO Finland
Femoral artery PTA
6.0
6.3
16
27
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
11.1
6.3
11
10
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
11.1
6.3
11
10
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.1
6.3
59
293
RJ126, ,
NOMESCO Finland
18.2
6.3
9
5
K65.8
ICD-10 Finland
Other peritonitis
18.2
6.3
9
5
RJ210, ,
NOMESCO Finland
18.2
6.3
9
5
306
Kela drug reimbursment
Erythropoietin and darbepoetin
18.2
6.3
9
5
B01AB05
ATC
enoxaparin; parenteral
1.6
6.3
203
1450
RD240, ,
NOMESCO Finland
+∞
6.3
6
*
A51.5
ICD-10 Finland
Early syphilis, latent
+∞
6.3
6
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.1
6.2
25
82
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
26.9
6.2
8
*
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
26.9
6.2
8
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.7
6.2
32
121
K63.5
ICD-10 Finland
Polyp of colon
3.2
6.2
24
77
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.7
6.2
140
917
R18
ICD-10 Finland
Ascites
3.6
6.2
20
57
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
4.0
6.2
17
43
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.3
6.2
23
72
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
7.8
6.1
13
17
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
2.5
6.1
36
146
XA800
NOMESCO Finland
Neuropsychological investigation
2.3
6.1
44
196
A10BH05
ATC
linagliptin; oral
2.4
6.1
40
171
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.3
6.1
43
190
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
8.7
6.1
12
14
ZXE90
NOMESCO Finland
More than 22 hours
10.1
6.0
11
11
QX4YT
NOMESCO Finland
Puncture of superficial collection under ultrasound guidance
10.1
6.0
11
11
J46
ICD-10 Finland
Status asthmaticus
3.4
6.0
21
63
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.4
6.0
21
63
NH1AD
NOMESCO Finland
Ankle and foot CT
3.4
6.0
21
63
N05CF02
ATC
zolpidem; oral
1.7
6.0
120
760
SPAT1312
SPAT
General health counselling
0.6
6.0
91
1464
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Infectious Disease
44 [38004484]
44 [38004484]
3.5e+00
4.6e+00
4.5e+00
1.0e+50
4.8e+00
4.8e+00
3.8e+00
cases:31.54%
controls:1.41%
cases:34.58%
controls:0.55%
cases:6.64%
controls:0.08%
cases:38.04%
controls:0.00%
cases:9.42%
controls:0.08%
cases:36.89%
controls:0.48%
cases:42.12%
controls:1.57%
228
102
495
7128
250
40
473
7190
48
6
675
7224
275
0
448
7230
68
6
654
7218
263
34
450
7118
270
105
371
6580
Extracorporeal dialysis
Z49.1 [45537649]
Z49.1 [45537649]
4.4e+00
5.0e+00
5.0e+00
—
—
4.9e+00
4.3e+00
cases:6.36%
controls:0.08%
cases:11.34%
controls:0.08%
cases:9.54%
controls:0.07%
—
—
—
—
cases:13.60%
controls:0.11%
cases:10.76%
controls:0.16%
46
6
677
7224
82
6
641
7224
69
5
654
7225
—
—
97
8
616
7144
69
11
572
6674
Nephrology
39 [38004479]
39 [38004479]
3.3e+00
3.7e+00
4.4e+00
—
4.4e+00
3.7e+00
3.1e+00
cases:21.30%
controls:1.00%
cases:23.37%
controls:0.73%
cases:18.26%
controls:0.28%
—
—
cases:18.98%
controls:0.28%
cases:23.70%
controls:0.77%
cases:21.06%
controls:1.21%
154
72
569
7158
169
53
554
7177
132
20
591
7210
—
137
20
585
7204
169
55
544
7097
135
81
506
6604
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
2.0e+00
2.7e+00
4.5e+00
—
4.0e+00
3.6e+00
3.6e+00
cases:7.88%
controls:1.09%
cases:11.07%
controls:0.82%
cases:8.30%
controls:0.10%
—
—
cases:7.34%
controls:0.15%
cases:27.35%
controls:0.99%
cases:60.53%
controls:4.22%
57
79
666
7151
80
59
643
7171
60
7
663
7223
—
53
11
669
7213
195
71
518
7081
388
282
253
6403
Chronic kidney disease, unspecified
N18.9 [45553438]
N18.9 [45553438]
3.5e+00
3.5e+00
3.7e+00
1.0e+50
3.7e+00
3.2e+00
2.7e+00
cases:15.77%
controls:0.58%
cases:12.03%
controls:0.43%
cases:3.73%
controls:0.10%
cases:1.94%
controls:0.00%
cases:3.32%
controls:0.08%
cases:9.40%
controls:0.41%
cases:11.54%
controls:0.91%
114
42
609
7188
87
31
636
7199
27
7
696
7223
14
0
709
7230
24
6
698
7218
67
29
646
7123
74
61
567
6624
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
2.5e+00
3.2e+00
4.4e+00
—
3.9e+00
3.4e+00
2.0e+00
cases:7.33%
controls:0.68%
cases:9.13%
controls:0.41%
cases:5.39%
controls:0.07%
—
—
cases:5.12%
controls:0.11%
cases:13.46%
controls:0.53%
cases:22.93%
controls:3.86%
53
49
670
7181
66
30
657
7200
39
5
684
7225
—
37
8
685
7216
96
38
617
7114
147
258
494
6427
Outpatient Visit
OP [9202]
OP [9202]
1.8e+00
2.4e+00
1.6e+00
6.5e+00
1.8e+00
2.4e+00
2.5e+00
cases:93.36%
controls:69.88%
cases:91.29%
controls:49.75%
cases:39.56%
controls:11.84%
cases:75.66%
controls:0.46%
cases:43.49%
controls:11.64%
cases:92.01%
controls:51.75%
cases:97.50%
controls:77.05%
675
5052
48
2178
660
3597
63
3633
286
856
437
6374
547
33
176
7197
314
841
408
6383
656
3701
57
3451
625
5151
16
1534
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
2.3e+00
3.0e+00
4.2e+00
—
3.4e+00
3.2e+00
2.5e+00
cases:7.33%
controls:0.82%
cases:9.68%
controls:0.54%
cases:6.36%
controls:0.10%
—
—
cases:4.57%
controls:0.15%
cases:15.99%
controls:0.74%
cases:24.02%
controls:2.62%
53
59
670
7171
70
39
653
7191
46
7
677
7223
—
33
11
689
7213
114
53
599
7099
154
175
487
6510
Insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E10.2 [2000503132]
N08.39*E10.2 [2000503132]
3.2e+00
3.0e+00
3.4e+00
—
3.4e+00
2.9e+00
2.6e+00
cases:4.43%
controls:0.19%
cases:3.60%
controls:0.18%
cases:2.07%
controls:0.07%
—
—
cases:2.49%
controls:0.08%
cases:3.51%
controls:0.20%
cases:3.74%
controls:0.30%
32
14
691
7216
26
13
697
7217
15
5
708
7225
—
18
6
704
7218
25
14
688
7138
24
20
617
6665
FISTULA - Fistula
FISTULA-1 [2002330212]
FISTULA-1 [2002330212]
4.1e+00
4.7e+00
—
—
—
5.1e+00
4.2e+00
cases:4.70%
controls:0.08%
cases:8.30%
controls:0.08%
—
—
—
—
—
—
cases:11.78%
controls:0.08%
cases:10.61%
controls:0.18%
34
6
689
7224
60
6
663
7224
—
—
—
84
6
629
7146
68
12
573
6673
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
2.6e+00
3.1e+00
3.1e+00
—
3.2e+00
3.1e+00
2.8e+00
cases:49.52%
controls:7.03%
cases:34.16%
controls:2.25%
cases:6.64%
controls:0.30%
—
—
cases:5.26%
controls:0.22%
cases:25.39%
controls:1.47%
cases:19.50%
controls:1.47%
358
508
365
6722
247
163
476
7067
48
22
675
7208
—
38
16
684
7208
181
105
532
7047
125
98
516
6587
Hemodialysis
TK800 [2001305768]
TK800 [2001305768]
3.8e+00
4.8e+00
—
—
—
4.9e+00
4.3e+00
cases:8.85%
controls:0.21%
cases:11.89%
controls:0.11%
—
—
—
—
—
—
cases:14.45%
controls:0.13%
cases:13.73%
controls:0.21%
64
15
659
7215
86
8
637
7222
—
—
—
103
9
610
7143
88
14
553
6671
Kidney transplant status
Z94.0 [45566477]
Z94.0 [45566477]
2.9e+00
2.7e+00
2.6e+00
1.0e+50
2.6e+00
3.1e+00
3.6e+00
cases:3.60%
controls:0.21%
cases:2.63%
controls:0.18%
cases:1.52%
controls:0.11%
cases:1.66%
controls:0.00%
cases:1.52%
controls:0.11%
cases:4.91%
controls:0.24%
cases:9.52%
controls:0.30%
26
15
697
7215
19
13
704
7217
11
8
712
7222
12
0
711
7230
11
8
711
7216
35
17
678
7135
61
20
580
6665
alfacalcidol; oral, parenteral
A11CC03 [21600818]
A11CC03 [21600818]
3.9e+00
4.2e+00
—
—
—
4.5e+00
4.2e+00
cases:11.07%
controls:0.25%
cases:11.07%
controls:0.18%
—
—
—
—
—
—
cases:11.50%
controls:0.14%
cases:13.73%
controls:0.24%
80
18
643
7212
80
13
643
7217
—
—
—
82
10
631
7142
88
16
553
6669
Reagin Ab [Titer] in Serum by VDRL
50690-7 [3029634]
50690-7 [3029634]
3.1e+00
3.9e+00
1.0e+50
—
1.0e+50
4.9e+00
4.7e+00
cases:2.63%
controls:0.12%
cases:3.46%
controls:0.07%
cases:0.83%
controls:0.00%
—
—
cases:0.69%
controls:0.00%
cases:11.64%
controls:0.10%
cases:38.53%
controls:0.58%
19
9
704
7221
25
5
698
7225
6
0
717
7230
—
5
0
717
7224
83
7
630
7145
247
39
394
6646
Other chronic renal failure
N18.8 [45534123]
N18.8 [45534123]
3.3e+00
3.1e+00
2.6e+00
1.0e+50
2.3e+00
2.9e+00
2.2e+00
cases:5.53%
controls:0.22%
cases:4.15%
controls:0.19%
cases:0.97%
controls:0.07%
cases:0.69%
controls:0.00%
cases:0.83%
controls:0.08%
cases:3.09%
controls:0.17%
cases:3.43%
controls:0.40%
40
16
683
7214
30
14
693
7216
7
5
716
7225
5
0
718
7230
6
6
716
7218
22
12
691
7140
22
27
619
6658
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
1.9e+00
2.7e+00
3.5e+00
—
3.5e+00
2.7e+00
1.9e+00
cases:7.19%
controls:1.15%
cases:8.71%
controls:0.66%
cases:2.35%
controls:0.07%
—
—
cases:3.46%
controls:0.11%
cases:12.76%
controls:1.02%
cases:24.65%
controls:4.70%
52
83
671
7147
63
48
660
7182
17
5
706
7225
—
25
8
697
7216
91
73
622
7079
158
314
483
6371
clozapine; oral, parenteral
N05AH02 [21604542]
N05AH02 [21604542]
2.5e+00
2.6e+00
2.5e+00
—
2.8e+00
2.9e+00
2.8e+00
cases:2.63%
controls:0.22%
cases:2.63%
controls:0.21%
cases:1.52%
controls:0.12%
—
—
cases:1.80%
controls:0.11%
cases:2.66%
controls:0.15%
cases:3.28%
controls:0.21%
19
16
704
7214
19
15
704
7215
11
9
712
7221
—
13
8
709
7216
19
11
694
7141
21
14
620
6671
Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26009-1 [3019539]
26009-1 [3019539]
2.6e+00
3.8e+00
1.0e+50
—
1.0e+50
4.7e+00
4.7e+00
cases:2.07%
controls:0.15%
cases:3.04%
controls:0.07%
cases:0.69%
controls:0.00%
—
—
cases:0.69%
controls:0.00%
cases:8.27%
controls:0.08%
cases:32.29%
controls:0.43%
15
11
708
7219
22
5
701
7225
5
0
718
7230
—
5
0
717
7224
59
6
654
7146
207
29
434
6656
darbepoetin alfa; parenteral
B03XA02 [21601134]
B03XA02 [21601134]
4.0e+00
4.1e+00
—
—
—
3.9e+00
3.8e+00
cases:7.88%
controls:0.15%
cases:9.68%
controls:0.18%
—
—
—
—
—
—
cases:9.54%
controls:0.21%
cases:9.83%
controls:0.25%
57
11
666
7219
70
13
653
7217
—
—
—
68
15
645
7137
63
17
578
6668
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
2.3e+00
3.4e+00
—
—
4.1e+00
3.4e+00
2.5e+00
cases:6.22%
controls:0.64%
cases:8.16%
controls:0.30%
—
—
—
—
cases:4.02%
controls:0.07%
cases:11.36%
controls:0.41%
cases:21.37%
controls:2.15%
45
46
678
7184
59
22
664
7208
—
—
29
5
693
7219
81
29
632
7123
137
144
504
6541
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
2.0e+00
2.7e+00
3.3e+00
1.0e+50
2.8e+00
2.6e+00
2.2e+00
cases:29.32%
controls:5.26%
cases:16.74%
controls:1.38%
cases:4.29%
controls:0.17%
cases:1.11%
controls:0.00%
cases:3.60%
controls:0.22%
cases:14.17%
controls:1.23%
cases:22.93%
controls:3.22%
212
380
511
6850
121
100
602
7130
31
12
692
7218
8
0
715
7230
26
16
696
7208
101
88
612
7064
147
215
494
6470
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2731-8 [3000067]
2.7e+00
3.0e+00
—
—
3.6e+00
3.7e+00
2.5e+00
cases:6.92%
controls:0.50%
cases:7.61%
controls:0.41%
—
—
—
—
cases:3.32%
controls:0.10%
cases:13.74%
controls:0.41%
cases:22.78%
controls:2.30%
50
36
673
7194
55
30
668
7200
—
—
24
7
698
7217
98
29
615
7123
146
154
495
6531
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
1.9e+00
2.8e+00
2.7e+00
—
2.8e+00
2.8e+00
2.4e+00
cases:23.65%
controls:4.51%
cases:17.15%
controls:1.24%
cases:2.77%
controls:0.19%
—
—
cases:3.05%
controls:0.19%
cases:16.69%
controls:1.26%
cases:31.67%
controls:3.96%
171
326
552
6904
124
90
599
7140
20
14
703
7216
—
22
14
700
7210
119
90
594
7062
203
265
438
6420
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
2.4e+00
3.1e+00
—
—
4.2e+00
3.4e+00
2.1e+00
cases:7.33%
controls:0.72%
cases:9.27%
controls:0.44%
—
—
—
—
cases:5.12%
controls:0.08%
cases:13.60%
controls:0.55%
cases:23.56%
controls:3.74%
53
52
670
7178
67
32
656
7198
—
—
37
6
685
7218
97
39
616
7113
151
250
490
6435
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
2.2e+00
2.7e+00
2.6e+00
1.0e+50
2.9e+00
2.7e+00
1.9e+00
cases:13.97%
controls:1.76%
cases:7.33%
controls:0.51%
cases:0.97%
controls:0.07%
cases:0.97%
controls:0.00%
cases:1.25%
controls:0.07%
cases:5.89%
controls:0.43%
cases:8.74%
controls:1.42%
101
127
622
7103
53
37
670
7193
7
5
716
7225
7
0
716
7230
9
5
713
7219
42
31
671
7121
56
95
585
6590
Hospital outpatient
ZY010 [2001311599]
ZY010 [2001311599]
1.5e+00
2.3e+00
2.2e+00
1.0e+50
2.7e+00
3.5e+00
2.8e+00
cases:1.24%
controls:0.28%
cases:2.35%
controls:0.24%
cases:0.83%
controls:0.10%
cases:0.69%
controls:0.00%
cases:1.39%
controls:0.10%
cases:8.13%
controls:0.27%
cases:8.89%
controls:0.58%
9
20
714
7210
17
17
706
7213
6
7
717
7223
5
0
718
7230
10
7
712
7217
58
19
655
7133
57
39
584
6646
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
3.4e+00
3.8e+00
—
—
—
4.0e+00
3.8e+00
cases:7.19%
controls:0.26%
cases:9.41%
controls:0.24%
—
—
—
—
—
—
cases:11.78%
controls:0.25%
cases:12.32%
controls:0.31%
52
19
671
7211
68
17
655
7213
—
—
—
84
18
629
7134
79
21
562
6664
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
2.5e+00
3.4e+00
3.8e+00
1.0e+50
—
3.2e+00
2.1e+00
cases:30.84%
controls:3.61%
cases:20.89%
controls:0.90%
cases:3.04%
controls:0.07%
cases:3.18%
controls:0.00%
—
—
cases:10.80%
controls:0.50%
cases:4.21%
controls:0.54%
223
261
500
6969
151
65
572
7165
22
5
701
7225
23
0
700
7230
—
77
36
636
7116
27
36
614
6649
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
2.4e+00
3.1e+00
—
—
4.0e+00
3.3e+00
2.0e+00
cases:7.19%
controls:0.72%
cases:9.27%
controls:0.44%
—
—
—
—
cases:5.12%
controls:0.10%
cases:13.32%
controls:0.55%
cases:22.62%
controls:3.74%
52
52
671
7178
67
32
656
7198
—
—
37
7
685
7217
95
39
618
7113
145
250
496
6435
Chronic kidney disease
N18 [45582391]
N18 [45582391]
4.0e+00
4.1e+00
—
—
—
3.7e+00
2.8e+00
cases:7.88%
controls:0.15%
cases:4.15%
controls:0.07%
—
—
—
—
—
—
cases:3.23%
controls:0.08%
cases:5.30%
controls:0.33%
57
11
666
7219
30
5
693
7225
—
—
—
23
6
690
7146
34
22
607
6663
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
1.8e+00
2.2e+00
3.2e+00
—
3.6e+00
2.1e+00
1.5e+00
cases:5.81%
controls:1.01%
cases:6.36%
controls:0.76%
cases:4.15%
controls:0.18%
—
—
cases:4.57%
controls:0.12%
cases:7.29%
controls:0.95%
cases:14.82%
controls:3.83%
42
73
681
7157
46
55
677
7175
30
13
693
7217
—
33
9
689
7215
52
68
661
7084
95
256
546
6429
Vascular Surgery
77 [38004496]
77 [38004496]
1.8e+00
2.5e+00
3.5e+00
1.0e+50
2.6e+00
2.2e+00
1.7e+00
cases:12.86%
controls:2.38%
cases:11.62%
controls:1.05%
cases:4.29%
controls:0.14%
cases:0.97%
controls:0.00%
cases:3.60%
controls:0.28%
cases:9.96%
controls:1.23%
cases:15.29%
controls:3.26%
93
172
630
7058
84
76
639
7154
31
10
692
7220
7
0
716
7230
26
20
696
7204
71
88
642
7064
98
218
543
6467
Other extensive ultrasound examination of artery
PG1DE [2001309713]
PG1DE [2001309713]
3.2e+00
4.2e+00
1.0e+50
—
1.0e+50
3.2e+00
3.4e+00
cases:8.44%
controls:0.37%
cases:7.05%
controls:0.11%
cases:1.80%
controls:0.00%
—
—
cases:1.25%
controls:0.00%
cases:4.21%
controls:0.18%
cases:9.20%
controls:0.33%
61
27
662
7203
51
8
672
7222
13
0
710
7230
—
9
0
713
7224
30
13
683
7139
59
22
582
6663
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
1.7e+00
2.5e+00
2.9e+00
1.0e+50
2.7e+00
2.2e+00
1.9e+00
cases:25.45%
controls:5.80%
cases:14.52%
controls:1.31%
cases:2.90%
controls:0.17%
cases:1.24%
controls:0.00%
cases:2.49%
controls:0.18%
cases:12.20%
controls:1.54%
cases:20.75%
controls:3.68%
184
419
539
6811
105
95
618
7135
21
12
702
7218
9
0
714
7230
18
13
704
7211
87
110
626
7042
133
246
508
6439
Preparatory care for dialysis
Z49.0 [45571361]
Z49.0 [45571361]
4.7e+00
4.8e+00
1.0e+50
1.0e+50
—
4.3e+00
—
cases:8.71%
controls:0.08%
cases:7.61%
controls:0.07%
cases:3.18%
controls:0.00%
cases:2.90%
controls:0.00%
—
—
cases:5.05%
controls:0.07%
—
—
63
6
660
7224
55
5
668
7225
23
0
700
7230
21
0
702
7230
—
36
5
677
7147
—
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
1.3e+00
2.3e+00
2.5e+00
—
2.8e+00
2.8e+00
1.9e+00
cases:4.43%
controls:1.22%
cases:6.64%
controls:0.69%
cases:0.83%
controls:0.07%
—
—
cases:1.52%
controls:0.10%
cases:11.92%
controls:0.78%
cases:24.49%
controls:4.68%
32
88
691
7142
48
50
675
7180
6
5
717
7225
—
11
7
711
7217
85
56
628
7096
157
313
484
6372
calcium carbonate; oral
A12AA04 [21600863]
A12AA04 [21600863]
3.3e+00
3.4e+00
—
—
—
3.7e+00
3.1e+00
cases:8.71%
controls:0.36%
cases:6.09%
controls:0.21%
—
—
—
—
—
—
cases:6.87%
controls:0.18%
cases:7.80%
controls:0.39%
63
26
660
7204
44
15
679
7215
—
—
—
49
13
664
7139
50
26
591
6659
calcium carbonate
A02AC01 [21600065]
A02AC01 [21600065]
3.3e+00
3.4e+00
—
—
—
3.7e+00
3.1e+00
cases:8.71%
controls:0.36%
cases:6.09%
controls:0.21%
—
—
—
—
—
—
cases:6.87%
controls:0.18%
cases:7.80%
controls:0.39%
63
26
660
7204
44
15
679
7215
—
—
—
49
13
664
7139
50
26
591
6659
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
2.1e+00
2.4e+00
2.4e+00
—
2.3e+00
2.4e+00
1.7e+00
cases:42.46%
controls:8.28%
cases:25.59%
controls:2.92%
cases:4.15%
controls:0.37%
—
—
cases:3.60%
controls:0.36%
cases:24.40%
controls:2.84%
cases:37.44%
controls:9.87%
307
599
416
6631
185
211
538
7019
30
27
693
7203
—
26
26
696
7198
174
203
539
6949
240
660
401
6025
prazosin; oral
C02CA01 [21600411]
C02CA01 [21600411]
2.8e+00
3.1e+00
2.9e+00
—
—
2.7e+00
1.9e+00
cases:4.70%
controls:0.30%
cases:4.01%
controls:0.19%
cases:1.52%
controls:0.08%
—
—
—
—
cases:2.95%
controls:0.21%
cases:2.96%
controls:0.45%
34
22
689
7208
29
14
694
7216
11
6
712
7224
—
—
21
15
692
7137
19
30
622
6655
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
2.0e+00
2.8e+00
—
—
3.9e+00
2.7e+00
2.0e+00
cases:7.33%
controls:1.07%
cases:8.30%
controls:0.57%
—
—
—
—
cases:3.46%
controls:0.07%
cases:12.62%
controls:1.01%
cases:24.18%
controls:4.29%
53
77
670
7153
60
41
663
7189
—
—
25
5
697
7219
90
72
623
7080
155
287
486
6398
tacrolimus; oral, parenteral
L04AD02 [21603925]
L04AD02 [21603925]
3.4e+00
2.9e+00
—
—
—
3.5e+00
3.5e+00
cases:2.07%
controls:0.07%
cases:1.94%
controls:0.11%
—
—
—
—
—
—
cases:3.65%
controls:0.11%
cases:7.18%
controls:0.24%
15
5
708
7225
14
8
709
7222
—
—
—
26
8
687
7144
46
16
595
6669
pH of Specimen
17433-4 [3019225]
17433-4 [3019225]
1.9e+00
2.0e+00
3.8e+00
—
3.4e+00
2.0e+00
3.4e-01
cases:6.09%
controls:0.93%
cases:6.50%
controls:0.93%
cases:5.39%
controls:0.12%
—
—
cases:4.29%
controls:0.15%
cases:6.31%
controls:0.91%
cases:3.90%
controls:2.80%
44
67
679
7163
47
67
676
7163
39
9
684
7221
—
31
11
691
7213
45
65
668
7087
25
187
616
6498
End-stage renal disease
N18.0 [45601717]
N18.0 [45601717]
4.2e+00
—
—
1.0e+50
—
4.4e+00
4.4e+00
cases:6.92%
controls:0.11%
—
—
—
—
cases:1.38%
controls:0.00%
—
—
cases:5.61%
controls:0.07%
cases:6.86%
controls:0.09%
50
8
673
7222
—
—
10
0
713
7230
—
40
5
673
7147
44
6
597
6679
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
1.7e+00
2.3e+00
2.9e+00
—
2.2e+00
2.2e+00
1.7e+00
cases:28.08%
controls:6.40%
cases:13.97%
controls:1.55%
cases:2.90%
controls:0.17%
—
—
cases:2.22%
controls:0.25%
cases:11.22%
controls:1.41%
cases:19.81%
controls:4.37%
203
463
520
6767
101
112
622
7118
21
12
702
7218
—
16
18
706
7206
80
101
633
7051
127
292
514
6393
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
3.2e+00
3.6e+00
1.0e+50
1.0e+50
1.0e+50
3.6e+00
2.5e+00
cases:17.15%
controls:0.80%
cases:8.58%
controls:0.26%
cases:1.24%
controls:0.00%
cases:1.38%
controls:0.00%
cases:1.25%
controls:0.00%
cases:5.05%
controls:0.14%
cases:4.06%
controls:0.36%
124
58
599
7172
62
19
661
7211
9
0
714
7230
10
0
713
7230
9
0
713
7224
36
10
677
7142
26
24
615
6661
Treatment of a patient needing special arrangements
WYA30 [2001310874]
WYA30 [2001310874]
3.0e+00
3.5e+00
—
—
—
3.2e+00
3.1e+00
cases:16.18%
controls:1.00%
cases:8.16%
controls:0.26%
—
—
—
—
—
—
cases:10.10%
controls:0.46%
cases:22.31%
controls:1.33%
117
72
606
7158
59
19
664
7211
—
—
—
72
33
641
7119
143
89
498
6596
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
TPH15 [2001309600]
2.8e+00
3.6e+00
—
—
—
3.5e+00
2.7e+00
cases:7.05%
controls:0.46%
cases:4.84%
controls:0.14%
—
—
—
—
—
—
cases:4.63%
controls:0.14%
cases:9.52%
controls:0.67%
51
33
672
7197
35
10
688
7220
—
—
—
33
10
680
7142
61
45
580
6640
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
4.5e-01
1.8e+00
2.3e+00
—
2.0e+00
3.1e+00
3.5e+00
cases:4.01%
controls:2.60%
cases:8.16%
controls:1.48%
cases:3.60%
controls:0.39%
—
—
cases:2.49%
controls:0.33%
cases:32.26%
controls:2.15%
cases:76.13%
controls:8.50%
29
188
694
7042
59
107
664
7123
26
28
697
7202
—
18
24
704
7200
230
154
483
6998
488
568
153
6117
Blood transfusion
WW500 [2001310603]
WW500 [2001310603]
3.3e+00
3.9e+00
1.0e+50
—
1.0e+50
3.0e+00
2.5e+00
cases:4.84%
controls:0.18%
cases:3.18%
controls:0.07%
cases:0.69%
controls:0.00%
—
—
cases:0.69%
controls:0.00%
cases:2.10%
controls:0.11%
cases:3.43%
controls:0.28%
35
13
688
7217
23
5
700
7225
5
0
718
7230
—
5
0
717
7224
15
8
698
7144
22
19
619
6666
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
1.3e+00
2.0e+00
2.7e+00
—
2.6e+00
2.4e+00
1.6e+00
cases:6.09%
controls:1.80%
cases:5.26%
controls:0.76%
cases:1.80%
controls:0.12%
—
—
cases:0.97%
controls:0.07%
cases:9.12%
controls:0.89%
cases:25.90%
controls:6.40%
44
130
679
7100
38
55
685
7175
13
9
710
7221
—
7
5
715
7219
65
64
648
7088
166
428
475
6257
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
1.3e+00
1.8e+00
3.2e+00
—
3.1e+00
1.8e+00
1.1e+00
cases:7.05%
controls:1.99%
cases:7.19%
controls:1.23%
cases:2.35%
controls:0.10%
—
—
cases:2.91%
controls:0.14%
cases:9.40%
controls:1.69%
cases:20.12%
controls:7.79%
51
144
672
7086
52
89
671
7141
17
7
706
7223
—
21
10
701
7214
67
121
646
7031
129
521
512
6164
Difficulties in perfomrming procedure
ZXD30 [2001311389]
ZXD30 [2001311389]
3.2e+00
3.7e+00
—
—
—
2.8e+00
2.6e+00
cases:8.44%
controls:0.36%
cases:4.29%
controls:0.11%
—
—
—
—
—
—
cases:1.96%
controls:0.13%
cases:6.86%
controls:0.55%
61
26
662
7204
31
8
692
7222
—
—
—
14
9
699
7143
44
37
597
6648
Standard cardiac ultrasound examination
FM1AE [2001303278]
FM1AE [2001303278]
2.0e+00
2.4e+00
2.9e+00
1.0e+50
—
2.5e+00
2.1e+00
cases:16.18%
controls:2.48%
cases:9.27%
controls:0.91%
cases:1.80%
controls:0.10%
cases:2.07%
controls:0.00%
—
—
cases:8.70%
controls:0.74%
cases:17.94%
controls:2.50%
117
179
606
7051
67
66
656
7164
13
7
710
7223
15
0
708
7230
—
62
53
651
7099
115
167
526
6518
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
2.8e+00
2.9e+00
—
—
—
3.4e+00
3.0e+00
cases:11.48%
controls:0.80%
cases:6.22%
controls:0.36%
—
—
—
—
—
—
cases:6.45%
controls:0.24%
cases:12.32%
controls:0.69%
83
58
640
7172
45
26
678
7204
—
—
—
46
17
667
7135
79
46
562
6639
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
2.8e+00
2.9e+00
—
—
—
3.4e+00
3.0e+00
cases:11.48%
controls:0.80%
cases:6.22%
controls:0.36%
—
—
—
—
—
—
cases:6.45%
controls:0.24%
cases:12.32%
controls:0.69%
83
58
640
7172
45
26
678
7204
—
—
—
46
17
667
7135
79
46
562
6639
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
2.8e+00
2.9e+00
—
—
—
3.4e+00
3.0e+00
cases:11.48%
controls:0.80%
cases:6.22%
controls:0.36%
—
—
—
—
—
—
cases:6.45%
controls:0.24%
cases:12.32%
controls:0.69%
83
58
640
7172
45
26
678
7204
—
—
—
46
17
667
7135
79
46
562
6639
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
2.8e+00
2.9e+00
—
—
—
3.4e+00
3.0e+00
cases:11.48%
controls:0.80%
cases:6.22%
controls:0.36%
—
—
—
—
—
—
cases:6.45%
controls:0.24%
cases:12.32%
controls:0.69%
83
58
640
7172
45
26
678
7204
—
—
—
46
17
667
7135
79
46
562
6639
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
2.8e+00
2.9e+00
—
—
—
3.4e+00
3.0e+00
cases:11.48%
controls:0.80%
cases:6.22%
controls:0.36%
—
—
—
—
—
—
cases:6.45%
controls:0.24%
cases:12.32%
controls:0.69%
83
58
640
7172
45
26
678
7204
—
—
—
46
17
667
7135
79
46
562
6639
Hypertension secondary to other renal disorders
I15.1 [45557535]
I15.1 [45557535]
2.6e+00
3.3e+00
—
1.0e+50
—
3.4e+00
2.8e+00
cases:2.21%
controls:0.17%
cases:2.49%
controls:0.10%
—
—
cases:2.07%
controls:0.00%
—
—
cases:2.81%
controls:0.10%
cases:3.28%
controls:0.21%
16
12
707
7218
18
7
705
7223
—
15
0
708
7230
—
20
7
693
7145
21
14
620
6671
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
1.2e+00
1.9e+00
2.7e+00
—
2.5e+00
2.2e+00
1.6e+00
cases:4.01%
controls:1.24%
cases:3.73%
controls:0.59%
cases:1.24%
controls:0.08%
—
—
cases:0.83%
controls:0.07%
cases:6.73%
controls:0.81%
cases:19.19%
controls:4.73%
29
90
694
7140
27
43
696
7187
9
6
714
7224
—
6
5
716
7219
48
58
665
7094
123
316
518
6369
Measurement of heart muscle perfusion with exercise
XF655 [2001303392]
XF655 [2001303392]
2.5e+00
3.6e+00
—
—
—
2.9e+00
2.9e+00
cases:3.73%
controls:0.33%
cases:2.49%
controls:0.07%
—
—
—
—
—
—
cases:1.82%
controls:0.10%
cases:2.50%
controls:0.13%
27
24
696
7206
18
5
705
7225
—
—
—
13
7
700
7145
16
9
625
6676
Kidney ultrasound examination
KA1AE [2001305627]
KA1AE [2001305627]
3.6e+00
3.0e+00
—
—
—
2.7e+00
2.7e+00
cases:6.78%
controls:0.19%
cases:2.21%
controls:0.11%
—
—
—
—
—
—
cases:0.98%
controls:0.07%
cases:2.50%
controls:0.18%
49
14
674
7216
16
8
707
7222
—
—
—
7
5
706
7147
16
12
625
6673
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
1.1e+00
1.5e+00
2.9e+00
—
2.5e+00
2.1e+00
1.9e+00
cases:9.96%
controls:3.65%
cases:11.76%
controls:2.92%
cases:7.61%
controls:0.47%
—
—
cases:6.23%
controls:0.55%
cases:22.72%
controls:3.54%
cases:54.91%
controls:15.17%
72
264
651
6966
85
211
638
7019
55
34
668
7196
—
45
40
677
7184
162
253
551
6899
352
1014
289
5671
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
1.4e+00
2.0e+00
2.5e+00
1.0e+50
2.6e+00
1.8e+00
1.5e+00
cases:5.12%
controls:1.26%
cases:4.43%
controls:0.64%
cases:1.66%
controls:0.14%
cases:0.69%
controls:0.00%
cases:2.08%
controls:0.15%
cases:4.91%
controls:0.82%
cases:7.33%
controls:1.77%
37
91
686
7139
32
46
691
7184
12
10
711
7220
5
0
718
7230
15
11
707
7213
35
59
678
7093
47
118
594
6567
Chronic viral hepatitis C
B18.2 [45590846]
B18.2 [45590846]
2.8e+00
3.3e+00
—
1.0e+50
1.0e+50
3.1e+00
2.7e+00
cases:2.49%
controls:0.15%
cases:1.80%
controls:0.07%
—
—
cases:1.52%
controls:0.00%
cases:0.97%
controls:0.00%
cases:2.38%
controls:0.11%
cases:2.96%
controls:0.21%
18
11
705
7219
13
5
710
7225
—
11
0
712
7230
7
0
715
7224
17
8
696
7144
19
14
622
6671
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
2.2e+00
2.6e+00
3.9e+00
—
—
2.3e+00
8.5e-01
cases:4.84%
controls:0.54%
cases:5.53%
controls:0.44%
cases:3.87%
controls:0.08%
—
—
—
—
cases:5.33%
controls:0.56%
cases:5.15%
controls:2.27%
35
39
688
7191
40
32
683
7198
28
6
695
7224
—
—
38
40
675
7112
33
152
608
6533
ciclosporin; oral, parenteral
L04AD01 [21603924]
L04AD01 [21603924]
2.7e+00
2.9e+00
—
—
—
3.0e+00
3.2e+00
cases:3.32%
controls:0.24%
cases:2.35%
controls:0.14%
—
—
—
—
—
—
cases:2.95%
controls:0.15%
cases:4.37%
controls:0.18%
24
17
699
7213
17
10
706
7220
—
—
—
21
11
692
7141
28
12
613
6673
Left side
ZXA05 [2001311347]
ZXA05 [2001311347]
1.3e+00
2.1e+00
1.9e+00
1.0e+50
2.9e+00
1.9e+00
1.7e+00
cases:13.42%
controls:3.91%
cases:9.13%
controls:1.27%
cases:0.97%
controls:0.15%
cases:2.07%
controls:0.00%
cases:1.66%
controls:0.10%
cases:8.56%
controls:1.34%
cases:15.29%
controls:3.16%
97
283
626
6947
66
92
657
7138
7
11
716
7219
15
0
708
7230
12
7
710
7217
61
96
652
7056
98
211
543
6474
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
9.1e-01
1.5e+00
3.0e+00
—
2.6e+00
2.0e+00
1.4e+00
cases:10.24%
controls:4.38%
cases:13.42%
controls:3.24%
cases:9.13%
controls:0.50%
—
—
cases:7.89%
controls:0.61%
cases:23.84%
controls:4.03%
cases:47.27%
controls:17.56%
74
317
649
6913
97
234
626
6996
66
36
657
7194
—
57
44
665
7180
170
288
543
6864
303
1174
338
5511
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
1.6e+00
2.4e+00
3.4e+00
—
—
2.3e+00
1.6e+00
cases:5.12%
controls:1.05%
cases:4.15%
controls:0.39%
cases:2.07%
controls:0.07%
—
—
—
—
cases:3.37%
controls:0.34%
cases:7.49%
controls:1.54%
37
76
686
7154
30
28
693
7202
15
5
708
7225
—
—
24
24
689
7128
48
103
593
6582
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
1.3e+00
1.8e+00
2.2e+00
—
2.7e+00
1.7e+00
1.7e+00
cases:5.39%
controls:1.55%
cases:5.53%
controls:0.91%
cases:1.11%
controls:0.12%
—
—
cases:1.25%
controls:0.08%
cases:5.61%
controls:1.12%
cases:26.21%
controls:6.07%
39
112
684
7118
40
66
683
7164
8
9
715
7221
—
9
6
713
7218
40
80
673
7072
168
406
473
6279
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
L04AA06 [21603896]
2.5e+00
2.5e+00
—
—
—
3.0e+00
3.3e+00
cases:3.32%
controls:0.28%
cases:2.63%
controls:0.22%
—
—
—
—
—
—
cases:4.49%
controls:0.22%
cases:9.52%
controls:0.37%
24
20
699
7210
19
16
704
7214
—
—
—
32
16
681
7136
61
25
580
6660
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
1.1e+00
1.5e+00
2.9e+00
—
2.6e+00
2.0e+00
1.2e+00
cases:9.27%
controls:3.42%
cases:9.82%
controls:2.39%
cases:3.32%
controls:0.18%
—
—
cases:3.88%
controls:0.29%
cases:17.25%
controls:2.77%
cases:37.13%
controls:14.69%
67
247
656
6983
71
173
652
7057
24
13
699
7217
—
28
21
694
7203
123
198
590
6954
238
982
403
5703
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
1.7e+00
2.9e+00
2.8e+00
—
—
2.4e+00
1.5e+00
cases:13.14%
controls:2.67%
cases:9.41%
controls:0.57%
cases:1.52%
controls:0.10%
—
—
—
—
cases:7.01%
controls:0.70%
cases:9.67%
controls:2.36%
95
193
628
7037
68
41
655
7189
11
7
712
7223
—
—
50
50
663
7102
62
158
579
6527
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
2.7e+00
3.2e+00
—
1.0e+50
—
2.9e+00
2.4e+00
cases:13.42%
controls:1.01%
cases:8.99%
controls:0.41%
—
—
cases:1.24%
controls:0.00%
—
—
cases:6.73%
controls:0.41%
cases:10.30%
controls:0.99%
97
73
626
7157
65
30
658
7200
—
9
0
714
7230
—
48
29
665
7123
66
66
575
6619
Venereal disease screening
171128005 [4064905]
171128005 [4064905]
2.3e+00
2.8e+00
—
—
—
3.0e+00
3.0e+00
cases:5.53%
controls:0.57%
cases:2.49%
controls:0.15%
—
—
—
—
—
—
cases:2.66%
controls:0.14%
cases:7.33%
controls:0.37%
40
41
683
7189
18
11
705
7219
—
—
—
19
10
694
7142
47
25
594
6660
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
2.7e+00
2.6e+00
—
—
—
2.9e+00
2.9e+00
cases:11.62%
controls:0.91%
cases:6.22%
controls:0.47%
—
—
—
—
—
—
cases:6.45%
controls:0.38%
cases:12.48%
controls:0.75%
84
66
639
7164
45
34
678
7196
—
—
—
46
27
667
7125
80
50
561
6635
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
2.7e+00
2.6e+00
—
—
—
2.9e+00
2.9e+00
cases:11.62%
controls:0.91%
cases:6.22%
controls:0.47%
—
—
—
—
—
—
cases:6.45%
controls:0.38%
cases:12.48%
controls:0.75%
84
66
639
7164
45
34
678
7196
—
—
—
46
27
667
7125
80
50
561
6635
FEV1
20150-9 [3024653]
20150-9 [3024653]
2.7e+00
2.6e+00
—
—
—
2.9e+00
2.9e+00
cases:11.62%
controls:0.91%
cases:6.22%
controls:0.47%
—
—
—
—
—
—
cases:6.45%
controls:0.38%
cases:12.48%
controls:0.75%
84
66
639
7164
45
34
678
7196
—
—
—
46
27
667
7125
80
50
561
6635
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
1.0e+00
1.9e+00
2.1e+00
—
2.8e+00
1.8e+00
1.4e+00
cases:6.36%
controls:2.32%
cases:4.84%
controls:0.72%
cases:0.97%
controls:0.12%
—
—
cases:1.39%
controls:0.08%
cases:5.05%
controls:0.84%
cases:10.92%
controls:2.92%
46
168
677
7062
35
52
688
7178
7
9
716
7221
—
10
6
712
7218
36
60
677
7092
70
195
571
6490
Right side
ZXA00 [2001311346]
ZXA00 [2001311346]
1.4e+00
2.1e+00
2.5e+00
1.0e+50
1.8e+00
1.7e+00
1.6e+00
cases:13.97%
controls:3.79%
cases:8.58%
controls:1.15%
cases:1.80%
controls:0.15%
cases:1.24%
controls:0.00%
cases:1.11%
controls:0.18%
cases:6.59%
controls:1.30%
cases:15.44%
controls:3.53%
101
274
622
6956
62
83
661
7147
13
11
710
7219
9
0
714
7230
8
13
714
7211
47
93
666
7059
99
236
542
6449
dalteparin; parenteral
B01AB04 [21600975]
B01AB04 [21600975]
1.4e+00
3.0e+00
—
—
—
3.4e+00
3.2e+00
cases:1.38%
controls:0.33%
cases:1.94%
controls:0.10%
—
—
—
—
—
—
cases:2.38%
controls:0.08%
cases:2.18%
controls:0.09%
10
24
713
7206
14
7
709
7223
—
—
—
17
6
696
7146
14
6
627
6679
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
8.4e-01
1.3e+00
1.8e+00
—
1.6e+00
2.4e+00
3.0e+00
cases:9.82%
controls:4.48%
cases:12.59%
controls:3.71%
cases:5.26%
controls:0.93%
—
—
cases:4.02%
controls:0.80%
cases:35.90%
controls:4.95%
cases:80.50%
controls:16.77%
71
324
652
6906
91
268
632
6962
38
67
685
7163
—
29
58
693
7166
256
354
457
6798
516
1121
125
5564
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
19232-8 [3007628]
1.6e+00
2.7e+00
—
—
2.3e+00
3.7e+00
3.0e+00
cases:1.94%
controls:0.40%
cases:3.46%
controls:0.25%
—
—
—
—
cases:0.69%
controls:0.07%
cases:8.98%
controls:0.24%
cases:21.53%
controls:1.36%
14
29
709
7201
25
18
698
7212
—
—
5
5
717
7219
64
17
649
7135
138
91
503
6594
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
8.5e-01
1.3e+00
1.8e+00
—
1.6e+00
2.4e+00
3.0e+00
cases:9.82%
controls:4.45%
cases:12.59%
controls:3.73%
cases:5.26%
controls:0.93%
—
—
cases:4.02%
controls:0.83%
cases:35.90%
controls:4.89%
cases:80.50%
controls:16.65%
71
322
652
6908
91
270
632
6960
38
67
685
7163
—
29
60
693
7164
256
350
457
6802
516
1113
125
5572
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 [3015322]
2865-4 [3015322]
3.4e+00
3.2e+00
—
—
—
2.6e+00
1.8e+00
cases:2.77%
controls:0.10%
cases:1.66%
controls:0.07%
—
—
—
—
—
—
cases:2.24%
controls:0.17%
cases:4.68%
controls:0.84%
20
7
703
7223
12
5
711
7225
—
—
—
16
12
697
7140
30
56
611
6629
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
8.6e-01
1.3e+00
1.8e+00
—
1.6e+00
2.4e+00
3.0e+00
cases:9.82%
controls:4.38%
cases:12.59%
controls:3.73%
cases:5.26%
controls:0.94%
—
—
cases:3.88%
controls:0.83%
cases:35.76%
controls:4.88%
cases:80.50%
controls:16.66%
71
317
652
6913
91
270
632
6960
38
68
685
7162
—
28
60
694
7164
255
349
458
6803
516
1114
125
5571
Other healthcare associate professional
Z3229 [2001311561]
Z3229 [2001311561]
2.0e+00
2.2e+00
—
1.0e+50
2.2e+00
2.1e+00
2.4e+00
cases:11.62%
controls:1.73%
cases:4.98%
controls:0.59%
—
—
cases:1.38%
controls:0.00%
cases:1.11%
controls:0.12%
cases:3.93%
controls:0.48%
cases:4.52%
controls:0.45%
84
125
639
7105
36
43
687
7187
—
10
0
713
7230
8
9
714
7215
28
34
685
7118
29
30
612
6655
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
7.9e-01
1.3e+00
1.9e+00
—
1.6e+00
2.3e+00
3.0e+00
cases:9.41%
controls:4.48%
cases:12.59%
controls:3.93%
cases:5.26%
controls:0.86%
—
—
cases:4.02%
controls:0.82%
cases:35.76%
controls:5.27%
cases:80.81%
controls:17.08%
68
324
655
6906
91
284
632
6946
38
62
685
7168
—
29
59
693
7165
255
377
458
6775
518
1142
123
5543
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
7.7e-01
1.3e+00
1.8e+00
—
1.6e+00
2.4e+00
3.0e+00
cases:9.54%
controls:4.66%
cases:12.59%
controls:3.85%
cases:5.26%
controls:0.87%
—
—
cases:4.02%
controls:0.82%
cases:35.76%
controls:4.95%
cases:80.81%
controls:18.01%
69
337
654
6893
91
278
632
6952
38
63
685
7167
—
29
59
693
7165
255
354
458
6798
518
1204
123
5481
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
7.6e-01
1.3e+00
1.8e+00
—
1.6e+00
2.4e+00
2.9e+00
cases:9.54%
controls:4.70%
cases:12.59%
controls:3.86%
cases:5.26%
controls:0.87%
—
—
cases:4.02%
controls:0.83%
cases:35.76%
controls:4.95%
cases:80.81%
controls:18.07%
69
340
654
6890
91
279
632
6951
38
63
685
7167
—
29
60
693
7164
255
354
458
6798
518
1208
123
5477
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 [3043747]
32731-2 [3043747]
3.4e+00
3.2e+00
—
—
—
2.6e+00
1.6e+00
cases:2.77%
controls:0.10%
cases:1.66%
controls:0.07%
—
—
—
—
—
—
cases:2.24%
controls:0.17%
cases:4.68%
controls:0.97%
20
7
703
7223
12
5
711
7225
—
—
—
16
12
697
7140
30
65
611
6620
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 [3043723]
32730-4 [3043723]
3.4e+00
3.2e+00
—
—
—
2.5e+00
1.6e+00
cases:2.77%
controls:0.10%
cases:1.66%
controls:0.07%
—
—
—
—
—
—
cases:2.24%
controls:0.18%
cases:4.68%
controls:0.96%
20
7
703
7223
12
5
711
7225
—
—
—
16
13
697
7139
30
64
611
6621
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 [3005229]
2868-8 [3005229]
3.4e+00
3.2e+00
—
—
—
2.5e+00
1.6e+00
cases:2.77%
controls:0.10%
cases:1.66%
controls:0.07%
—
—
—
—
—
—
cases:2.24%
controls:0.18%
cases:4.68%
controls:0.97%
20
7
703
7223
12
5
711
7225
—
—
—
16
13
697
7139
30
65
611
6620
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
4.1e-01
5.1e-01
1.8e+00
2.8e+00
1.7e+00
5.3e-01
2.9e+00
cases:15.63%
controls:10.97%
cases:15.35%
controls:9.79%
cases:10.65%
controls:1.98%
cases:2.07%
controls:0.12%
cases:9.42%
controls:1.88%
cases:21.46%
controls:13.83%
cases:94.54%
controls:47.87%
113
793
610
6437
111
708
612
6522
77
143
646
7087
15
9
708
7221
68
136
654
7088
153
989
560
6163
606
3200
35
3485
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
8.1e-01
1.2e+00
1.8e+00
—
1.6e+00
2.3e+00
3.0e+00
cases:9.68%
controls:4.56%
cases:12.45%
controls:4.09%
cases:5.26%
controls:0.91%
—
—
cases:4.02%
controls:0.83%
cases:36.04%
controls:5.41%
cases:80.66%
controls:17.70%
70
330
653
6900
90
296
633
6934
38
66
685
7164
—
29
60
693
7164
257
387
456
6765
517
1183
124
5502
Paranoid schizophrenia continuous
F20.00 [2000501920]
F20.00 [2000501920]
2.5e+00
3.0e+00
—
1.0e+50
—
2.3e+00
2.8e+00
cases:2.35%
controls:0.19%
cases:2.07%
controls:0.11%
—
—
cases:1.52%
controls:0.00%
—
—
cases:1.40%
controls:0.14%
cases:2.03%
controls:0.12%
17
14
706
7216
15
8
708
7222
—
11
0
712
7230
—
10
10
703
7142
13
8
628
6677
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]
40988-8 [3044254]
2.6e+00
2.5e+00
—
—
—
3.6e+00
1.8e+00
cases:2.21%
controls:0.17%
cases:1.66%
controls:0.14%
—
—
—
—
—
—
cases:4.63%
controls:0.13%
cases:3.43%
controls:0.60%
16
12
707
7218
12
10
711
7220
—
—
—
33
9
680
7143
22
40
619
6645
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
3.9e-01
1.2e+00
2.0e+00
—
1.7e+00
2.5e+00
3.1e+00
cases:5.67%
controls:3.91%
cases:10.79%
controls:3.49%
cases:4.98%
controls:0.73%
—
—
cases:3.88%
controls:0.72%
cases:33.24%
controls:3.86%
cases:77.69%
controls:13.48%
41
283
682
6947
78
252
645
6978
36
53
687
7177
—
28
52
694
7172
237
276
476
6876
498
901
143
5784
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
7.1e-01
1.3e+00
1.7e+00
—
1.6e+00
2.3e+00
2.9e+00
cases:9.68%
controls:5.01%
cases:13.28%
controls:4.15%
cases:5.26%
controls:0.97%
—
—
cases:4.16%
controls:0.87%
cases:35.76%
controls:5.31%
cases:81.12%
controls:19.00%
70
362
653
6868
96
300
627
6930
38
70
685
7160
—
30
63
692
7161
255
380
458
6772
520
1270
121
5415
Monitored bed care
WX892 [2001310850]
WX892 [2001310850]
2.0e+00
3.3e+00
—
—
—
3.3e+00
1.9e+00
cases:6.50%
controls:0.97%
cases:4.15%
controls:0.17%
—
—
—
—
—
—
cases:4.35%
controls:0.17%
cases:7.49%
controls:1.15%
47
70
676
7160
30
12
693
7218
—
—
—
31
12
682
7140
48
77
593
6608
Sytologyspecimen from mouth of uterus
XLD00 [2001306651]
XLD00 [2001306651]
2.2e+00
2.8e+00
—
—
—
3.0e+00
2.4e+00
cases:6.78%
controls:0.83%
cases:4.29%
controls:0.28%
—
—
—
—
—
—
cases:4.63%
controls:0.24%
cases:7.49%
controls:0.70%
49
60
674
7170
31
20
692
7210
—
—
—
33
17
680
7135
48
47
593
6638
Thorax CT examination
GD1AD [2001303618]
GD1AD [2001303618]
2.6e+00
3.1e+00
—
—
—
3.1e+00
1.5e+00
cases:3.60%
controls:0.28%
cases:2.49%
controls:0.11%
—
—
—
—
—
—
cases:1.54%
controls:0.07%
cases:2.18%
controls:0.49%
26
20
697
7210
18
8
705
7222
—
—
—
11
5
702
7147
14
33
627
6652
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
4.4e-01
1.2e+00
2.9e+00
1.0e+50
2.0e+00
2.3e+00
1.8e+00
cases:3.60%
controls:2.35%
cases:5.67%
controls:1.70%
cases:3.18%
controls:0.18%
cases:0.69%
controls:0.00%
cases:2.49%
controls:0.33%
cases:16.97%
controls:2.00%
cases:40.25%
controls:9.86%
26
170
697
7060
41
123
682
7107
23
13
700
7217
5
0
718
7230
18
24
704
7200
121
143
592
7009
258
659
383
6026
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
7.4e-01
1.2e+00
1.8e+00
—
1.4e+00
2.2e+00
2.9e+00
cases:9.54%
controls:4.77%
cases:12.59%
controls:4.33%
cases:5.26%
controls:0.90%
—
—
cases:3.88%
controls:0.94%
cases:35.48%
controls:5.61%
cases:81.12%
controls:19.13%
69
345
654
6885
91
313
632
6917
38
65
685
7165
—
28
68
694
7156
253
401
460
6751
520
1279
121
5406
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
76080-1 [46235759]
2.6e+00
2.5e+00
—
—
—
3.7e+00
1.5e+00
cases:2.63%
controls:0.19%
cases:1.80%
controls:0.15%
—
—
—
—
—
—
cases:4.77%
controls:0.13%
cases:3.28%
controls:0.76%
19
14
704
7216
13
11
710
7219
—
—
—
34
9
679
7143
21
51
620
6634
Protein [Mass/volume] in Urine
2888-6 [3037121]
2888-6 [3037121]
1.3e+00
2.3e+00
1.0e+50
—
—
3.6e+00
4.3e+00
cases:1.24%
controls:0.33%
cases:1.38%
controls:0.14%
cases:0.69%
controls:0.00%
—
—
—
—
cases:9.68%
controls:0.28%
cases:35.10%
controls:0.72%
9
24
714
7206
10
10
713
7220
5
0
718
7230
—
—
69
20
644
7132
225
48
416
6637
Hemolysis interference index of Serum or Plasma
46424-8 [3052851]
46424-8 [3052851]
1.8e+00
2.1e+00
—
—
—
3.7e+00
2.7e+00
cases:0.97%
controls:0.17%
cases:1.11%
controls:0.14%
—
—
—
—
—
—
cases:12.62%
controls:0.35%
cases:9.98%
controls:0.75%
7
12
716
7218
8
10
715
7220
—
—
—
90
25
623
7127
64
50
577
6635
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
6.8e-01
1.3e+00
1.7e+00
—
1.3e+00
2.4e+00
2.8e+00
cases:10.79%
controls:5.80%
cases:14.66%
controls:4.62%
cases:6.64%
controls:1.23%
—
—
cases:4.71%
controls:1.30%
cases:39.55%
controls:5.75%
cases:82.37%
controls:21.29%
78
419
645
6811
106
334
617
6896
48
89
675
7141
—
34
94
688
7130
282
411
431
6741
528
1423
113
5262
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
1.8e+00
2.3e+00
2.3e+00
1.0e+50
—
1.9e+00
1.9e+00
cases:8.02%
controls:1.42%
cases:4.15%
controls:0.44%
cases:1.80%
controls:0.18%
cases:1.24%
controls:0.00%
—
—
cases:4.21%
controls:0.64%
cases:9.05%
controls:1.48%
58
103
665
7127
30
32
693
7198
13
13
710
7217
9
0
714
7230
—
30
46
683
7106
58
99
583
6586
Systemic arterial pressure
364090009 [4238447]
364090009 [4238447]
2.1e+00
3.0e+00
—
—
—
2.7e+00
2.4e+00
cases:2.49%
controls:0.30%
cases:1.38%
controls:0.07%
—
—
—
—
—
—
cases:0.98%
controls:0.07%
cases:3.28%
controls:0.31%
18
22
705
7208
10
5
713
7225
—
—
—
7
5
706
7147
21
21
620
6664
methylprednisolone; oral, parenteral
H02AB04 [21602732]
H02AB04 [21602732]
1.4e+00
2.2e+00
2.1e+00
—
1.4e+00
2.3e+00
2.2e+00
cases:6.64%
controls:1.77%
cases:4.15%
controls:0.48%
cases:0.97%
controls:0.12%
—
—
cases:0.69%
controls:0.18%
cases:5.47%
controls:0.56%
cases:9.67%
controls:1.23%
48
128
675
7102
30
35
693
7195
7
9
716
7221
—
5
13
717
7211
39
40
674
7112
62
82
579
6603
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3216-9 [3020427]
1.6e+00
3.1e+00
—
—
—
2.9e+00
2.5e+00
cases:1.24%
controls:0.25%
cases:1.52%
controls:0.07%
—
—
—
—
—
—
cases:2.66%
controls:0.15%
cases:9.36%
controls:0.85%
9
18
714
7212
11
5
712
7225
—
—
—
19
11
694
7141
60
57
581
6628
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
2.9e+00
—
—
—
—
4.2e+00
3.0e+00
cases:1.24%
controls:0.07%
—
—
—
—
—
—
—
—
cases:4.49%
controls:0.07%
cases:10.76%
controls:0.61%
9
5
714
7225
—
—
—
—
32
5
681
7147
69
41
572
6644
Ulcer of lower limb, not elsewhere classified
L97 [45591659]
L97 [45591659]
2.3e+00
3.5e+00
—
—
—
2.1e+00
2.2e+00
cases:3.46%
controls:0.36%
cases:2.63%
controls:0.08%
—
—
—
—
—
—
cases:1.82%
controls:0.22%
cases:5.62%
controls:0.67%
25
26
698
7204
19
6
704
7224
—
—
—
13
16
700
7136
36
45
605
6640
Psychiatry
26 [38004469]
26 [38004469]
1.2e+00
1.7e+00
2.0e+00
1.0e+50
2.0e+00
1.8e+00
1.3e+00
cases:16.32%
controls:5.46%
cases:10.79%
controls:2.27%
cases:5.67%
controls:0.80%
cases:3.73%
controls:0.00%
cases:5.82%
controls:0.80%
cases:11.78%
controls:2.21%
cases:16.85%
controls:5.07%
118
395
605
6835
78
164
645
7066
41
58
682
7172
27
0
696
7230
42
58
680
7166
84
158
629
6994
108
339
533
6346
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
-1.9e-01
7.8e-01
1.5e+00
2.4e+00
1.3e+00
1.8e+00
2.2e+00
cases:9.96%
controls:11.76%
cases:22.82%
controls:11.95%
cases:10.65%
controls:2.68%
cases:1.94%
controls:0.18%
cases:9.28%
controls:2.63%
cases:53.86%
controls:16.29%
cases:90.02%
controls:50.65%
72
850
651
6380
165
864
558
6366
77
194
646
7036
14
13
709
7217
67
190
655
7034
384
1165
329
5987
577
3386
64
3299
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
1.6e+00
1.8e+00
1.5e+00
—
1.9e+00
1.8e+00
1.3e+00
cases:20.61%
controls:5.02%
cases:20.33%
controls:3.87%
cases:5.39%
controls:1.20%
—
—
cases:6.09%
controls:0.98%
cases:20.34%
controls:4.05%
cases:20.59%
controls:6.85%
149
363
574
6867
147
280
576
6950
39
87
684
7143
—
44
71
678
7153
145
290
568
6862
132
458
509
6227
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
13969-1 [3005785]
1.4e+00
2.5e+00
2.6e+00
—
—
2.0e+00
1.4e+00
cases:2.49%
controls:0.64%
cases:3.46%
controls:0.29%
cases:0.97%
controls:0.07%
—
—
—
—
cases:4.77%
controls:0.66%
cases:9.05%
controls:2.51%
18
46
705
7184
25
21
698
7209
7
5
716
7225
—
—
34
47
679
7105
58
168
583
6517
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
NK6QA [2001308500]
2.6e+00
2.6e+00
—
—
—
2.5e+00
2.2e+00
cases:7.19%
controls:0.57%
cases:3.46%
controls:0.28%
—
—
—
—
—
—
cases:3.23%
controls:0.28%
cases:4.37%
controls:0.49%
52
41
671
7189
25
20
698
7210
—
—
—
23
20
690
7132
28
33
613
6652
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
2.0e+00
2.8e+00
—
—
—
2.9e+00
2.1e+00
cases:7.19%
controls:1.01%
cases:8.02%
controls:0.55%
—
—
—
—
—
—
cases:14.59%
controls:0.89%
cases:25.12%
controls:4.02%
52
73
671
7157
58
40
665
7190
—
—
—
104
64
609
7088
161
269
480
6416
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
2.2e-01
8.5e-01
1.7e+00
2.5e+00
1.5e+00
1.5e+00
1.7e+00
cases:17.70%
controls:14.73%
cases:27.80%
controls:14.14%
cases:15.21%
controls:3.06%
cases:1.94%
controls:0.17%
cases:12.47%
controls:3.10%
cases:52.17%
controls:19.88%
cases:88.92%
controls:58.25%
128
1065
595
6165
201
1022
522
6208
110
221
613
7009
14
12
709
7218
90
224
632
7000
372
1422
341
5730
570
3894
71
2791
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
8.8e-01
2.1e+00
—
—
—
3.3e+00
3.4e+00
cases:2.63%
controls:1.11%
cases:4.01%
controls:0.51%
—
—
—
—
—
—
cases:13.18%
controls:0.53%
cases:48.67%
controls:2.93%
19
80
704
7150
29
37
694
7193
—
—
—
94
38
619
7114
312
196
329
6489
Acute renal failure, unspecified
N17.9 [45567829]
N17.9 [45567829]
2.5e+00
3.8e+00
1.0e+50
—
—
2.2e+00
1.3e+00
cases:2.63%
controls:0.22%
cases:3.46%
controls:0.08%
cases:0.97%
controls:0.00%
—
—
—
—
cases:0.84%
controls:0.10%
cases:1.72%
controls:0.46%
19
16
704
7214
25
6
698
7224
7
0
716
7230
—
—
6
7
707
7145
11
31
630
6654
Monitoring vital functions without anesthesia
WX000 [2001310756]
WX000 [2001310756]
2.5e+00
2.2e+00
—
—
—
2.9e+00
2.1e+00
cases:2.35%
controls:0.19%
cases:0.97%
controls:0.11%
—
—
—
—
—
—
cases:1.26%
controls:0.07%
cases:2.18%
controls:0.27%
17
14
706
7216
7
8
716
7222
—
—
—
9
5
704
7147
14
18
627
6667
Internal Medicine
11 [38004456]
11 [38004456]
1.1e+00
1.6e+00
2.1e+00
—
1.8e+00
1.6e+00
1.4e+00
cases:43.71%
controls:20.28%
cases:29.60%
controls:7.62%
cases:7.33%
controls:0.98%
—
—
cases:6.37%
controls:1.11%
cases:28.19%
controls:7.30%
cases:46.18%
controls:16.93%
316
1466
407
5764
214
551
509
6679
53
71
670
7159
—
46
80
676
7144
201
522
512
6630
296
1132
345
5553
Major dressing of wound of skin of lower limb
QDB10 [2001309970]
QDB10 [2001309970]
2.1e+00
2.7e+00
1.0e+50
—
—
2.6e+00
2.2e+00
cases:4.15%
controls:0.53%
cases:2.90%
controls:0.19%
cases:1.11%
controls:0.00%
—
—
—
—
cases:2.66%
controls:0.20%
cases:6.40%
controls:0.76%
30
38
693
7192
21
14
702
7216
8
0
715
7230
—
—
19
14
694
7138
41
51
600
6634
Outpatient Hospital
22 [8756]
22 [8756]
1.1e+00
1.7e+00
2.3e+00
—
2.0e+00
1.4e+00
1.1e+00
cases:48.41%
controls:23.64%
cases:29.05%
controls:6.83%
cases:7.33%
controls:0.77%
—
—
cases:5.96%
controls:0.87%
cases:23.42%
controls:6.73%
cases:38.38%
controls:17.31%
350
1709
373
5521
210
494
513
6736
53
56
670
7174
—
43
63
679
7161
167
481
546
6671
246
1157
395
5528
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
DM1QA [2001301761]
2.5e+00
2.9e+00
—
—
—
2.2e+00
2.1e+00
cases:6.09%
controls:0.53%
cases:2.49%
controls:0.14%
—
—
—
—
—
—
cases:1.54%
controls:0.18%
cases:3.74%
controls:0.49%
44
38
679
7192
18
10
705
7220
—
—
—
11
13
702
7139
24
33
617
6652
Abdominal X-ray examination without contrast
JN3AA [2001305553]
JN3AA [2001305553]
1.9e+00
2.7e+00
—
—
—
2.8e+00
2.2e+00
cases:3.60%
controls:0.57%
cases:2.07%
controls:0.14%
—
—
—
—
—
—
cases:2.24%
controls:0.14%
cases:2.18%
controls:0.24%
26
41
697
7189
15
10
708
7220
—
—
—
16
10
697
7142
14
16
627
6669
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
2.6e+00
2.8e+00
—
1.0e+50
—
2.3e+00
2.0e+00
cases:9.41%
controls:0.80%
cases:5.12%
controls:0.33%
—
—
cases:0.69%
controls:0.00%
—
—
cases:3.37%
controls:0.36%
cases:8.58%
controls:1.21%
68
58
655
7172
37
24
686
7206
—
5
0
718
7230
—
24
26
689
7126
55
81
586
6604
High dependency care
WX882 [2001310847]
WX882 [2001310847]
2.4e+00
2.9e+00
—
—
—
2.8e+00
1.5e+00
cases:3.04%
controls:0.29%
cases:1.52%
controls:0.08%
—
—
—
—
—
—
cases:1.40%
controls:0.08%
cases:2.03%
controls:0.46%
22
21
701
7209
11
6
712
7224
—
—
—
10
6
703
7146
13
31
628
6654
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
2704-5 [3028626]
2.9e+00
3.5e+00
—
—
—
3.2e+00
8.1e-01
cases:3.32%
controls:0.19%
cases:2.35%
controls:0.07%
—
—
—
—
—
—
cases:1.68%
controls:0.07%
cases:1.56%
controls:0.70%
24
14
699
7216
17
5
706
7225
—
—
—
12
5
701
7147
10
47
631
6638
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
9.1e-01
2.3e+00
—
—
—
3.6e+00
3.7e+00
cases:1.66%
controls:0.68%
cases:2.63%
controls:0.28%
—
—
—
—
—
—
cases:8.84%
controls:0.25%
cases:42.28%
controls:1.80%
12
49
711
7181
19
20
704
7210
—
—
—
63
18
650
7134
271
120
370
6565
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
NA3AA [2001307026]
2.2e+00
3.5e+00
1.0e+50
—
—
2.8e+00
1.1e+00
cases:8.71%
controls:1.08%
cases:5.67%
controls:0.18%
cases:1.11%
controls:0.00%
—
—
—
—
cases:3.51%
controls:0.21%
cases:3.59%
controls:1.24%
63
78
660
7152
41
13
682
7217
8
0
715
7230
—
—
25
15
688
7137
23
83
618
6602
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
1.2e+00
2.1e+00
1.7e+00
—
2.2e+00
2.6e+00
1.5e+00
cases:4.98%
controls:1.54%
cases:7.05%
controls:0.94%
cases:0.97%
controls:0.18%
—
—
cases:0.97%
controls:0.11%
cases:10.80%
controls:0.88%
cases:21.22%
controls:5.55%
36
111
687
7119
51
68
672
7162
7
13
716
7217
—
7
8
715
7216
77
63
636
7089
136
371
505
6314
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
4.5e-01
1.0e+00
2.0e+00
—
1.6e+00
1.9e+00
2.5e+00
cases:13.83%
controls:9.28%
cases:19.78%
controls:7.95%
cases:8.58%
controls:1.22%
—
—
cases:7.34%
controls:1.51%
cases:43.20%
controls:10.21%
cases:86.43%
controls:34.14%
100
671
623
6559
143
575
580
6655
62
88
661
7142
—
53
109
669
7115
308
730
405
6422
554
2282
87
4403
Immunization
WW200 [2001310599]
WW200 [2001310599]
4.0e+00
—
1.0e+50
1.0e+50
1.0e+50
—
5.5e+00
cases:10.37%
controls:0.22%
—
—
cases:1.24%
controls:0.00%
cases:70.40%
controls:0.00%
cases:0.69%
controls:0.00%
—
—
cases:42.12%
controls:0.28%
75
16
648
7214
—
9
0
714
7230
509
0
214
7230
5
0
717
7224
—
270
19
371
6666
Other diagnostic examination of periferal vessel
XPX99 [2001309755]
XPX99 [2001309755]
1.9e+00
2.8e+00
—
—
—
2.3e+00
2.3e+00
cases:4.56%
controls:0.68%
cases:3.18%
controls:0.19%
—
—
—
—
—
—
cases:3.23%
controls:0.34%
cases:7.80%
controls:0.81%
33
49
690
7181
23
14
700
7216
—
—
—
23
24
690
7128
50
54
591
6631
Chronic respiratory failure
J96.1 [45557632]
J96.1 [45557632]
2.3e+00
2.6e+00
—
1.0e+50
—
2.5e+00
1.9e+00
cases:1.11%
controls:0.11%
cases:1.11%
controls:0.08%
—
—
cases:0.83%
controls:0.00%
—
—
cases:1.40%
controls:0.11%
cases:1.40%
controls:0.21%
8
8
715
7222
8
6
715
7224
—
6
0
717
7230
—
10
8
703
7144
9
14
632
6671
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
8.2e-01
1.7e+00
2.0e+00
—
2.0e+00
1.6e+00
1.1e+00
cases:4.43%
controls:2.01%
cases:5.39%
controls:1.05%
cases:1.66%
controls:0.22%
—
—
cases:1.66%
controls:0.22%
cases:6.73%
controls:1.40%
cases:24.18%
controls:9.21%
32
145
691
7085
39
76
684
7154
12
16
711
7214
—
12
16
710
7208
48
100
665
7052
155
616
486
6069
Type 2 diabetes mellitus, with renal complications
E11.2 [45605400]
E11.2 [45605400]
2.6e+00
2.6e+00
—
—
—
2.7e+00
1.5e+00
cases:5.12%
controls:0.40%
cases:2.49%
controls:0.19%
—
—
—
—
—
—
cases:1.96%
controls:0.14%
cases:2.03%
controls:0.46%
37
29
686
7201
18
14
705
7216
—
—
—
14
10
699
7142
13
31
628
6654
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
1.4e+00
2.1e+00
2.0e+00
1.0e+50
—
2.2e+00
1.6e+00
cases:13.14%
controls:3.50%
cases:5.95%
controls:0.76%
cases:1.11%
controls:0.15%
cases:0.97%
controls:0.00%
—
—
cases:5.61%
controls:0.67%
cases:10.30%
controls:2.24%
95
253
628
6977
43
55
680
7175
8
11
715
7219
7
0
716
7230
—
40
48
673
7104
66
150
575
6535
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
2.9e+00
3.5e+00
—
—
—
2.9e+00
3.1e-01
cases:5.53%
controls:0.32%
cases:5.81%
controls:0.18%
—
—
—
—
—
—
cases:5.61%
controls:0.34%
cases:3.43%
controls:2.54%
40
23
683
7207
42
13
681
7217
—
—
—
40
24
673
7128
22
170
619
6515
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
1961-2 [3015235]
3.1e+00
3.5e+00
—
—
—
2.7e+00
4.5e-01
cases:2.90%
controls:0.14%
cases:2.35%
controls:0.07%
—
—
—
—
—
—
cases:1.96%
controls:0.14%
cases:1.56%
controls:1.00%
21
10
702
7220
17
5
706
7225
—
—
—
14
10
699
7142
10
67
631
6618
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
1.6e+00
2.0e+00
2.2e+00
—
2.3e+00
1.8e+00
1.7e+00
cases:5.12%
controls:1.08%
cases:4.98%
controls:0.69%
cases:0.97%
controls:0.11%
—
—
cases:0.69%
controls:0.07%
cases:4.91%
controls:0.87%
cases:15.44%
controls:3.20%
37
78
686
7152
36
50
687
7180
7
8
716
7222
—
5
5
717
7219
35
62
678
7090
99
214
542
6471
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
7.4e-01
1.1e+00
2.1e+00
—
1.9e+00
1.8e+00
1.6e+00
cases:11.48%
controls:5.85%
cases:10.37%
controls:3.86%
cases:4.98%
controls:0.64%
—
—
cases:4.29%
controls:0.65%
cases:25.81%
controls:5.29%
cases:62.25%
controls:24.77%
83
423
640
6807
75
279
648
6951
36
46
687
7184
—
31
47
691
7177
184
378
529
6774
399
1656
242
5029
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
1.7e+00
2.0e+00
—
—
1.9e+00
2.1e+00
1.5e+00
cases:16.04%
controls:3.53%
cases:7.47%
controls:1.09%
—
—
—
—
cases:1.25%
controls:0.18%
cases:6.87%
controls:0.85%
cases:14.35%
controls:3.58%
116
255
607
6975
54
79
669
7151
—
—
9
13
713
7211
49
61
664
7091
92
239
549
6446
Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]
FM1BE [2001303285]
1.4e+00
3.1e+00
—
—
—
2.7e+00
2.0e+00
cases:3.04%
controls:0.76%
cases:1.80%
controls:0.08%
—
—
—
—
—
—
cases:1.68%
controls:0.11%
cases:4.52%
controls:0.63%
22
55
701
7175
13
6
710
7224
—
—
—
12
8
701
7144
29
42
612
6643
Remowal of suture of skin
TQW40 [2001310146]
TQW40 [2001310146]
1.5e+00
2.6e+00
—
—
—
3.1e+00
1.9e+00
cases:2.49%
controls:0.54%
cases:2.63%
controls:0.19%
—
—
—
—
—
—
cases:2.10%
controls:0.10%
cases:5.15%
controls:0.79%
18
39
705
7191
19
14
704
7216
—
—
—
15
7
698
7145
33
53
608
6632
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
2.4e+00
2.5e+00
—
—
—
2.5e+00
1.8e+00
cases:9.41%
controls:0.97%
cases:3.87%
controls:0.33%
—
—
—
—
—
—
cases:2.95%
controls:0.25%
cases:5.15%
controls:0.88%
68
70
655
7160
28
24
695
7206
—
—
—
21
18
692
7134
33
59
608
6626
Oxygen saturation in Capillary blood
2709-4 [3021901]
2709-4 [3021901]
3.5e+00
3.0e+00
—
—
—
2.7e+00
4.3e-01
cases:2.63%
controls:0.08%
cases:1.38%
controls:0.07%
—
—
—
—
—
—
cases:0.98%
controls:0.07%
cases:0.94%
controls:0.61%
19
6
704
7224
10
5
713
7225
—
—
—
7
5
706
7147
6
41
635
6644
Occupational therapy
R4120 [2001310234]
R4120 [2001310234]
2.0e+00
2.3e+00
—
—
—
2.6e+00
2.2e+00
cases:4.43%
controls:0.64%
cases:2.21%
controls:0.22%
—
—
—
—
—
—
cases:1.68%
controls:0.13%
cases:5.77%
controls:0.67%
32
46
691
7184
16
16
707
7214
—
—
—
12
9
701
7143
37
45
604
6640
General Practice Dentistry
1223G0001X [38003675]
1223G0001X [38003675]
2.1e+00
2.2e+00
1.0e+50
—
—
2.5e+00
2.4e+00
cases:4.43%
controls:0.58%
cases:2.21%
controls:0.25%
cases:1.38%
controls:0.00%
—
—
—
—
cases:3.51%
controls:0.31%
cases:5.15%
controls:0.51%
32
42
691
7188
16
18
707
7212
10
0
713
7230
—
—
25
22
688
7130
33
34
608
6651
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
1.6e+00
2.0e+00
2.1e+00
—
—
1.8e+00
1.6e+00
cases:11.48%
controls:2.45%
cases:5.95%
controls:0.83%
cases:0.97%
controls:0.12%
—
—
—
—
cases:4.91%
controls:0.87%
cases:13.42%
controls:3.11%
83
177
640
7053
43
60
680
7170
7
9
716
7221
—
—
35
62
678
7090
86
208
555
6477
T1D - yes
T1D-1 [2002330228]
T1D-1 [2002330228]
—
3.5e+00
—
—
—
3.1e+00
2.4e+00
—
—
cases:2.21%
controls:0.07%
—
—
—
—
—
—
cases:2.38%
controls:0.11%
cases:2.18%
controls:0.19%
—
16
5
707
7225
—
—
—
17
8
696
7144
14
13
627
6672
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
1.5e+00
1.6e+00
1.5e+00
—
1.3e+00
1.7e+00
1.3e+00
cases:26.97%
controls:7.39%
cases:22.41%
controls:5.42%
cases:6.36%
controls:1.44%
—
—
cases:5.26%
controls:1.47%
cases:24.54%
controls:5.79%
cases:26.99%
controls:8.92%
195
534
528
6696
162
392
561
6838
46
104
677
7126
—
38
106
684
7118
175
414
538
6738
173
596
468
6089
Inpatient Hospital
21 [8717]
21 [8717]
9.9e-01
1.5e+00
2.2e+00
—
1.8e+00
1.3e+00
1.1e+00
cases:51.87%
controls:28.59%
cases:31.54%
controls:8.93%
cases:10.10%
controls:1.19%
—
—
cases:7.34%
controls:1.33%
cases:26.79%
controls:8.93%
cases:43.06%
controls:20.15%
375
2067
348
5163
228
646
495
6584
73
86
650
7144
—
53
96
669
7128
191
639
522
6513
276
1347
365
5338
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
1.9e+00
2.2e+00
—
1.0e+50
2.3e+00
2.5e+00
2.4e+00
cases:11.20%
controls:1.83%
cases:4.98%
controls:0.59%
—
—
cases:0.69%
controls:0.00%
cases:0.69%
controls:0.07%
cases:6.03%
controls:0.52%
cases:9.36%
controls:0.97%
81
132
642
7098
36
43
687
7187
—
5
0
718
7230
5
5
717
7219
43
37
670
7115
60
65
581
6620
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
6.5e-01
9.4e-01
1.8e+00
—
1.4e+00
2.0e+00
2.2e+00
cases:8.99%
controls:4.92%
cases:8.99%
controls:3.72%
cases:3.87%
controls:0.68%
—
—
cases:2.49%
controls:0.62%
cases:25.67%
controls:4.61%
cases:68.64%
controls:19.54%
65
356
658
6874
65
269
658
6961
28
49
695
7181
—
18
45
704
7179
183
330
530
6822
440
1306
201
5379
Infraclavicular plexus blockade
WX203 [2001310779]
WX203 [2001310779]
2.8e+00
2.8e+00
—
—
—
—
3.3e+00
cases:1.52%
controls:0.10%
cases:1.11%
controls:0.07%
—
—
—
—
—
—
—
—
cases:4.84%
controls:0.18%
11
7
712
7223
8
5
715
7225
—
—
—
—
31
12
610
6673
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4542-7 [3012336]
2.5e+00
2.6e+00
—
—
—
1.6e+00
2.2e+00
cases:4.01%
controls:0.35%
cases:2.90%
controls:0.22%
—
—
—
—
—
—
cases:1.40%
controls:0.28%
cases:9.67%
controls:1.23%
29
25
694
7205
21
16
702
7214
—
—
—
10
20
703
7132
62
82
579
6603
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
1.6e+00
2.1e+00
2.3e+00
—
—
1.6e+00
1.3e+00
cases:8.85%
controls:1.88%
cases:4.29%
controls:0.54%
cases:0.83%
controls:0.08%
—
—
—
—
cases:4.21%
controls:0.92%
cases:9.05%
controls:2.72%
64
136
659
7094
31
39
692
7191
6
6
717
7224
—
—
30
66
683
7086
58
182
583
6503
Catheterisation of bladder
TKC20 [2001306020]
TKC20 [2001306020]
1.7e+00
2.9e+00
—
—
—
2.5e+00
1.7e+00
cases:4.56%
controls:0.84%
cases:4.15%
controls:0.24%
—
—
—
—
—
—
cases:2.24%
controls:0.18%
cases:5.46%
controls:1.09%
33
61
690
7169
30
17
693
7213
—
—
—
16
13
697
7139
35
73
606
6612
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
5.1e-02
6.5e-01
1.5e+00
2.1e+00
1.3e+00
1.4e+00
1.9e+00
cases:15.49%
controls:14.84%
cases:28.77%
controls:17.34%
cases:15.08%
controls:3.87%
cases:2.07%
controls:0.26%
cases:12.60%
controls:3.89%
cases:58.20%
controls:25.92%
cases:92.20%
controls:62.98%
112
1073
611
6157
208
1254
515
5976
109
280
614
6950
15
19
708
7211
91
281
631
6943
415
1854
298
5298
591
4210
50
2475
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
620-5 [3007853]
1.3e+00
1.5e+00
2.8e+00
—
—
1.6e+00
1.5e+00
cases:3.73%
controls:1.01%
cases:3.04%
controls:0.68%
cases:1.38%
controls:0.08%
—
—
—
—
cases:3.51%
controls:0.73%
cases:16.22%
controls:4.23%
27
73
696
7157
22
49
701
7181
10
6
713
7224
—
—
25
52
688
7100
104
283
537
6402
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
33863-2 [3030366]
2.5e+00
—
—
—
—
3.3e+00
2.9e+00
cases:2.21%
controls:0.19%
—
—
—
—
—
—
—
—
cases:3.09%
controls:0.11%
cases:12.95%
controls:0.78%
16
14
707
7216
—
—
—
—
22
8
691
7144
83
52
558
6633
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.1e-02
4.4e-01
1.4e+00
2.3e+00
1.3e+00
1.2e+00
2.0e+00
cases:17.84%
controls:17.68%
cases:30.43%
controls:21.89%
cases:16.18%
controls:4.34%
cases:2.63%
controls:0.28%
cases:13.85%
controls:4.37%
cases:60.45%
controls:30.73%
cases:95.32%
controls:72.43%
129
1278
594
5952
220
1583
503
5647
117
314
606
6916
19
20
704
7210
100
316
622
6908
431
2198
282
4954
611
4842
30
1843
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-3.8e-01
4.6e-01
9.1e-01
—
—
3.5e+00
5.6e+00
cases:14.80%
controls:20.19%
cases:6.92%
controls:4.48%
cases:1.80%
controls:0.73%
—
—
—
—
cases:11.08%
controls:0.38%
cases:66.77%
controls:0.75%
107
1460
616
5770
50
324
673
6906
13
53
710
7177
—
—
79
27
634
7125
428
50
213
6635
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
1.6e+00
1.7e+00
1.9e+00
—
1.3e+00
1.8e+00
1.7e+00
cases:24.48%
controls:6.22%
cases:11.34%
controls:2.28%
cases:2.77%
controls:0.44%
—
—
cases:1.39%
controls:0.39%
cases:12.62%
controls:2.28%
cases:29.02%
controls:6.78%
177
450
546
6780
82
165
641
7065
20
32
703
7198
—
10
28
712
7196
90
163
623
6989
186
453
455
6232
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
4.0e-01
1.0e+00
2.5e+00
1.0e+50
1.8e+00
1.9e+00
1.5e+00
cases:5.81%
controls:3.97%
cases:7.75%
controls:2.90%
cases:4.56%
controls:0.40%
cases:0.69%
controls:0.00%
cases:3.19%
controls:0.57%
cases:18.93%
controls:3.31%
cases:43.53%
controls:15.00%
42
287
681
6943
56
210
667
7020
33
29
690
7201
5
0
718
7230
23
41
699
7183
135
237
578
6915
279
1003
362
5682
prednisone
A07EA03 [21600655]
A07EA03 [21600655]
1.4e+00
2.0e+00
2.1e+00
—
2.2e+00
1.9e+00
1.2e+00
cases:6.36%
controls:1.66%
cases:3.87%
controls:0.55%
cases:0.69%
controls:0.08%
—
—
cases:0.97%
controls:0.11%
cases:3.09%
controls:0.49%
cases:2.81%
controls:0.87%
46
120
677
7110
28
40
695
7190
5
6
718
7224
—
7
8
715
7216
22
35
691
7117
18
58
623
6627
prednisone; oral
H02AB07 [21602735]
H02AB07 [21602735]
1.4e+00
2.0e+00
2.1e+00
—
2.2e+00
1.9e+00
1.2e+00
cases:6.36%
controls:1.66%
cases:3.87%
controls:0.55%
cases:0.69%
controls:0.08%
—
—
cases:0.97%
controls:0.11%
cases:3.09%
controls:0.49%
cases:2.81%
controls:0.87%
46
120
677
7110
28
40
695
7190
5
6
718
7224
—
7
8
715
7216
22
35
691
7117
18
58
623
6627
Supraclavicular plexus blockade
WX202 [2001310778]
WX202 [2001310778]
3.9e+00
—
—
—
—
2.5e+00
2.2e+00
cases:4.01%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.84%
controls:0.07%
cases:0.94%
controls:0.10%
29
6
694
7224
—
—
—
—
6
5
707
7147
6
7
635
6678
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
1.8e+00
1.9e+00
—
—
—
2.6e+00
2.2e+00
cases:2.21%
controls:0.37%
cases:1.11%
controls:0.17%
—
—
—
—
—
—
cases:3.23%
controls:0.24%
cases:7.49%
controls:0.88%
16
27
707
7203
8
12
715
7218
—
—
—
23
17
690
7135
48
59
593
6626
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
6.4e-01
1.1e+00
1.2e+00
2.0e+00
1.1e+00
1.4e+00
1.1e+00
cases:9.82%
controls:5.45%
cases:11.62%
controls:4.05%
cases:5.67%
controls:1.83%
cases:0.83%
controls:0.11%
cases:5.26%
controls:1.83%
cases:19.35%
controls:5.66%
cases:38.53%
controls:17.29%
71
394
652
6836
84
293
639
6937
41
132
682
7098
6
8
717
7222
38
132
684
7092
138
405
575
6747
247
1156
394
5529
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
77190-7 [46237023]
1.5e+00
2.2e+00
—
—
—
3.2e+00
3.0e+00
cases:0.97%
controls:0.22%
cases:0.97%
controls:0.11%
—
—
—
—
—
—
cases:2.10%
controls:0.08%
cases:10.92%
controls:0.58%
7
16
716
7214
7
8
716
7222
—
—
—
15
6
698
7146
70
39
571
6646
Urinary tract ultrasound examination
KH1AE [2001306329]
KH1AE [2001306329]
2.4e+00
2.0e+00
—
—
—
2.5e+00
1.4e+00
cases:6.64%
controls:0.62%
cases:1.80%
controls:0.25%
—
—
—
—
—
—
cases:2.10%
controls:0.17%
cases:2.65%
controls:0.64%
48
45
675
7185
13
18
710
7212
—
—
—
15
12
698
7140
17
43
624
6642
Oral Surgery
19 [38004464]
19 [38004464]
2.0e+00
2.4e+00
2.1e+00
—
—
2.0e+00
2.1e+00
cases:5.12%
controls:0.73%
cases:3.46%
controls:0.33%
cases:0.69%
controls:0.08%
—
—
—
—
cases:2.95%
controls:0.42%
cases:6.55%
controls:0.88%
37
53
686
7177
25
24
698
7206
5
6
718
7224
—
—
21
30
692
7122
42
59
599
6626
Hypertensive renal disease with renal failure
I12.0 [45596187]
I12.0 [45596187]
2.9e+00
—
—
—
—
2.8e+00
2.7e+00
cases:1.24%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.12%
controls:0.07%
cases:1.09%
controls:0.07%
9
5
714
7225
—
—
—
—
8
5
705
7147
7
5
634
6680
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
1.2e+00
1.4e+00
1.5e+00
—
1.6e+00
1.4e+00
1.3e+00
cases:8.02%
controls:2.66%
cases:6.64%
controls:1.73%
cases:1.94%
controls:0.46%
—
—
cases:2.22%
controls:0.44%
cases:7.01%
controls:1.79%
cases:9.83%
controls:2.92%
58
192
665
7038
48
125
675
7105
14
33
709
7197
—
16
32
706
7192
50
128
663
7024
63
195
578
6490
Limited function/disability (L)
L28 [2002000647]
L28 [2002000647]
1.3e+00
1.6e+00
1.5e+00
—
2.4e+00
1.8e+00
1.2e+00
cases:6.64%
controls:1.91%
cases:4.84%
controls:1.02%
cases:0.83%
controls:0.19%
—
—
cases:1.39%
controls:0.12%
cases:6.45%
controls:1.16%
cases:10.30%
controls:3.22%
48
138
675
7092
35
74
688
7156
6
14
717
7216
—
10
9
712
7215
46
83
667
7069
66
215
575
6470
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
1.2e+00
1.6e+00
2.3e+00
—
—
1.6e+00
1.6e+00
cases:8.30%
controls:2.75%
cases:3.73%
controls:0.76%
cases:0.83%
controls:0.08%
—
—
—
—
cases:3.79%
controls:0.80%
cases:10.92%
controls:2.45%
60
199
663
7031
27
55
696
7175
6
6
717
7224
—
—
27
57
686
7095
70
164
571
6521
Atherosclerotic heart disease
I25.1 [45596196]
I25.1 [45596196]
7.0e-01
1.4e+00
2.2e+00
1.0e+50
2.0e+00
1.3e+00
6.7e-01
cases:8.16%
controls:4.23%
cases:7.05%
controls:1.77%
cases:2.90%
controls:0.33%
cases:2.35%
controls:0.00%
cases:2.63%
controls:0.37%
cases:7.71%
controls:2.34%
cases:9.83%
controls:5.28%
59
306
664
6924
51
128
672
7102
21
24
702
7206
17
0
706
7230
19
27
703
7197
55
167
658
6985
63
353
578
6332
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
-3.1e-02
4.0e-01
1.4e+00
2.2e+00
1.2e+00
1.1e+00
1.8e+00
cases:19.09%
controls:19.57%
cases:32.50%
controls:24.43%
cases:18.53%
controls:5.21%
cases:3.18%
controls:0.35%
cases:15.93%
controls:5.26%
cases:62.55%
controls:34.93%
cases:96.10%
controls:80.40%
138
1415
585
5815
235
1766
488
5464
134
377
589
6853
23
25
700
7205
115
380
607
6844
446
2498
267
4654
616
5375
25
1310
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
1.0e+00
1.8e+00
2.1e+00
—
1.4e+00
1.7e+00
1.5e+00
cases:6.09%
controls:2.23%
cases:7.33%
controls:1.29%
cases:1.38%
controls:0.17%
—
—
cases:0.83%
controls:0.21%
cases:8.27%
controls:1.58%
cases:30.73%
controls:8.92%
44
161
679
7069
53
93
670
7137
10
12
713
7218
—
6
15
716
7209
59
113
654
7039
197
596
444
6089
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
-3.7e-02
4.0e-01
1.4e+00
2.2e+00
1.2e+00
1.1e+00
1.8e+00
cases:18.95%
controls:19.53%
cases:32.50%
controls:24.36%
cases:18.53%
controls:5.19%
cases:3.18%
controls:0.36%
cases:15.93%
controls:5.25%
cases:62.41%
controls:34.79%
cases:96.10%
controls:80.01%
137
1412
586
5818
235
1761
488
5469
134
375
589
6855
23
26
700
7204
115
379
607
6845
445
2488
268
4664
616
5349
25
1336
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
-3.4e-02
4.0e-01
1.4e+00
2.2e+00
1.2e+00
1.1e+00
1.8e+00
cases:18.95%
controls:19.47%
cases:32.50%
controls:24.37%
cases:18.53%
controls:5.21%
cases:3.18%
controls:0.36%
cases:15.93%
controls:5.26%
cases:62.41%
controls:34.87%
cases:96.10%
controls:80.15%
137
1408
586
5822
235
1762
488
5468
134
377
589
6853
23
26
700
7204
115
380
607
6844
445
2494
268
4658
616
5358
25
1327
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
-3.7e-02
4.0e-01
1.4e+00
2.2e+00
1.2e+00
1.1e+00
1.8e+00
cases:18.95%
controls:19.53%
cases:32.50%
controls:24.40%
cases:18.53%
controls:5.20%
cases:3.18%
controls:0.36%
cases:15.93%
controls:5.26%
cases:62.55%
controls:34.93%
cases:96.10%
controls:80.30%
137
1412
586
5818
235
1764
488
5466
134
376
589
6854
23
26
700
7204
115
380
607
6844
446
2498
267
4654
616
5368
25
1317
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
-3.8e-02
4.0e-01
1.4e+00
2.2e+00
1.2e+00
1.1e+00
1.8e+00
cases:18.95%
controls:19.54%
cases:32.50%
controls:24.40%
cases:18.53%
controls:5.21%
cases:3.18%
controls:0.36%
cases:15.93%
controls:5.26%
cases:62.55%
controls:34.93%
cases:96.10%
controls:80.31%
137
1413
586
5817
235
1764
488
5466
134
377
589
6853
23
26
700
7204
115
380
607
6844
446
2498
267
4654
616
5369
25
1316
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
-3.7e-02
4.0e-01
1.4e+00
2.2e+00
1.2e+00
1.1e+00
1.8e+00
cases:18.95%
controls:19.53%
cases:32.50%
controls:24.41%
cases:18.53%
controls:5.23%
cases:3.18%
controls:0.36%
cases:15.93%
controls:5.26%
cases:62.55%
controls:34.93%
cases:96.10%
controls:80.30%
137
1412
586
5818
235
1765
488
5465
134
378
589
6852
23
26
700
7204
115
380
607
6844
446
2498
267
4654
616
5368
25
1317
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
-3.9e-02
4.0e-01
1.4e+00
2.2e+00
1.2e+00
1.1e+00
1.8e+00
cases:18.95%
controls:19.56%
cases:32.50%
controls:24.43%
cases:18.53%
controls:5.24%
cases:3.18%
controls:0.36%
cases:15.93%
controls:5.27%
cases:62.83%
controls:35.03%
cases:96.10%
controls:80.43%
137
1414
586
5816
235
1766
488
5464
134
379
589
6851
23
26
700
7204
115
381
607
6843
448
2505
265
4647
616
5377
25
1308
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
7.2e-01
1.5e+00
1.8e+00
—
1.9e+00
1.3e+00
9.9e-01
cases:4.56%
controls:2.27%
cases:4.98%
controls:1.19%
cases:1.52%
controls:0.25%
—
—
cases:1.52%
controls:0.24%
cases:3.93%
controls:1.12%
cases:6.71%
controls:2.60%
33
164
690
7066
36
86
687
7144
11
18
712
7212
—
11
17
711
7207
28
80
685
7072
43
174
598
6511
Urgent procedure
ZXD05 [2001311386]
ZXD05 [2001311386]
1.1e+00
2.3e+00
2.0e+00
1.0e+50
2.0e+00
1.6e+00
1.2e+00
cases:13.69%
controls:4.79%
cases:8.16%
controls:0.93%
cases:0.97%
controls:0.14%
cases:0.83%
controls:0.00%
cases:0.69%
controls:0.10%
cases:5.47%
controls:1.17%
cases:9.98%
controls:3.19%
99
346
624
6884
59
67
664
7163
7
10
716
7220
6
0
717
7230
5
7
717
7217
39
84
674
7068
64
213
577
6472
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
1.1e+00
1.8e+00
1.8e+00
—
—
2.0e+00
1.3e+00
cases:7.47%
controls:2.64%
cases:5.67%
controls:0.97%
cases:1.11%
controls:0.18%
—
—
—
—
cases:10.52%
controls:1.50%
cases:29.95%
controls:10.02%
54
191
669
7039
41
70
682
7160
8
13
715
7217
—
—
75
107
638
7045
192
670
449
6015
tinzaparin; parenteral
B01AB10 [21600981]
B01AB10 [21600981]
1.9e+00
2.4e+00
—
—
2.0e+00
1.9e+00
1.9e+00
cases:3.04%
controls:0.47%
cases:3.18%
controls:0.30%
—
—
—
—
cases:0.69%
controls:0.10%
cases:2.66%
controls:0.41%
cases:6.86%
controls:1.05%
22
34
701
7196
23
22
700
7208
—
—
5
7
717
7217
19
29
694
7123
44
70
597
6615
High resolution CT examination of lungs
GD1DD [2001303632]
GD1DD [2001303632]
2.4e+00
2.8e+00
—
—
—
2.9e+00
1.4e+00
cases:4.43%
controls:0.43%
cases:3.18%
controls:0.19%
—
—
—
—
—
—
cases:1.26%
controls:0.07%
cases:1.09%
controls:0.28%
32
31
691
7199
23
14
700
7216
—
—
—
9
5
704
7147
7
19
634
6666
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
6.7e-02
5.1e-01
1.4e+00
1.8e+00
1.1e+00
1.2e+00
2.0e+00
cases:17.43%
controls:16.49%
cases:27.39%
controls:18.52%
cases:11.76%
controls:3.21%
cases:1.11%
controls:0.18%
cases:9.56%
controls:3.31%
cases:54.70%
controls:25.91%
cases:94.23%
controls:69.18%
126
1192
597
6038
198
1339
525
5891
85
232
638
6998
8
13
715
7217
69
239
653
6985
390
1853
323
5299
604
4625
37
2060
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
33944-0 [3047169]
2.2e+00
2.3e+00
—
—
—
2.3e+00
1.3e+00
cases:1.66%
controls:0.19%
cases:0.97%
controls:0.10%
—
—
—
—
—
—
cases:1.40%
controls:0.14%
cases:3.28%
controls:0.94%
12
14
711
7216
7
7
716
7223
—
—
—
10
10
703
7142
21
63
620
6622
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 [3023465]
2874-6 [3023465]
3.4e+00
—
—
—
—
3.0e+00
1.7e+00
cases:2.35%
controls:0.08%
—
—
—
—
—
—
—
—
cases:2.10%
controls:0.11%
cases:4.21%
controls:0.78%
17
6
706
7224
—
—
—
—
15
8
698
7144
27
52
614
6633
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
1.3e+00
2.2e+00
—
—
—
2.8e+00
1.7e+00
cases:2.21%
controls:0.61%
cases:3.04%
controls:0.35%
—
—
—
—
—
—
cases:7.15%
controls:0.46%
cases:15.91%
controls:3.28%
16
44
707
7186
22
25
701
7205
—
—
—
51
33
662
7119
102
219
539
6466
Nursing episode
950 [44777714]
950 [44777714]
1.1e+00
1.2e+00
1.7e+00
—
1.8e+00
1.4e+00
8.3e-01
cases:4.15%
controls:1.40%
cases:2.63%
controls:0.79%
cases:1.52%
controls:0.29%
—
—
cases:1.80%
controls:0.30%
cases:3.51%
controls:0.88%
cases:6.08%
controls:2.75%
30
101
693
7129
19
57
704
7173
11
21
712
7209
—
13
22
709
7202
25
63
688
7089
39
184
602
6501
Emergency Room Visit
ER [9203]
ER [9203]
1.2e+00
1.5e+00
1.8e+00
—
1.1e+00
1.3e+00
1.1e+00
cases:64.45%
controls:34.91%
cases:38.17%
controls:12.01%
cases:9.41%
controls:1.70%
—
—
cases:5.26%
controls:1.90%
cases:35.34%
controls:12.75%
cases:59.44%
controls:32.12%
466
2524
257
4706
276
868
447
6362
68
123
655
7107
—
38
137
684
7087
252
912
461
6240
381
2147
260
4538
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
36916-5 [3034860]
2.2e+00
2.3e+00
—
—
—
2.3e+00
1.2e+00
cases:1.66%
controls:0.19%
cases:0.97%
controls:0.10%
—
—
—
—
—
—
cases:1.40%
controls:0.14%
cases:3.12%
controls:0.96%
12
14
711
7216
7
7
716
7223
—
—
—
10
10
703
7142
20
64
621
6621
carvedilol; oral
C07AG02 [21601700]
C07AG02 [21601700]
1.3e+00
1.6e+00
2.2e+00
—
1.2e+00
1.7e+00
1.2e+00
cases:3.32%
controls:0.95%
cases:3.32%
controls:0.68%
cases:1.11%
controls:0.12%
—
—
cases:0.83%
controls:0.25%
cases:3.23%
controls:0.63%
cases:2.65%
controls:0.78%
24
69
699
7161
24
49
699
7181
8
9
715
7221
—
6
18
716
7206
23
45
690
7107
17
52
624
6633
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
-2.5e-01
1.4e+00
—
—
—
3.3e+00
3.2e+00
cases:0.69%
controls:0.89%
cases:1.94%
controls:0.47%
—
—
—
—
—
—
cases:10.52%
controls:0.43%
cases:37.44%
controls:2.27%
5
64
718
7166
14
34
709
7196
—
—
—
75
31
638
7121
240
152
401
6533
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
TQX10 [2001310152]
1.8e+00
1.9e+00
—
—
—
2.5e+00
1.8e+00
cases:4.15%
controls:0.69%
cases:1.52%
controls:0.24%
—
—
—
—
—
—
cases:2.24%
controls:0.20%
cases:4.21%
controls:0.72%
30
50
693
7180
11
17
712
7213
—
—
—
16
14
697
7138
27
48
614
6637
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
57778-3 [40760888]
2.3e+00
2.5e+00
—
—
—
2.1e+00
1.1e+00
cases:1.66%
controls:0.17%
cases:0.97%
controls:0.08%
—
—
—
—
—
—
cases:0.98%
controls:0.13%
cases:2.34%
controls:0.78%
12
12
711
7218
7
6
716
7224
—
—
—
7
9
706
7143
15
52
626
6633
Kappa light chains/Lambda light chains [Mass Ratio] in Serum
15189-4 [3007778]
15189-4 [3007778]
2.2e+00
2.3e+00
—
—
—
2.2e+00
1.3e+00
cases:1.66%
controls:0.19%
cases:0.97%
controls:0.10%
—
—
—
—
—
—
cases:1.26%
controls:0.14%
cases:3.12%
controls:0.90%
12
14
711
7216
7
7
716
7223
—
—
—
9
10
704
7142
20
60
621
6625
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
1.4e+00
1.6e+00
—
—
2.2e+00
1.6e+00
1.2e+00
cases:4.15%
controls:1.09%
cases:3.60%
controls:0.73%
—
—
—
—
cases:1.66%
controls:0.19%
cases:4.63%
controls:0.94%
cases:8.42%
controls:2.78%
30
79
693
7151
26
53
697
7177
—
—
12
14
710
7210
33
67
680
7085
54
186
587
6499
Seronegative rheumatoid arthritis
M06.0 [45577103]
M06.0 [45577103]
1.9e+00
2.0e+00
—
1.0e+50
—
2.2e+00
1.8e+00
cases:1.24%
controls:0.19%
cases:1.24%
controls:0.17%
—
—
cases:0.83%
controls:0.00%
—
—
cases:1.12%
controls:0.13%
cases:1.87%
controls:0.30%
9
14
714
7216
9
12
714
7218
—
6
0
717
7230
—
8
9
705
7143
12
20
629
6665
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46083-2 [3043362]
46083-2 [3043362]
—
2.8e+00
—
—
—
2.0e+00
3.2e+00
—
—
cases:1.11%
controls:0.07%
—
—
—
—
—
—
cases:1.40%
controls:0.20%
cases:13.57%
controls:0.66%
—
8
5
715
7225
—
—
—
10
14
703
7138
87
44
554
6641
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46082-4 [3046524]
46082-4 [3046524]
—
2.8e+00
—
—
—
2.0e+00
3.2e+00
—
—
cases:1.11%
controls:0.07%
—
—
—
—
—
—
cases:1.40%
controls:0.20%
cases:13.57%
controls:0.66%
—
8
5
715
7225
—
—
—
10
14
703
7138
87
44
554
6641
Hematology
82 [38004501]
82 [38004501]
1.2e+00
1.4e+00
1.7e+00
1.0e+50
2.1e+00
1.6e+00
7.8e-01
cases:3.32%
controls:1.04%
cases:2.49%
controls:0.61%
cases:1.38%
controls:0.26%
cases:1.11%
controls:0.00%
cases:1.39%
controls:0.18%
cases:3.37%
controls:0.71%
cases:3.43%
controls:1.60%
24
75
699
7155
18
44
705
7186
10
19
713
7211
8
0
715
7230
10
13
712
7211
24
51
689
7101
22
107
619
6578
Cathetrisation of artery
TPH07 [2001309747]
TPH07 [2001309747]
1.7e+00
2.3e+00
—
—
—
2.4e+00
1.4e+00
cases:5.81%
controls:1.11%
cases:2.49%
controls:0.25%
—
—
—
—
—
—
cases:3.09%
controls:0.28%
cases:5.46%
controls:1.36%
42
80
681
7150
18
18
705
7212
—
—
—
22
20
691
7132
35
91
606
6594
clopidogrel; oral
B01AC04 [21600989]
B01AC04 [21600989]
9.8e-01
1.2e+00
1.6e+00
—
1.5e+00
1.6e+00
1.0e+00
cases:6.36%
controls:2.49%
cases:4.70%
controls:1.48%
cases:2.07%
controls:0.43%
—
—
cases:1.52%
controls:0.35%
cases:7.57%
controls:1.65%
cases:9.67%
controls:3.69%
46
180
677
7050
34
107
689
7123
15
31
708
7199
—
11
25
711
7199
54
118
659
7034
62
247
579
6438
Intensive care
WX872 [2001310844]
WX872 [2001310844]
1.8e+00
2.6e+00
—
—
—
2.2e+00
1.3e+00
cases:4.56%
controls:0.75%
cases:1.24%
controls:0.10%
—
—
—
—
—
—
cases:1.54%
controls:0.18%
cases:2.18%
controls:0.61%
33
54
690
7176
9
7
714
7223
—
—
—
11
13
702
7139
14
41
627
6644
Pulmonary Disease
29 [38004472]
29 [38004472]
9.0e-01
1.3e+00
1.6e+00
—
1.5e+00
1.5e+00
1.0e+00
cases:17.43%
controls:7.93%
cases:13.42%
controls:3.96%
cases:4.01%
controls:0.80%
—
—
cases:3.19%
controls:0.73%
cases:16.41%
controls:4.36%
cases:23.09%
controls:9.66%
126
573
597
6657
97
286
626
6944
29
58
694
7172
—
23
53
699
7171
117
312
596
6840
148
646
493
6039
Implantation of vascular injection port
TPX10 [2001309608]
TPX10 [2001309608]
3.0e+00
—
—
—
—
2.9e+00
1.9e+00
cases:2.63%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.54%
controls:0.08%
cases:1.72%
controls:0.25%
19
10
704
7220
—
—
—
—
11
6
702
7146
11
17
630
6668
TREATMENT - Hemodialysis, center
TREATMENT-21 [2002330236]
TREATMENT-21 [2002330236]
4.1e+00
—
1.0e+50
—
—
—
3.7e+00
cases:4.15%
controls:0.07%
—
—
cases:0.83%
controls:0.00%
—
—
—
—
—
—
cases:2.81%
controls:0.07%
30
5
693
7225
—
6
0
717
7230
—
—
—
18
5
623
6680
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
TNX10 [2001308560]
1.4e+00
2.0e+00
—
1.0e+50
—
2.7e+00
1.7e+00
cases:3.18%
controls:0.82%
cases:1.94%
controls:0.26%
—
—
cases:0.97%
controls:0.00%
—
—
cases:1.96%
controls:0.14%
cases:2.81%
controls:0.52%
23
59
700
7171
14
19
709
7211
—
7
0
716
7230
—
14
10
699
7142
18
35
623
6650
Extraction of multiple teeth
EBA15 [2001301927]
EBA15 [2001301927]
2.3e+00
2.1e+00
—
—
—
2.1e+00
1.3e+00
cases:2.07%
controls:0.22%
cases:1.24%
controls:0.15%
—
—
—
—
—
—
cases:0.98%
controls:0.13%
cases:1.87%
controls:0.51%
15
16
708
7214
9
11
714
7219
—
—
—
7
9
706
7143
12
34
629
6651
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
1.3e+00
1.9e+00
—
—
—
2.0e+00
2.5e+00
cases:4.15%
controls:1.15%
cases:2.77%
controls:0.41%
—
—
—
—
—
—
cases:2.66%
controls:0.36%
cases:14.82%
controls:1.42%
30
83
693
7147
20
30
703
7200
—
—
—
19
26
694
7126
95
95
546
6590
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
6.8e-02
4.6e-01
1.5e+00
2.5e+00
1.5e+00
9.2e-01
8.9e-01
cases:17.15%
controls:16.21%
cases:27.25%
controls:19.06%
cases:14.25%
controls:3.60%
cases:2.77%
controls:0.24%
cases:13.99%
controls:3.63%
cases:48.67%
controls:27.36%
cases:82.06%
controls:65.16%
124
1172
599
6058
197
1378
526
5852
103
260
620
6970
20
17
703
7213
101
262
621
6962
347
1957
366
5195
526
4356
115
2329
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
6.8e-02
4.8e-01
1.5e+00
2.4e+00
1.5e+00
9.5e-01
9.0e-01
cases:17.01%
controls:16.07%
cases:27.25%
controls:18.87%
cases:14.38%
controls:3.58%
cases:2.63%
controls:0.25%
cases:13.99%
controls:3.57%
cases:48.95%
controls:27.00%
cases:81.75%
controls:64.49%
123
1162
600
6068
197
1364
526
5866
104
259
619
6971
19
18
704
7212
101
258
621
6966
349
1931
364
5221
524
4311
117
2374
Foot and toes X-ray examination
NH3AA [2001308267]
NH3AA [2001308267]
1.7e+00
2.4e+00
—
—
—
2.0e+00
1.7e+00
cases:6.09%
controls:1.22%
cases:2.49%
controls:0.24%
—
—
—
—
—
—
cases:1.96%
controls:0.28%
cases:4.99%
controls:0.96%
44
88
679
7142
18
17
705
7213
—
—
—
14
20
699
7132
32
64
609
6621
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
50797-0 [3029379]
2.3e+00
—
—
—
—
3.2e+00
2.2e+00
cases:0.83%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.07%
cases:4.21%
controls:0.51%
6
6
717
7224
—
—
—
—
12
5
701
7147
27
34
614
6651
magnesium hydroxide; oral
A02AA04 [21600052]
A02AA04 [21600052]
2.0e+00
2.2e+00
—
—
—
1.7e+00
1.8e+00
cases:2.07%
controls:0.29%
cases:2.35%
controls:0.26%
—
—
—
—
—
—
cases:1.68%
controls:0.32%
cases:3.43%
controls:0.60%
15
21
708
7209
17
19
706
7211
—
—
—
12
23
701
7129
22
40
619
6645
magnesium hydroxide; oral
G04BX01 [21602658]
G04BX01 [21602658]
2.0e+00
2.2e+00
—
—
—
1.7e+00
1.8e+00
cases:2.07%
controls:0.29%
cases:2.35%
controls:0.26%
—
—
—
—
—
—
cases:1.68%
controls:0.32%
cases:3.43%
controls:0.60%
15
21
708
7209
17
19
706
7211
—
—
—
12
23
701
7129
22
40
619
6645
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
6.0e-01
1.1e+00
2.0e+00
—
2.0e+00
1.2e+00
7.6e-01
cases:7.61%
controls:4.34%
cases:4.98%
controls:1.74%
cases:1.80%
controls:0.24%
—
—
cases:1.66%
controls:0.24%
cases:4.91%
controls:1.58%
cases:11.08%
controls:5.49%
55
314
668
6916
36
126
687
7104
13
17
710
7213
—
12
17
710
7207
35
113
678
7039
71
367
570
6318
Other disorders resulting from impaired renal tubular function
N25.8 [45582397]
N25.8 [45582397]
4.3e+00
—
—
—
—
—
3.3e+00
cases:5.95%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:3.12%
controls:0.12%
43
6
680
7224
—
—
—
—
—
20
8
621
6677
X-ray mammography
HA1AA [2001303884]
HA1AA [2001303884]
1.9e+00
1.7e+00
—
—
—
2.4e+00
1.6e+00
cases:3.73%
controls:0.59%
cases:1.24%
controls:0.22%
—
—
—
—
—
—
cases:2.10%
controls:0.20%
cases:3.43%
controls:0.72%
27
43
696
7187
9
16
714
7214
—
—
—
15
14
698
7138
22
48
619
6637
Thorax extensive CT-examination
GD1BD [2001303621]
GD1BD [2001303621]
1.8e+00
1.9e+00
—
1.0e+50
—
2.5e+00
1.5e+00
cases:3.18%
controls:0.55%
cases:1.24%
controls:0.19%
—
—
cases:0.83%
controls:0.00%
—
—
cases:2.38%
controls:0.21%
cases:2.34%
controls:0.54%
23
40
700
7190
9
14
714
7216
—
6
0
717
7230
—
17
15
696
7137
15
36
626
6649
Type 1 diabetes mellitus, With multiple complications
E10.7 [45571655]
E10.7 [45571655]
1.4e+00
1.5e+00
1.7e+00
—
1.9e+00
1.0e+00
7.4e-01
cases:4.43%
controls:1.11%
cases:3.46%
controls:0.77%
cases:1.11%
controls:0.21%
—
—
cases:1.66%
controls:0.25%
cases:2.81%
controls:1.01%
cases:3.43%
controls:1.68%
32
80
691
7150
25
56
698
7174
8
15
715
7215
—
12
18
710
7206
20
72
693
7080
22
112
619
6573
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
50796-2 [3029338]
2.3e+00
—
—
—
—
3.2e+00
2.1e+00
cases:0.83%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.07%
cases:4.21%
controls:0.55%
6
6
717
7224
—
—
—
—
12
5
701
7147
27
37
614
6648
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 [3005715]
20578-1 [3005715]
2.5e+00
2.7e+00
1.0e+50
—
—
—
2.3e+00
cases:1.38%
controls:0.11%
cases:1.24%
controls:0.08%
cases:0.69%
controls:0.00%
—
—
—
—
—
—
cases:3.74%
controls:0.39%
10
8
713
7222
9
6
714
7224
5
0
718
7230
—
—
—
24
26
617
6659
methenamine; oral
J01XX05 [21603065]
J01XX05 [21603065]
2.1e+00
1.8e+00
—
—
—
1.9e+00
1.8e+00
cases:1.24%
controls:0.15%
cases:0.97%
controls:0.17%
—
—
—
—
—
—
cases:1.12%
controls:0.17%
cases:1.72%
controls:0.30%
9
11
714
7219
7
12
716
7218
—
—
—
8
12
705
7140
11
20
630
6665
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
68438-1 [40771025]
1.2e+00
1.4e+00
2.0e+00
—
1.3e+00
1.6e+00
1.4e+00
cases:9.96%
controls:3.08%
cases:9.13%
controls:2.49%
cases:1.52%
controls:0.21%
—
—
cases:1.25%
controls:0.35%
cases:12.90%
controls:3.05%
cases:39.16%
controls:14.05%
72
223
651
7007
66
180
657
7050
11
15
712
7215
—
9
25
713
7199
92
218
621
6934
251
939
390
5746
Written specialist consultation based on a referral from a dentist or a physician
WZC10 [2001310887]
WZC10 [2001310887]
2.3e+00
2.7e+00
—
—
—
2.5e+00
—
cases:5.53%
controls:0.61%
cases:2.90%
controls:0.19%
—
—
—
—
—
—
cases:2.38%
controls:0.20%
—
—
40
44
683
7186
21
14
702
7216
—
—
—
17
14
696
7138
—
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
1.1e+00
2.1e+00
2.3e+00
—
—
2.5e+00
1.9e+00
cases:3.46%
controls:1.19%
cases:2.90%
controls:0.37%
cases:0.69%
controls:0.07%
—
—
—
—
cases:7.01%
controls:0.64%
cases:23.40%
controls:4.47%
25
86
698
7144
21
27
702
7203
5
5
718
7225
—
—
50
46
663
7106
150
299
491
6386
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
1.3e+00
2.0e+00
1.5e+00
—
1.5e+00
2.2e+00
2.0e+00
cases:7.33%
controls:2.16%
cases:7.19%
controls:1.01%
cases:0.83%
controls:0.18%
—
—
cases:0.83%
controls:0.18%
cases:13.88%
controls:1.76%
cases:35.26%
controls:6.91%
53
156
670
7074
52
73
671
7157
6
13
717
7217
—
6
13
716
7211
99
126
614
7026
226
462
415
6223
Metastasis
OMOP4998856 [36769180]
OMOP4998856 [36769180]
2.2e+00
2.7e+00
—
1.0e+50
—
2.6e+00
1.4e+00
cases:1.11%
controls:0.12%
cases:1.38%
controls:0.10%
—
—
cases:0.83%
controls:0.00%
—
—
cases:1.12%
controls:0.08%
cases:0.94%
controls:0.24%
8
9
715
7221
10
7
713
7223
—
6
0
717
7230
—
8
6
705
7146
6
16
635
6669
Secondary malignant neoplasm of other specified sites
C79.8 [45547524]
C79.8 [45547524]
2.2e+00
2.7e+00
—
1.0e+50
—
2.6e+00
1.4e+00
cases:1.11%
controls:0.12%
cases:1.38%
controls:0.10%
—
—
cases:0.83%
controls:0.00%
—
—
cases:1.12%
controls:0.08%
cases:0.94%
controls:0.24%
8
9
715
7221
10
7
713
7223
—
6
0
717
7230
—
8
6
705
7146
6
16
635
6669
Pelvis X-ray examination
NE1AA [2001307792]
NE1AA [2001307792]
1.4e+00
2.2e+00
—
—
—
2.1e+00
1.7e+00
cases:3.18%
controls:0.80%
cases:1.52%
controls:0.17%
—
—
—
—
—
—
cases:1.82%
controls:0.22%
cases:4.37%
controls:0.81%
23
58
700
7172
11
12
712
7218
—
—
—
13
16
700
7136
28
54
613
6631
moxonidine; oral
C02AC05 [21600401]
C02AC05 [21600401]
1.8e+00
1.7e+00
1.4e+00
—
2.6e+00
1.4e+00
8.1e-01
cases:4.98%
controls:0.84%
cases:2.90%
controls:0.55%
cases:0.69%
controls:0.17%
—
—
cases:1.11%
controls:0.08%
cases:2.24%
controls:0.59%
cases:2.03%
controls:0.91%
36
61
687
7169
21
40
702
7190
5
12
718
7218
—
8
6
714
7218
16
42
697
7110
13
61
628
6624
Chronic ulcer skin
S97 [2002001061]
S97 [2002001061]
1.7e+00
2.2e+00
—
—
—
2.2e+00
1.3e+00
cases:3.04%
controls:0.58%
cases:1.80%
controls:0.21%
—
—
—
—
—
—
cases:1.68%
controls:0.18%
cases:3.59%
controls:0.96%
22
42
701
7188
13
15
710
7215
—
—
—
12
13
701
7139
23
64
618
6621
Deposits [accretions] on teeth betel
K03.65 [2000502690]
K03.65 [2000502690]
8.7e-01
1.3e+00
—
—
2.8e+00
1.2e+00
1.2e+00
cases:6.36%
controls:2.78%
cases:3.73%
controls:1.01%
—
—
—
—
cases:1.39%
controls:0.08%
cases:4.35%
controls:1.34%
cases:14.66%
controls:4.89%
46
201
677
7029
27
73
696
7157
—
—
10
6
712
7218
31
96
682
7056
94
327
547
6358
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
35559-4 [3035797]
2.6e+00
—
—
—
—
2.9e+00
2.0e+00
cases:1.24%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.10%
cases:4.21%
controls:0.58%
9
7
714
7223
—
—
—
—
12
7
701
7145
27
39
614
6646
Ultrasound examination of lower leg veins
PH2AE [2001309451]
PH2AE [2001309451]
1.9e+00
2.2e+00
—
—
—
2.1e+00
1.2e+00
cases:7.05%
controls:1.11%
cases:3.04%
controls:0.33%
—
—
—
—
—
—
cases:1.40%
controls:0.18%
cases:4.21%
controls:1.35%
51
80
672
7150
22
24
701
7206
—
—
—
10
13
703
7139
27
90
614
6595
Need for immunization against influenza
Z25.1 [45581017]
Z25.1 [45581017]
—
-1.0e+50
—
1.0e+50
—
4.4e+00
3.0e+00
—
—
cases:0.00%
controls:0.55%
—
—
cases:84.37%
controls:0.00%
—
—
cases:33.10%
controls:0.63%
cases:22.46%
controls:1.41%
—
0
40
723
7190
—
610
0
113
7230
—
236
45
477
7107
144
94
497
6591
Icteric interference index of Serum or Plasma
46426-3 [3051651]
46426-3 [3051651]
—
—
—
—
—
4.2e+00
3.2e+00
—
—
—
—
—
—
—
—
—
—
cases:4.35%
controls:0.07%
cases:2.50%
controls:0.10%
—
—
—
—
—
31
5
682
7147
16
7
625
6678
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
11253-2 [3026250]
—
—
—
—
—
4.0e+00
3.3e+00
—
—
—
—
—
—
—
—
—
—
cases:3.65%
controls:0.07%
cases:6.55%
controls:0.25%
—
—
—
—
—
26
5
687
7147
42
17
599
6668
Subcutaneous
ZX112 [2001311492]
ZX112 [2001311492]
2.3e+00
2.8e+00
—
—
—
2.2e+00
1.4e+00
cases:1.24%
controls:0.12%
cases:1.11%
controls:0.07%
—
—
—
—
—
—
cases:1.12%
controls:0.13%
cases:0.78%
controls:0.19%
9
9
714
7221
8
5
715
7225
—
—
—
8
9
705
7143
5
13
636
6672
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
E11.7 [45561950]
1.9e+00
1.9e+00
2.0e+00
—
1.6e+00
1.5e+00
8.3e-01
cases:4.98%
controls:0.82%
cases:3.73%
controls:0.59%
cases:1.24%
controls:0.17%
—
—
cases:0.83%
controls:0.17%
cases:2.38%
controls:0.53%
cases:2.50%
controls:1.11%
36
59
687
7171
27
43
696
7187
9
12
714
7218
—
6
12
716
7212
17
38
696
7114
16
74
625
6611
PEEP
WX722 [2001310825]
WX722 [2001310825]
2.3e+00
1.7e+00
—
—
—
2.1e+00
1.2e+00
cases:3.32%
controls:0.36%
cases:1.24%
controls:0.24%
—
—
—
—
—
—
cases:2.10%
controls:0.27%
cases:2.81%
controls:0.82%
24
26
699
7204
9
17
714
7213
—
—
—
15
19
698
7133
18
55
623
6630
Cardiology
6 [38004451]
6 [38004451]
9.4e-01
1.2e+00
1.5e+00
1.0e+50
1.3e+00
1.4e+00
8.9e-01
cases:20.47%
controls:9.14%
cases:12.72%
controls:4.18%
cases:3.04%
controls:0.71%
cases:2.63%
controls:0.00%
cases:2.08%
controls:0.60%
cases:14.45%
controls:3.97%
cases:24.18%
controls:11.53%
148
661
575
6569
92
302
631
6928
22
51
701
7179
19
0
704
7230
15
43
707
7181
103
284
610
6868
155
771
486
5914
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
1.2e+00
2.6e+00
—
—
—
1.9e+00
1.4e+00
cases:3.32%
controls:0.98%
cases:2.21%
controls:0.17%
—
—
—
—
—
—
cases:2.10%
controls:0.32%
cases:4.84%
controls:1.18%
24
71
699
7159
16
12
707
7218
—
—
—
15
23
698
7129
31
79
610
6606
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 [3029713]
51435-6 [3029713]
2.6e+00
—
—
—
—
2.7e+00
1.9e+00
cases:1.24%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.82%
controls:0.13%
cases:4.21%
controls:0.63%
9
7
714
7223
—
—
—
—
13
9
700
7143
27
42
614
6643
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
8.2e-01
1.2e+00
1.3e+00
—
1.5e+00
1.5e+00
9.0e-01
cases:15.63%
controls:7.52%
cases:8.44%
controls:2.74%
cases:1.94%
controls:0.55%
—
—
cases:2.35%
controls:0.51%
cases:9.68%
controls:2.40%
cases:15.60%
controls:6.99%
113
544
610
6686
61
198
662
7032
14
40
709
7190
—
17
37
705
7187
69
172
644
6980
100
467
541
6218
More than five and less than seven hours
ZXE30 [2001311411]
ZXE30 [2001311411]
2.0e+00
3.1e+00
—
—
—
—
2.0e+00
cases:3.46%
controls:0.48%
cases:2.21%
controls:0.10%
—
—
—
—
—
—
—
—
cases:2.34%
controls:0.33%
25
35
698
7195
16
7
707
7223
—
—
—
—
15
22
626
6663
Treponema pallidum Ab [Presence] in Serum
22587-0 [3019832]
22587-0 [3019832]
1.4e+00
2.0e+00
—
—
—
2.2e+00
1.5e+00
cases:2.77%
controls:0.68%
cases:2.63%
controls:0.36%
—
—
—
—
—
—
cases:2.95%
controls:0.34%
cases:11.08%
controls:2.78%
20
49
703
7181
19
26
704
7204
—
—
—
21
24
692
7128
71
186
570
6499
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
5.5e-01
1.4e+00
—
—
1.8e+00
2.1e+00
1.8e+00
cases:3.73%
controls:2.20%
cases:4.43%
controls:1.09%
—
—
—
—
cases:1.11%
controls:0.18%
cases:12.20%
controls:1.72%
cases:33.70%
controls:7.96%
27
159
696
7071
32
79
691
7151
—
—
8
13
714
7211
87
123
626
7029
216
532
425
6153
Nonallergic asthma
J45.1 [45557625]
J45.1 [45557625]
1.6e+00
2.3e+00
—
1.0e+50
—
1.8e+00
1.4e+00
cases:3.73%
controls:0.82%
cases:2.07%
controls:0.21%
—
—
cases:1.38%
controls:0.00%
—
—
cases:1.82%
controls:0.29%
cases:2.96%
controls:0.76%
27
59
696
7171
15
15
708
7215
—
10
0
713
7230
—
13
21
700
7131
19
51
622
6634
Intraoperative use of conventional X-ray imaging
ZXM10 [2001311446]
ZXM10 [2001311446]
1.6e+00
2.6e+00
—
—
—
1.8e+00
1.1e+00
cases:1.94%
controls:0.39%
cases:2.49%
controls:0.19%
—
—
—
—
—
—
cases:1.68%
controls:0.28%
cases:2.34%
controls:0.82%
14
28
709
7202
18
14
705
7216
—
—
—
12
20
701
7132
15
55
626
6630
Gastroenterology
10 [38004455]
10 [38004455]
1.1e+00
1.3e+00
1.7e+00
1.0e+50
7.0e-01
1.5e+00
1.4e+00
cases:12.86%
controls:4.51%
cases:6.92%
controls:1.95%
cases:1.66%
controls:0.30%
cases:1.24%
controls:0.00%
cases:0.83%
controls:0.42%
cases:8.42%
controls:1.97%
cases:20.75%
controls:6.18%
93
326
630
6904
50
141
673
7089
12
22
711
7208
9
0
714
7230
6
30
716
7194
60
141
653
7011
133
413
508
6272
Other dialysis
Z49.2 [45576160]
Z49.2 [45576160]
—
—
—
—
—
3.8e+00
3.2e+00
—
—
—
—
—
—
—
—
—
—
cases:3.79%
controls:0.08%
cases:2.50%
controls:0.10%
—
—
—
—
—
27
6
686
7146
16
7
625
6678
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
1.1e+00
1.6e+00
1.9e+00
—
1.1e+00
1.3e+00
1.2e+00
cases:8.99%
controls:3.26%
cases:4.70%
controls:0.98%
cases:1.52%
controls:0.24%
—
—
cases:0.69%
controls:0.22%
cases:4.63%
controls:1.34%
cases:13.88%
controls:4.73%
65
236
658
6994
34
71
689
7159
11
17
712
7213
—
5
16
717
7208
33
96
680
7056
89
316
552
6369
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
14933-6 [3026493]
1.2e+00
1.5e+00
1.9e+00
—
—
1.5e+00
8.7e-01
cases:8.02%
controls:2.60%
cases:7.33%
controls:1.66%
cases:1.24%
controls:0.19%
—
—
—
—
cases:9.26%
controls:2.18%
cases:21.84%
controls:10.44%
58
188
665
7042
53
120
670
7110
9
14
714
7216
—
—
66
156
647
6996
140
698
501
5987
Nausea and vomiting
R11 [45539317]
R11 [45539317]
1.5e+00
1.9e+00
—
—
—
2.3e+00
1.3e+00
cases:3.04%
controls:0.72%
cases:1.38%
controls:0.21%
—
—
—
—
—
—
cases:1.26%
controls:0.13%
cases:3.12%
controls:0.88%
22
52
701
7178
10
15
713
7215
—
—
—
9
9
704
7143
20
59
621
6626
Body CT examination
JN4AD [2001310897]
JN4AD [2001310897]
2.4e+00
1.8e+00
—
—
—
1.8e+00
9.6e-01
cases:4.15%
controls:0.39%
cases:1.66%
controls:0.28%
—
—
—
—
—
—
cases:2.24%
controls:0.38%
cases:2.65%
controls:1.03%
30
28
693
7202
12
20
711
7210
—
—
—
16
27
697
7125
17
69
624
6616
Ultrasound examination of mammary glands
HA1AE [2001303886]
HA1AE [2001303886]
1.6e+00
1.7e+00
—
—
—
2.2e+00
1.4e+00
cases:3.04%
controls:0.61%
cases:1.52%
controls:0.29%
—
—
—
—
—
—
cases:1.68%
controls:0.18%
cases:2.34%
controls:0.58%
22
44
701
7186
11
21
712
7209
—
—
—
12
13
701
7139
15
39
626
6646
Lipemic interference index of Serum or Plasma
46425-5 [3051611]
46425-5 [3051611]
—
—
—
—
—
4.0e+00
2.9e+00
—
—
—
—
—
—
—
—
—
—
cases:4.35%
controls:0.08%
cases:2.65%
controls:0.15%
—
—
—
—
—
31
6
682
7146
17
10
624
6675
Ambulatory ECG
XF404 [2001303370]
XF404 [2001303370]
1.2e+00
2.2e+00
—
—
—
1.7e+00
1.8e+00
cases:3.46%
controls:1.02%
cases:1.94%
controls:0.22%
—
—
—
—
—
—
cases:1.54%
controls:0.29%
cases:5.46%
controls:0.99%
25
74
698
7156
14
16
709
7214
—
—
—
11
21
702
7131
35
66
606
6619
Bilateral
ZXA10 [2001311348]
ZXA10 [2001311348]
1.6e+00
2.1e+00
—
—
—
1.7e+00
1.3e+00
cases:10.37%
controls:2.19%
cases:4.70%
controls:0.58%
—
—
—
—
—
—
cases:4.35%
controls:0.84%
cases:9.05%
controls:2.53%
75
158
648
7072
34
42
689
7188
—
—
—
31
60
682
7092
58
169
583
6516
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
1.4e+00
1.7e+00
—
—
—
2.1e+00
1.6e+00
cases:2.07%
controls:0.54%
cases:1.66%
controls:0.32%
—
—
—
—
—
—
cases:2.81%
controls:0.34%
cases:10.14%
controls:2.20%
15
39
708
7191
12
23
711
7207
—
—
—
20
24
693
7128
65
147
576
6538
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
1.2e+00
1.6e+00
—
—
—
2.1e+00
2.0e+00
cases:2.07%
controls:0.65%
cases:1.24%
controls:0.26%
—
—
—
—
—
—
cases:3.51%
controls:0.45%
cases:12.79%
controls:2.03%
15
47
708
7183
9
19
714
7211
—
—
—
25
32
688
7120
82
136
559
6549
Need for immunization against other specified single viral diseases
Z25.8 [45547296]
Z25.8 [45547296]
6.2e-01
1.1e+00
—
1.0e+50
2.7e+00
2.8e+00
1.3e+00
cases:0.69%
controls:0.37%
cases:1.52%
controls:0.53%
—
—
cases:14.80%
controls:0.00%
cases:1.25%
controls:0.08%
cases:7.71%
controls:0.52%
cases:4.21%
controls:1.23%
5
27
718
7203
11
38
712
7192
—
107
0
616
7230
9
6
713
7218
55
37
658
7115
27
82
614
6603
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
1.4e+00
1.5e+00
—
—
1.7e+00
2.3e+00
1.6e+00
cases:3.32%
controls:0.86%
cases:2.35%
controls:0.53%
—
—
—
—
cases:0.69%
controls:0.12%
cases:5.61%
controls:0.60%
cases:17.16%
controls:4.11%
24
62
699
7168
17
38
706
7192
—
—
5
9
717
7215
40
43
673
7109
110
275
531
6410
Construction of arteriovenous fistula from radial artery
PBL10 [2001308892]
PBL10 [2001308892]
4.4e+00
—
—
—
—
1.0e+50
2.4e+00
cases:5.26%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.68%
controls:0.00%
cases:1.25%
controls:0.12%
38
5
685
7225
—
—
—
—
12
0
701
7152
8
8
633
6677
Other investigative procedure of eye
XCW99 [2001301491]
XCW99 [2001301491]
1.6e+00
1.7e+00
1.8e+00
—
2.0e+00
1.5e+00
6.2e-01
cases:8.02%
controls:1.81%
cases:4.56%
controls:0.87%
cases:0.83%
controls:0.14%
—
—
cases:0.97%
controls:0.14%
cases:4.91%
controls:1.10%
cases:4.99%
controls:2.74%
58
131
665
7099
33
63
690
7167
6
10
717
7220
—
7
10
715
7214
35
79
678
7073
32
183
609
6502
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
5.7e-01
5.0e-01
5.5e-01
2.8e+00
5.0e-01
3.9e-01
1.4e+00
cases:89.21%
controls:82.45%
cases:77.73%
controls:67.95%
cases:33.89%
controls:22.85%
cases:15.91%
controls:1.09%
cases:33.52%
controls:23.35%
cases:77.56%
controls:70.13%
cases:97.82%
controls:91.82%
645
5961
78
1269
562
4913
161
2317
245
1652
478
5578
115
79
608
7151
242
1687
480
5537
553
5016
160
2136
627
6138
14
547
Eye pressure measurement
XCH00 [2001301234]
XCH00 [2001301234]
1.7e+00
2.4e+00
—
—
—
1.7e+00
8.9e-01
cases:2.35%
controls:0.44%
cases:2.35%
controls:0.22%
—
—
—
—
—
—
cases:1.82%
controls:0.32%
cases:2.96%
controls:1.24%
17
32
706
7198
17
16
706
7214
—
—
—
13
23
700
7129
19
83
622
6602
Psychologist
Z2445 [2001311558]
Z2445 [2001311558]
2.1e+00
2.6e+00
—
—
—
1.7e+00
2.0e+00
cases:3.04%
controls:0.40%
cases:1.52%
controls:0.11%
—
—
—
—
—
—
cases:0.84%
controls:0.15%
cases:1.72%
controls:0.24%
22
29
701
7201
11
8
712
7222
—
—
—
6
11
707
7141
11
16
630
6669
moxifloxacin; oral, parenteral
J01MA14 [21603021]
J01MA14 [21603021]
1.7e+00
1.8e+00
—
—
—
1.6e+00
1.5e+00
cases:5.26%
controls:1.02%
cases:1.38%
controls:0.22%
—
—
—
—
—
—
cases:1.54%
controls:0.31%
cases:4.52%
controls:1.05%
38
74
685
7156
10
16
713
7214
—
—
—
11
22
702
7130
29
70
612
6615
Severe anaemia associated with chronic renal failure
138 [2001600134]
138 [2001600134]
4.4e+00
—
—
—
—
1.0e+50
2.2e+00
cases:7.61%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.00%
cases:1.72%
controls:0.19%
55
7
668
7223
—
—
—
—
5
0
708
7152
11
13
630
6672
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
N08.39*E11.2 [2000503133]
N08.39*E11.2 [2000503133]
3.4e+00
—
—
—
—
—
3.2e+00
cases:6.09%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:4.84%
controls:0.21%
44
15
679
7215
—
—
—
—
—
31
14
610
6671
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
1.5e+00
1.7e+00
—
—
—
1.8e+00
1.6e+00
cases:9.54%
controls:2.20%
cases:4.56%
controls:0.89%
—
—
—
—
—
—
cases:4.07%
controls:0.67%
cases:15.13%
controls:3.62%
69
159
654
7071
33
64
690
7166
—
—
—
29
48
684
7104
97
242
544
6443
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
27811-9 [3000515]
1.7e+00
—
—
—
—
2.2e+00
2.6e+00
cases:1.24%
controls:0.22%
—
—
—
—
—
—
—
—
cases:1.54%
controls:0.17%
cases:7.64%
controls:0.58%
9
16
714
7214
—
—
—
—
11
12
702
7140
49
39
592
6646
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
2.3e+00
2.4e+00
—
—
—
1.8e+00
3.3e-01
cases:4.43%
controls:0.44%
cases:2.77%
controls:0.25%
—
—
—
—
—
—
cases:2.24%
controls:0.36%
cases:2.50%
controls:1.81%
32
32
691
7198
20
18
703
7212
—
—
—
16
26
697
7126
16
121
625
6564
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
5.8e-01
1.0e+00
1.5e+00
—
1.6e+00
1.0e+00
8.7e-01
cases:7.75%
controls:4.51%
cases:7.05%
controls:2.61%
cases:2.49%
controls:0.58%
—
—
cases:3.60%
controls:0.72%
cases:7.43%
controls:2.84%
cases:13.57%
controls:6.19%
56
326
667
6904
51
189
672
7041
18
42
705
7188
—
26
52
696
7172
53
203
660
6949
87
414
554
6271
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
FB1BD [2001302407]
1.3e+00
1.9e+00
—
1.0e+50
—
2.3e+00
1.1e+00
cases:2.07%
controls:0.59%
cases:1.66%
controls:0.25%
—
—
cases:1.24%
controls:0.00%
—
—
cases:1.12%
controls:0.11%
cases:2.50%
controls:0.85%
15
43
708
7187
12
18
711
7212
—
9
0
714
7230
—
8
8
705
7144
16
57
625
6628
Production of copy from X-ray picture
XX9AW [2001311036]
XX9AW [2001311036]
1.5e+00
2.8e+00
—
—
—
1.9e+00
1.8e+00
cases:0.69%
controls:0.15%
cases:1.52%
controls:0.10%
—
—
—
—
—
—
cases:1.12%
controls:0.17%
cases:2.03%
controls:0.33%
5
11
718
7219
11
7
712
7223
—
—
—
8
12
705
7140
13
22
628
6663
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
8.0e-01
1.8e+00
—
—
—
2.7e+00
2.0e+00
cases:2.63%
controls:1.20%
cases:3.73%
controls:0.61%
—
—
—
—
—
—
cases:8.13%
controls:0.59%
cases:22.93%
controls:4.05%
19
87
704
7143
27
44
696
7186
—
—
—
58
42
655
7110
147
271
494
6414
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
5.1e-01
9.9e-01
1.5e+00
—
7.0e-01
1.6e+00
1.8e+00
cases:12.59%
controls:7.97%
cases:15.35%
controls:6.31%
cases:4.70%
controls:1.05%
—
—
cases:2.08%
controls:1.04%
cases:30.72%
controls:8.07%
cases:72.39%
controls:29.21%
91
576
632
6654
111
456
612
6774
34
76
689
7154
—
15
75
707
7149
219
577
494
6575
464
1953
177
4732
Presence of electronic cardiac devices
Z95.0 [45571406]
Z95.0 [45571406]
1.5e+00
1.5e+00
—
1.0e+50
—
1.9e+00
1.5e+00
cases:2.35%
controls:0.53%
cases:1.94%
controls:0.43%
—
—
cases:0.83%
controls:0.00%
—
—
cases:2.95%
controls:0.45%
cases:3.59%
controls:0.79%
17
38
706
7192
14
31
709
7199
—
6
0
717
7230
—
21
32
692
7120
23
53
618
6632
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
1.1e+00
1.7e+00
1.7e+00
—
1.4e+00
1.9e+00
1.8e+00
cases:8.30%
controls:3.02%
cases:8.30%
controls:1.63%
cases:0.97%
controls:0.18%
—
—
cases:1.11%
controls:0.26%
cases:15.57%
controls:2.71%
cases:42.75%
controls:10.73%
60
218
663
7012
60
118
663
7112
7
13
716
7217
—
8
19
714
7205
111
194
602
6958
274
717
367
5968
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
9.5e-01
1.2e+00
2.5e+00
—
1.5e+00
1.1e+00
7.0e-01
cases:6.36%
controls:2.57%
cases:3.46%
controls:1.11%
cases:1.52%
controls:0.12%
—
—
cases:0.83%
controls:0.19%
cases:4.35%
controls:1.43%
cases:7.18%
controls:3.71%
46
186
677
7044
25
80
698
7150
11
9
712
7221
—
6
14
716
7210
31
102
682
7050
46
248
595
6437
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
24351-9 [3004588]
2.1e+00
1.8e+00
—
—
—
1.8e+00
7.6e-01
cases:2.90%
controls:0.37%
cases:1.52%
controls:0.26%
—
—
—
—
—
—
cases:1.96%
controls:0.32%
cases:4.06%
controls:1.93%
21
27
702
7203
11
19
712
7211
—
—
—
14
23
699
7129
26
129
615
6556
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
216
34
89.70
307.65
19.7
5.9
860.24
107.63
u/ml
—
130
8
218
41
75.30
307.65
2.9
2.6
31.85
42.41
%
2.70
61
22
467
871
13.05
281.75
31.5
6.5
1.11
1.04
mmol/l
3.85
461
813
252
227
16.40
253.85
8.9
4.8
246.85
384.81
mg/l
0.83
241
102
350
626
9.80
209.91
3.6
2.7
30.70
117.49
u/l
0.59
330
533
182
180
13.13
169.34
5.3
3.1
2.58
2.28
index
0.14
116
110
474
1653
6.30
133.23
9.3
4.3
91.96
90.32
%
0.66
467
1628
567
2359
7.23
128.86
11.5
4.0
66.76
81.05
e6/l
0.24
368
1657
654
3132
11.21
126.81
20.2
6.7
56.34
56.98
%
0.67
640
3008
76
19
44.52
126.61
2.9
3.0
0.61
0.60
mmol/l
0.13
76
19
357
1026
5.84
123.63
5.3
3.1
1.91
1.90
e6/l
0.00
179
497
652
3172
10.66
122.29
20.4
6.9
28.70
27.76
%
1.24
641
3032
614
2890
7.98
116.96
23.3
11.2
0.00
0.00
e9/l
0.37
541
2336
592
2764
6.97
111.57
16.6
5.5
36.75
36.07
g/l
2.27
578
2610
254
594
6.02
109.22
30.4
8.9
14.19
9.04
mmol/l
20.81
246
568
118
115
12.04
109.18
1.5
1.3
—
—
—
0
0
118
115
12.04
109.18
1.5
1.3
—
—
—
0
0
658
3430
10.08
108.13
20.1
6.8
1.91
1.93
e9/l
0.13
618
3035
661
3474
10.31
107.24
20.6
7.0
0.20
0.20
e9/l
0.25
619
3049
354
1126
5.15
105.72
5.3
2.9
0.58
1.10
e6/l
2.31
175
595
272
696
5.63
105.33
20.2
3.8
1.30
1.70
mmol/l
1.02
247
597
269
721
5.32
97.84
20.2
3.8
5.99
5.79
kpa
2.10
264
703
670
3730
10.40
97.05
26.1
10.0
3.90
4.10
e9/l
1.66
627
3257
445
1783
4.82
96.87
8.4
3.2
0.20
0.41
e6/l
2.40
344
1304
160
276
7.14
92.95
3.1
1.9
1.41
1.49
g/l
0.49
153
248
117
152
8.97
87.01
13.0
6.5
672.20
369.19
iu/ml
0.57
30
21
50
10
53.59
86.99
3.5
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
130
194
7.93
85.97
6.0
3.1
0.29
0.35
iu/ml
0.64
53
102
467
2067
4.48
85.76
9.4
3.4
28.57
81.52
e6/l
0.96
365
1578
292
935
4.53
83.20
11.8
2.6
22.67
23.54
%
0.58
287
888
85
5
191.94
83.07
15.9
3.8
5.13
5.98
mmol/l
—
85
5
111
143
8.97
83.00
2.7
1.5
155.00
154.87
au/ml
0.00
53
43
307
1073
4.21
76.68
11.0
2.6
12.32
13.68
umol/l
3.09
298
1012
605
3421
5.43
75.61
12.1
7.0
10.85
11.95
umol/l
1.89
594
3276
295
1014
4.20
75.19
11.1
2.6
2.11
2.32
g/l
8.02
284
948
137
251
6.48
74.27
2.3
1.3
—
—
—
0
0
214
618
4.48
68.28
8.5
3.3
6.55
4.56
kpa
7.81
206
603
317
1212
3.85
68.18
6.5
4.0
182.24
476.18
ng/l
1.95
270
942
105
159
7.54
68.02
1.7
1.3
223.39
254.61
u/ml
0.45
77
93
293
1091
3.81
65.03
8.7
3.9
0.81
0.82
mmol/l
0.57
283
1042
78
88
9.80
64.28
2.3
2.3
49.07
64.41
iu/ml
—
7
8
331
1403
3.48
59.02
8.0
2.7
3.94
4.68
e6/l
0.51
305
1286
611
3822
4.62
58.09
16.3
5.5
6.62
6.70
mmol/l
0.42
601
3648
45
24
19.91
57.43
1.1
1.0
—
—
—
0
0
74
92
8.84
56.44
7.4
6.1
10.83
10.62
mg/l
0.13
67
86
696
4892
9.60
55.32
21.9
8.4
85.41
80.22
u/l
2.06
683
4670
144
370
4.60
52.42
2.4
1.6
—
—
—
0
0
342
1586
3.17
50.79
5.3
2.5
—
—
—
0
0
43
27
16.86
50.72
32.7
42.9
119.23
113.23
ug/l
0.15
30
22
54
51
11.35
50.26
6.0
3.8
0.52
0.86
index
2.37
54
51
268
1084
3.32
50.10
3.2
1.9
—
—
—
0
0
217
771
3.58
49.92
2.9
1.8
—
—
—
0
0
59
67
9.49
48.15
5.9
3.7
15.04
12.88
index
0.71
54
51
221
820
3.43
47.18
2.9
1.8
—
—
—
0
0
63
89
7.65
43.00
1.2
1.1
—
—
—
0
0
95
204
5.20
42.60
2.9
2.5
9.88
10.53
g/l
0.69
90
186
209
794
3.28
42.42
3.9
3.1
5.98
8.08
umol/l
1.18
188
719
100
227
4.94
42.01
3.1
2.4
2.93
2.96
g/l
0.08
95
210
143
442
3.78
39.86
3.6
3.1
542.49
186.98
ng/l
2.58
137
403
100
238
4.71
39.60
3.1
2.4
3.52
3.84
g/l
1.06
95
221
100
238
4.71
39.60
3.1
2.4
3.96
4.27
g/l
2.02
95
221
100
238
4.71
39.60
3.1
2.4
7.37
7.21
g/l
0.41
95
221
503
3176
2.87
38.35
38.8
7.9
1.20
1.21
mmol/l
1.62
486
2778
37
30
12.94
37.78
9.2
1.8
345.14
97.22
ng/l
5.01
37
30
466
2845
2.76
37.68
29.5
7.3
1.20
1.21
mmol/l
1.18
450
2648
99
243
4.55
37.67
3.1
2.6
93.85
93.36
%
0.07
99
237
460
2804
2.72
37.08
4.7
2.5
76.02
75.50
nmol/l
0.14
436
2549
155
543
3.35
35.36
13.5
2.8
65.09
70.14
e9/l
1.14
87
405
697
5465
6.76
34.95
70.6
19.8
330.98
333.58
g/l
9.88
697
5445
58
96
6.48
34.11
1.6
1.4
—
—
—
0
0
89
218
4.51
33.86
1.1
1.3
99.95
205.55
miu/ml
2.10
20
103
167
627
3.16
33.85
2.8
2.5
0.24
0.21
g/l
4.17
156
583
137
456
3.47
33.82
2.1
1.6
—
—
—
0
0
47
64
7.78
33.00
1.0
1.0
—
—
—
0
0
505
3337
2.66
32.70
6.4
3.7
0.00
0.00
estimate
0.50
33
667
43
56
8.10
31.33
1.9
1.6
—
—
—
0
0
35
35
10.45
31.15
4.6
3.5
773.51
625.43
u/ml
0.37
35
35
505
3379
2.59
31.13
6.4
3.7
35.84
2.41
estimate
0.45
37
675
506
3392
2.59
31.02
6.4
3.8
0.00
0.51
estimate
0.53
32
616
386
2313
2.41
29.92
9.0
3.6
7.42
8.23
mmol/l
2.57
360
1983
155
597
3.03
29.76
4.0
3.4
—
—
—
0
0
82
208
4.31
29.73
2.8
2.7
0.41
1.02
g/l
1.04
77
187
101
303
3.71
29.00
6.4
1.9
—
—
—
0
0
113
370
3.43
28.38
6.0
2.0
—
—
—
0
0
41
59
7.30
27.39
5.1
4.1
—
—
—
0
0
422
2713
2.31
26.71
2.5
2.0
91.44
95.95
pmol/l
1.30
201
1472
444
2960
2.27
25.15
10.0
3.0
195.75
139.28
ug/l
3.46
432
2783
284
1588
2.29
24.60
5.3
2.2
2.18
2.87
mg/l
7.14
256
1383
72
192
4.05
24.33
1.5
1.2
—
—
—
0
0
170
774
2.56
23.19
12.7
9.9
5.12
5.10
kpa
0.10
164
748
170
775
2.55
23.12
12.7
9.8
11.56
12.40
kpa
1.45
164
752
167
760
2.55
22.76
12.6
10.0
-0.98
0.88
mmol/l
5.57
146
639
414
2754
2.16
22.64
2.6
2.0
1.45
1.43
mmol/l
0.25
398
2361
254
1398
2.25
22.46
2.2
1.4
2.17
2.55
g/l
2.42
133
872
55
132
4.42
21.32
2.3
1.4
—
—
—
0
0
121
497
2.72
20.12
2.8
2.7
63.63
67.00
g/l
4.65
115
465
123
511
2.69
20.00
4.1
2.6
64.31
69.73
ml/min/173m2
0.45
34
219
290
1745
2.10
19.94
1.9
1.7
19.81
20.15
nmol/l
0.17
256
1499
421
2912
2.05
19.64
28.3
12.9
1.30
1.22
inr
2.07
350
2383
703
6071
4.99
19.43
47.7
14.6
72.40
84.02
ml/min/173m2
16.69
691
5611
63
179
3.76
19.43
4.1
3.2
1.44
2.59
ratio
1.26
39
98
72
233
3.32
18.21
2.4
1.6
—
—
—
0
0
592
4725
2.32
18.06
7.1
4.2
15.33
10.93
mm/h
7.49
571
4443
284
1747
2.02
17.96
6.7
2.8
382.77
350.95
umol/l
5.67
269
1572
715
6321
6.65
17.63
49.6
15.4
25.64
23.90
mg/l
0.93
637
5180
107
443
2.66
17.41
8.3
3.2
114.18
132.22
g/l
11.42
107
433
29
47
6.38
17.31
2.1
2.2
760.04
496.15
e6/l
1.32
24
39
121
535
2.51
17.19
3.2
2.5
10.41
7.96
ug/l
0.29
101
488
211
1183
2.10
17.03
4.8
3.0
2.47
2.45
mmol/l
1.55
188
1069
54
152
3.76
16.86
1.8
1.4
—
—
—
0
0
97
390
2.71
16.70
7.7
2.6
0.55
0.62
%
1.79
97
390
46
117
4.13
16.52
1.6
1.3
2.76
5.05
u/ml
0.51
17
39
40
94
4.44
15.90
2.4
1.4
—
—
—
0
0
83
1822
0.39
15.55
6.8
3.9
0.00
0.01
estimate
1.15
33
618
244
1498
1.94
14.96
2.4
1.8
1.46
1.22
mg/l
0.48
193
1173
305
2017
1.88
14.88
3.2
2.2
168.69
267.59
u/l
1.24
299
1926
174
951
2.09
14.78
1.7
1.7
762.42
1189.25
nmol/l
11.25
131
747
22
33
6.84
14.09
1.3
1.7
—
—
—
0
0
22
33
6.84
14.09
1.3
1.7
—
—
—
0
0
43
117
3.84
14.09
1.7
1.3
5.35
3.94
u/ml
0.24
20
54
314
2127
1.83
13.95
9.0
3.6
156.88
59.10
mg/l
3.49
261
1392
153
2538
0.50
13.16
5.3
3.6
0.00
0.02
estimate
1.22
29
564
128
653
2.16
12.87
15.7
10.9
111.27
123.29
g/l
9.27
128
642
63
232
2.88
12.74
5.2
1.9
—
—
—
0
0
678
6004
2.75
12.30
12.6
6.3
38.72
39.30
mmol/mol
0.72
664
5684
23
42
5.62
12.18
2.1
2.1
—
—
—
0
0
53
185
3.01
11.79
1.3
1.1
—
—
—
0
0
53
186
2.99
11.68
1.3
1.1
—
—
—
0
0
516
4176
1.80
11.57
4.0
3.1
—
—
—
0
0
394
2961
1.72
11.46
5.0
2.9
—
—
estimate
—
0
0
57
211
2.85
11.42
5.6
1.8
—
—
—
0
0
74
316
2.49
11.19
1.7
1.4
—
—
—
0
0
306
2160
1.72
11.10
9.6
4.3
34.41
9.97
mg/mmol
4.53
244
1368
268
1828
1.74
10.98
4.7
3.3
7593.34
1180.94
ng/l
6.07
248
1537
19
16
12.16
10.88
8.0
8.8
10.54
4.81
kpa
6.01
19
16
23
47
5.02
10.79
1.1
1.0
—
—
—
0
0
25
57
4.51
10.33
1.6
1.4
26430.13
25476.72
e6/l
0.02
16
29
673
6034
2.43
10.16
7.2
4.3
1.41
1.35
mmol/l
1.29
655
5634
721
6716
5.89
10.04
32.0
11.9
27.22
28.52
u/l
1.42
715
6565
296
2114
1.67
10.00
7.2
3.6
2.35
2.36
mmol/l
0.27
271
1936
26
64
4.18
9.77
1.8
1.6
—
—
—
0
0
50
189
2.77
9.65
2.4
1.5
—
—
—
0
0
22
49
4.60
9.36
2.0
3.0
1614.55
1188.65
mg
0.32
22
49
726
6942
6.59
9.10
76.1
23.3
4.31
4.58
e12/l
27.71
720
6817
21
31
6.94
8.89
1.3
1.7
2.53
2.01
umol/l
1.29
21
26
21
47
4.57
8.88
1.2
2.3
209.60
206.68
e6/l
0.02
15
41
21
708
0.28
8.84
7.1
7.0
—
—
—
0
0
134
791
1.85
8.72
5.1
2.0
—
—
—
0
0
14
10
14.24
8.71
4.4
1.2
92.29
96.40
%
—
14
10
27
785
0.32
8.61
5.0
4.7
33.00
31.04
%
0.46
17
536
697
6431
2.75
8.44
61.4
18.3
4.03
3.98
mmol/l
3.26
690
6323
124
723
1.86
8.37
4.7
1.9
—
—
—
0
0
69
329
2.21
8.13
1.5
1.3
—
—
—
0
0
688
6328
2.45
8.05
8.6
5.1
4.38
4.64
mmol/l
9.58
674
5969
24
65
3.78
7.96
1.6
1.4
913.33
2053.98
e6/l
1.65
15
43
20
33
6.20
7.89
1.5
2.0
—
—
—
0
0
20
33
6.20
7.89
1.5
2.0
—
—
—
0
0
20
33
6.20
7.89
1.5
2.0
—
—
—
0
0
20
33
6.20
7.89
1.5
2.0
—
—
—
0
0
32
107
3.08
7.70
1.1
1.2
118.72
114.52
%
0.29
32
100
685
6310
2.33
7.61
8.6
5.0
1.34
1.41
mmol/l
5.07
671
5923
13
11
12.01
7.60
5.5
5.6
2.02
2.66
mg/l
0.37
13
11
73
366
2.10
7.58
1.8
1.8
0.28
0.34
mg/l
0.51
37
178
50
214
2.43
7.55
1.3
1.3
—
—
—
0
0
21
54
3.97
7.47
1.2
1.1
—
—
—
0
0
33
115
2.96
7.41
1.1
1.1
—
—
—
0
0
692
6414
2.44
7.37
9.3
5.7
2.57
2.74
mmol/l
5.83
674
6027
21
55
3.90
7.29
1.2
1.1
—
—
—
0
0
118
1846
0.57
7.23
4.6
3.2
0.00
0.06
estimate
0.63
28
544
24
70
3.51
7.17
1.2
1.2
—
—
—
0
0
21
56
3.83
7.12
1.2
1.1
—
—
—
0
0
21
56
3.83
7.12
1.2
1.1
—
—
—
0
0
10
6
16.88
6.76
2.2
1.3
—
—
—
0
0
45
198
2.36
6.42
2.5
1.6
—
—
—
0
0
71
1247
0.52
6.38
1.5
1.7
489.31
19677237.14
pmol/l
0.92
65
1052
50
232
2.24
6.31
2.1
2.8
—
—
—
0
0
28
98
2.93
6.27
2.7
1.5
—
—
—
0
0
93
1498
0.57
6.19
7.9
3.8
1.02
1.02
kg/l
0.89
66
982
21
62
3.46
6.18
1.2
1.1
—
—
—
0
0
22
67
3.35
6.18
1.2
1.2
—
—
—
0
0
39
167
2.41
5.92
2.4
1.6
17898.85
10511.07
e6/l
0.73
20
121
21
64
3.35
5.90
1.5
1.7
—
—
—
0
0
21
64
3.35
5.90
1.5
1.7
—
—
—
0
0
21
64
3.35
5.90
1.5
1.7
—
—
—
0
0
59
301
2.04
5.87
39.7
3.4
23.74
25.09
mmol/l
2.41
59
293
40
174
2.37
5.87
1.5
1.7
—
—
—
0
0
10
409
0.23
5.83
3.4
8.3
24.11
24.48
mmol/l
—
10
393
23
75
3.13
5.81
1.3
1.2
—
—
—
0
0
25
86
2.97
5.78
1.1
1.1
93.12
98.05
%
0.36
25
80
47
221
2.20
5.76
1.2
1.5
0.08
0.06
iu/ml
0.13
12
36
43
197
2.26
5.62
1.5
1.5
230.13
293.76
ug/g
1.30
36
117
40
816
0.46
5.57
1.4
2.0
3.44
3.70
ratio
0.79
29
661
17
47
3.68
5.51
1.0
1.1
16.68
6.54
iu/ml
—
5
15
210
1550
1.50
5.46
1.3
1.3
0.74
1.21
u/ml
1.15
18
432
15
29
5.26
5.41
3.3
1.7
136.60
74.47
ug/l
0.48
15
29
263
2040
1.45
5.29
6.1
2.8
64.58
64.71
u/l
0.01
257
1930
31
127
2.50
5.19
2.7
1.8
—
—
—
0
0
24
87
2.82
5.08
1.5
1.3
—
—
—
0
0
24
88
2.79
4.98
1.5
1.4
—
—
—
0
0
24
88
2.79
4.98
1.5
1.4
—
—
—
0
0
188
2467
0.68
4.88
4.5
3.7
110.66
62.81
ng/l
0.35
124
1734
6
254
0.23
4.86
1.2
1.7
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
13
26
5.07
4.64
2.5
1.5
201.46
149.65
%
0.96
13
26
12
22
5.53
4.61
1.7
1.4
—
—
—
0
0
14
32
4.44
4.45
7.4
3.1
63.21
73.92
mg/l
0.31
14
24
9
12
7.58
4.36
1.3
1.2
—
—
—
0
0
45
236
1.97
4.21
1.6
1.7
17.88
9.53
u/ml
—
8
58
8
10
8.07
4.07
1.8
1.8
—
—
—
0
0
32
150
2.19
4.02
1.5
1.6
—
—
—
0
0
68
414
1.71
3.96
10.5
4.4
2.16
1.68
mmol/l
0.46
40
306
34
165
2.11
3.92
1.2
1.2
—
—
—
0
0
14
43
3.30
3.92
2.1
3.6
103.86
99.49
%
0.17
14
43
51
287
1.84
3.88
2.4
2.0
16.15
7.90
iu/ml
—
6
72
10
19
5.32
3.83
1.4
1.8
—
—
—
0
0
30
592
0.49
3.81
1.3
1.7
3.38
3.53
mmol/l
0.23
18
429
27
122
2.26
3.71
1.0
1.1
—
2.12
—
0
8
32
157
2.09
3.61
2.1
1.4
—
—
—
0
0
7
10
7.05
3.37
1.0
1.1
—
—
—
0
0
14
48
2.95
3.31
1.9
1.2
—
—
—
0
0
13
43
3.06
3.26
1.2
1.2
—
—
—
0
0
45
260
1.78
3.18
1.9
2.0
3.84
4.35
mg/l
0.14
39
195
15
56
2.71
3.07
1.8
1.3
2.96
3.56
ug/l
0.28
15
48
7
12
5.88
3.02
1.3
1.3
1.14
1.17
mmol/l
—
7
12
506
4604
1.32
3.01
4.4
3.5
62.67
50.89
u/l
1.93
493
4377
12
37
3.28
2.94
4.3
1.6
—
—
—
0
0
5
6
8.38
2.75
1.4
2.2
—
—
—
0
0
5
6
8.38
2.75
1.6
1.5
90.60
40.00
umol/l
—
5
6
26
132
2.01
2.73
2.3
1.4
—
—
—
0
0
6
10
6.04
2.70
1.2
1.3
—
—
—
0
0
93
668
1.45
2.70
2.3
2.1
326.78
371.43
nmol/l
1.50
86
632
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
20
4.03
2.57
1.0
1.1
97.88
120.25
%
—
8
20
7
189
0.36
2.44
1.0
1.1
—
9.51
—
0
25
15
64
2.37
2.40
1.1
1.1
—
—
—
0
0
9
27
3.36
2.40
3.3
1.7
—
—
—
0
0
74
525
1.46
2.31
1.9
1.5
—
—
—
0
0
10
34
2.97
2.28
1.3
1.1
—
—
—
0
0
27
149
1.84
2.27
2.3
2.1
130.36
127.53
g/l
0.15
11
116
124
971
1.33
2.17
2.2
2.0
1.61
1.49
%
1.30
108
861
31
184
1.72
2.07
2.3
1.3
—
—
—
0
0
7
21
3.36
1.97
1.1
1.1
—
—
—
0
0
15
71
2.14
1.93
1.9
2.1
—
—
—
0
0
635
6083
1.33
1.88
7.9
5.0
6.10
5.98
mmol/l
1.14
607
5661
15
286
0.51
1.81
1.1
1.1
1.44
1.48
g/l
0.25
15
286
231
2633
0.82
1.71
4.4
4.9
15.13
2.11
ug/l
0.48
213
2406
16
82
1.97
1.70
1.9
2.0
—
—
—
0
0
16
291
0.54
1.68
5.7
6.7
1.82
1.61
%
0.18
16
277
7
25
2.82
1.65
1.0
1.2
—
—
—
0
0
16
84
1.92
1.60
1.4
1.4
—
—
—
0
0
16
84
1.92
1.60
1.4
1.4
—
—
—
0
0
16
85
1.90
1.56
1.4
1.4
—
—
—
0
0
13
66
1.99
1.44
1.2
1.0
309.23
278.10
mg/l
0.63
13
59
23
141
1.65
1.43
1.2
1.3
—
—
—
0
0
10
46
2.19
1.40
1.3
1.5
—
—
—
0
0
12
60
2.02
1.38
1.8
2.3
—
—
—
0
0
0
38
0.00
1.34
0.0
1.3
—
—
—
0
0
105
869
1.24
1.24
2.7
2.7
162.94
123.58
ug/g
0.51
89
718
599
5769
1.21
1.21
5.9
5.0
1.87
1.88
mu/l
0.12
568
5371
8
38
2.12
1.18
1.3
1.1
609.37
201.94
iu/ml
—
8
38
8
39
2.06
1.15
1.1
1.3
—
60.00
—
0
6
0
35
0.00
1.15
0.0
2.1
—
2.31
—
0
8
11
58
1.91
1.12
1.7
1.2
7.83
2.37
u/ml
0.39
11
33
78
632
1.26
1.12
4.7
4.7
5.78
17.28
ug/l
0.83
60
522
7
32
2.20
1.08
1.1
1.2
—
—
—
0
0
7
32
2.20
1.08
1.1
1.2
—
—
—
0
0
5
22
2.28
1.03
1.6
1.0
—
—
—
0
0
501
4778
1.15
1.03
4.4
4.1
14.08
14.76
pmol/l
8.74
478
4402
10
53
1.90
1.01
1.1
1.2
80.30
103.45
pmol/l
—
10
53
87
723
1.23
1.01
1.3
1.5
—
—
—
0
0
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
6
27
2.23
0.93
1.2
2.1
—
—
—
0
0
6
27
2.23
0.93
1.2
2.1
—
—
—
0
0
6
27
2.23
0.93
1.2
1.2
—
—
—
0
0
6
27
2.23
0.93
1.2
1.2
—
—
—
0
0
19
126
1.52
0.92
1.1
1.1
—
16.48
—
0
39
27
195
1.40
0.87
1.4
1.3
—
—
—
0
0
12
72
1.68
0.85
3.5
3.2
6.01
5.67
nmol/l
0.04
12
72
35
268
1.32
0.81
1.7
1.4
24.01
22.05
iu/l
0.13
28
219
26
350
0.73
0.80
12.7
3.8
50.51
49.29
%
0.08
26
345
19
132
1.45
0.76
1.2
1.3
—
430.00
—
0
10
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
8
132
0.60
0.74
2.5
1.5
—
—
—
0
0
9
55
1.64
0.73
13.1
1.6
—
—
—
0
0
6
106
0.56
0.73
3.0
1.5
—
—
—
0
0
22
295
0.74
0.68
1.5
1.1
0.91
0.90
g/l
0.02
22
295
21
156
1.36
0.61
2.1
1.3
15.06
14.15
e6/l
0.02
16
114
0
20
0.00
0.60
0.0
2.2
—
41.71
—
0
20
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
10
64
1.57
0.59
1.1
1.1
—
72.20
—
0
5
23
175
1.32
0.59
1.4
1.3
742.17
477.40
mg/l
0.62
23
167
197
2115
0.91
0.56
3.2
4.1
27.54
21.26
%
2.40
65
892
21
159
1.33
0.56
2.2
1.4
311.06
1369.08
e6/l
0.60
16
120
8
123
0.65
0.55
4.6
4.2
236.38
375.36
u/ml
—
8
116
24
186
1.30
0.55
2.5
2.4
854.46
5078.35
u/l
—
7
70
10
147
0.68
0.54
1.3
1.5
—
—
—
0
0
109
1196
0.90
0.47
1.4
1.3
34.23
29.34
iu/ml
0.11
31
381
31
257
1.22
0.43
2.5
3.0
30.54
44.03
u/ml
0.45
31
248
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
0.56
—
0
10
5
34
1.47
0.40
1.8
1.8
0.94
1.34
nmol/l
—
5
25
0
18
0.00
0.40
0.0
1.9
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
101
1099
0.91
0.39
1.4
1.3
6.68
10.28
u/ml
0.37
21
449
9
68
1.33
0.37
1.2
1.5
—
—
—
0
0
5
37
1.35
0.37
3.6
2.3
160.00
127.25
nmol/l
—
5
32
5
77
0.65
0.36
3.2
2.8
1.25
1.19
mmol/l
—
5
77
5
79
0.63
0.35
3.2
2.8
106.80
105.19
mmol/l
—
5
79
51
456
1.13
0.32
2.8
2.5
9.68
15.25
au/ml
—
5
48
10
131
0.76
0.31
1.7
1.6
85.06
55.89
ug/l
—
10
111
7
55
1.28
0.30
1.4
1.5
229.29
79.45
umol/l
—
7
55
7
56
1.25
0.29
1.3
1.4
—
—
—
0
0
33
288
1.15
0.29
13.2
4.5
23.95
24.82
mmol/l
1.08
33
272
28
241
1.17
0.29
1.5
1.7
352.43
283.47
mu/l
0.93
28
224
9
118
0.76
0.27
1.6
1.5
—
—
—
0
0
15
125
1.20
0.22
16.3
3.6
15.77
9.44
pmol/l
1.03
15
125
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
10.5
—
10.94
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
2.0
—
2.74
—
0
5
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
89
841
1.07
0.20
2.4
2.5
14.35
13.71
nmol/l
0.27
81
779
6
49
1.23
0.20
1.3
1.1
330.00
276.55
mg/l
—
6
42
6
51
1.18
0.19
1.3
1.1
—
—
—
0
0
10
81
1.24
0.19
1.2
1.3
—
—
—
0
0
9
82
1.10
0.15
1.1
1.1
—
—
—
0
0
26
285
0.91
0.14
7.5
3.6
1.01
1.02
ratio
3.00
20
270
37
346
1.07
0.12
1.7
1.9
51.46
37.20
nmol/l
1.41
37
337
35
374
0.93
0.12
3.8
3.6
4.34
4.63
pmol/l
1.09
30
332
5
47
1.06
0.09
1.4
1.1
—
—
—
0
0
17
155
1.10
0.09
1.3
1.2
3.81
3.69
mmol/l
0.17
17
147
5
65
0.77
0.08
1.2
1.1
—
—
—
0
0
6
75
0.80
0.07
1.2
1.1
—
—
—
0
0
15
163
0.92
0.07
2.3
1.9
5.47
4.21
iu/l
—
6
61
9
101
0.89
0.06
1.7
1.6
—
—
—
0
0
11
100
1.10
0.05
1.0
1.0
—
—
—
0
0
162
1608
1.01
0.02
2.7
3.0
0.77
0.71
ug/l
0.19
116
921
41
419
0.98
0.02
1.1
1.2
95.59
131.07
u/ml
—
7
171
14
145
0.96
0.00
1.1
1.6
—
—
—
0
0
34
341
1.00
0.00
1.1
1.0
—
—
—
0
0
7
70
1.00
0.00
4.3
2.8
19.71
19.53
nmol/l
—
7
64
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
2.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
50
1.00
-0.00
4.4
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
5.83
—
0
6
0
5
0.00
-0.00
0.0
5.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
6
59
1.02
-0.00
2.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_NEED_IMMUNI_OTH_SINGLE_VIRAL_DISEA – Need for immunization against other single viral diseases
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).